V ienna Life Science Report Sector Survey: Facts and ... - LISAvienna

Preface 

By building on more than a century 

of experience in science and medical 

research, Vienna has advanced to 

become one of the leading life science 

hubs in Europe in the past 20 years. 

This success is based on outstanding 

research performed by the scientists at 

the city’s universities and research institutions, 

on the entrepreneurial spirit 

and innovations developed by dynamic 

life science start-ups and established 

companies as well as on the financial 

and strategic investments made by the 

City of Vienna and the federal government. 

Over the last 10 years, the Austrian 

national funding bank, austria wirtschaftsservice 

(aws), has awarded 

roughly 430 million euros in grants, 

loans and guarantees to life science 

companies. Since 1998, the ZIT – The 

Technology Agency of the City of Vienna, 

the Vienna Science and Technology 

Fund and the Vienna Business 

Agency have also funded life science 

projects to the tune of 117 million euros. 

The custom-tailored funding and 

service instruments of these and other 

funding agencies such as FFG and INiTS, 

leveraged a multitude of private in- 

Peter Halwachs and Johannes Sarx 

LISAvienna Executive Board 

vestments and cooperation with large 

international enterprises. Moreover, a 

perfect interaction between universities, 

research institutes, and industry 

resulted in a knowledge and technology 

transfer that has been crucial for 

successful company developments. 

Since 2002, Life Science Austria Vienna 

(LISAvienna) has been successfully 

operating as a life science cluster 

organization providing information and 

advice for potential start-ups and new 

arrivals, as well as for life science businesses 

in general. The five core activities 

of LISAvienna include consulting, 

marketing, qualification, networking, 

and the compilation of life science related 

strategic studies. 

With this report LISAvienna aims to 

depict Vienna as a leading European 

research and business location in the 

field of the life sciences. The report 

provides the latest facts and figures 

which underscore the significance 

of the life sciences in Vienna. And is 

the first statistical survey according 

to the internationally accepted OECD 

and GMDN standards in Austria. In 

2010, the Life Science Cluster Vienna 

counted more than 400 companies of 

which 99 were biotech and medtech 

companies that were producing or 

developing products and processes 

in these fields. These core enterprises 

employed more than 9,000 people and 

generated 1.7 billion euros in sales in 

2010. Apart from these business activities, 

basic research is performed 

by 22 research institutions, which employ 

over 14,000 people. The survey is 

complemented by success stories of 

outstanding companies and provides 

an insight into the first-rate academic 

landscape in Vienna. It also includes 

an extensive company directory to encourage 

you to discover more about 

Vienna's scientific and business potential. 

Finally, we invite you to join BIO-Europe 

2013 in Vienna, Europe’s largest 

partnering conference serving the global 

biotech industry. 

We thank all those who contributed to 

this report and hope you enjoy reading 

it. 

3

intro 

Content 

Preface 3 

Life Sciences in Vienna at a Glance 6 

Vienna – Life Science Hub at the Heart of Europe 8 

Academia 

Industry 

Map: Academic Hot Spots in Vienna 14 

Spotlight on Research and Teaching 16 

Academic Directory 18 

Map: Life Science Companies in Vienna 28 

Biotechnology in Vienna – Facts & Figures 31 

Biotech Success Stories 34 

Medtech in Vienna – Facts & Figures 39 

Medtech Success Stories 42 

Company Directory 47 

Glossary 151 

Methodology 153 

Imprint 155 

5

6 

Life sciences in Vienna at a Glance 

Companies 

Vienna’s share in austrian Life sciences – Dedicated & active 

Vienna 

rest of austria 

Employees in 

dedicated & active 

life science companies: 

9,159 

employees in biotech companies: 7,498 

employees in medtech companies: 1,661 

Companies 

58% 

biotech 

37% 63% 

medtech 

Dedicated & active 

life science companies: 99 

Biotech companies: 61 

medtech companies: 38 

Life science related companies: 

305 

total number of 


404 

42% 

Revenues in dedicated & active 


eUr 1,718 m 

revenues in biotech companies: eUr 883 million 

revenues in medtech companies: eUr 835 million 

employees 

55% 

biotech 

27% 

medtech 

73% 

45% 

ComPanies 

Life Science Facts & Figures 

Vienna has a long tradition of excellent 

scientific and medical research. 

The traditions of the Second Vienna 

Medical School are manifested today 

in a focus on medical biotechnology 

centering on anti-infectives, immunology, 

oncology, production technologies 

and vaccinations. Another core area is 

medical technology, in particular electromechanical 

medical devices and 

software for medicine, telemedicine 

and e-health. 

Companies 

A recent study revealed that Vienna is 

currently home to more than 400 life 

science companies. Of these, 99 are 

considered to be active and dedicated 

biotechnology and medical technology 

companies, according to the OECD and 

GMDN criteria (see definition p. 151). 

Fig. 1: Total number of life science companies, 

employees (headcount) and revenues in the Viennese 

life science scene (2010). 

turnover 

29% 71% 

biotech 

52% 

medtech 

Fig. 2: Total share of Vienna’s companies in Austria’s life science industry in terms of company number, employees and turnover (2010). 

48%

aCaDemia 

These employ over 9,000 staff. The active 

and dedicated biotechnology and 

medical technology companies generated 

revenue to the tune of 1.7 billion 

euros in the year 2010. As expected, 

the research & development (R&D) to 

sales ratio in dedicated biotech companies 

of 151% is substantially higher 

than the R&D to sales ratio of dedicated 

medtech companies which is 26%. 

The difference is due to the intensive 

academia 

The basis for successful in-house 

company research often originates in 

outstanding academic research. In life 

science research and education, Vienna 

ranks top in Austria: Twenty-two research 

institutions are located in Vienna. 

Five universities, two applied universities, 

ten non-profit research institutes 

and five other organizations perform 

noteworthy research and teaching activities 

in the life sciences. With more 

than 35,000 students in the life sciences 

alone, Vienna educates more young 

scientists than any other city in Austria. 

Altogether, the 22 research institutions 

employ over 14,000 people. Numerous 

publications (5,182 in 2010) in international 

journals are evidence of the excellent 

research activities. 

Fig. 3: Life science research in Vienna: number 

of institutions, employees (headcount), students 

and publications 

research and the long development 

times that are necessary for biotechnological 

products. Furthermore, the 

biotech companies are very young 

compared to the medtech companies. 

The medtech companies, with an average 

age of 17.9 years, are more than 

twice as old as the average biotech 

company, which is 7.1 years. Vienna’s 

share in the Austrian life sciences is remarkable: 

58% of all Austrian biotech- 

total number of life science 

research institutions: 

22 

Universities: 5 

applied universities: 2 

non-profit research institutions: 10 

other: 5 


publications: 

5,182 

nology companies are located in Vienna. 

They account for 29% of the total revenue 

and employ 55% of all staff working 

in the Austrian biotech industry. 

Also, in the area of medical technology 

many companies are located in Vienna: 

37% of all Austrian firms are in the 

capital city. They generate 52% of the 

total revenue with 27% of the employees 

working in the medical technology 

branch in Austria. 


employees in 

research institutions: 

14,102 

total number of life science students: 

35,288 

7

8 

Vienna – Life science Hub at the Heart of europe 

Since the European Union has expanded 

eastwards, Vienna has reinforced 

its role as a business, academic and 

cultural hub for Central and Eastern 

Europe. With a highly qualified multinational 

workforce, a superb infrastructure 

and public service, Vienna is an 

Factbox Vienna 

› Austria's capital city 

› Area 415 km 2 

› Population 1.7 million 

(Metro area 2.4 million, 

Austria 8.4 million) 

› Population growth 

2000 – 2010 + 10 % 

› GDP per capita 44,700 euros 

(Austria 34,000 euros) 

ideal location for investments in the life 

sciences as well as for collaborations 

with researchers at first-rate academic 

institutions and hospitals. 

Good Quality of Life 

Vienna has always been known through- 

out the world as a city defined by its 

long history of art and culture. In addition 

to its numerous cultural offerings, 

the city is full of inherent natural beauty. 

Vienna is consistently ranked at the 

top of the list in international surveys 

on the quality of life. According to the 

2010 Mercer Quality of Living Survey, 

in which 221 cities were evaluated on 

the basis of personal safety, political 

and economic stability, healthcare, 

educational and recreational opportunities, 

Vienna was once again rated as 

the city with the world’s best quality 

of life. 

At the Heart of Europe 

introDUCtion 

Over the past 20 years, Vienna has 

grown into the political and economic 

center of Central Europe. The city is an 

ideal business location: whether as an 

east-west interface or as the headquarters 

for a company’s Central and Eastern 

European (CEE) business activities. 

Vienna is home to the CEE headquarters 

of some 300 international corporations 

such as Eli Lilly and Siemens. Vienna's 

international airport offers more nonstop 

flights to CEE destinations than any 

other airport. As a Danube port, a major 

rail hub and with its well-developed road 

systems and excellent public transport 

system Vienna’s infrastructure is ideal. 

Welcoming Business Environment 

Companies that settle in Vienna appreciate 

not only the proximity to the

XXXXX 

austria wirtschaftsservice 

We bring Life 

Sciences to Life. 

50.000 Euro 

Temporary Management: 

Financing of complementary 

management expertise 

awsg.at/maz 

200.000 Euro 

PreSeed: 

Financing of the 

pre-start phase 

preseed.at 

1.000.000 Euro 

Seedfi nancing: 

Financing of the start-up phase 

of high-tech companies 

seedfi nancing.at 

Wanted: Innovative products and procedures in the life sciences sector. What we offer: Optimal fi nancing mix for 

maximum growth effects. aws business development bank supports the establishment and development of hightech 

companies with fi nancing and targeted consultation, thereby strengthening Austria as a business location. 

For details and conditions of fi nancing please visit www.awsg.at 

www.awsg.at

10 

growth markets of the neighboring 

countries in Eastern Europe, but also 

the attractive tax system with a low 

corporate tax of 25% and the op tion 

of group taxation. Group taxation reductions 

allow international groups 

and companies with Austrian subsidiaries 

to transfer profits and losses 

between group subsidiaries and to reduce 

the overall corporate tax liability 

to a minimum. In addition to low rates 

of tax, there are generous deductions 

and exemptions for investments in 

research and education. R&D allowances 

of up to 25% (in special cases 

up to 35%) are available on research 

and development expenditures. The 

Austrian tax system grants a tax premium 

for research amounting to 10%. 

For the education and training of employees 

employers can claim a tax allowance 

of 20%. 

Dynamic Start-ups and 

Global Players 

The growing importance of Vienna as 

a life science cluster is reflected in the 

numerous start-ups, the emergence 

of new research centers and the establishment 

of subsidiaries by leading 

global life science companies. Numerous 

international corporations have a 

notable presence in Vienna. In addition 

to pursuing their sales activities in 

Central and Eastern Europe from their 

Vienna base, some of these subsidiaries 

also operate research and production 

facilities here. 

In 1997, Austria became the Baxter 

Group‘s biggest location outside America. 

Around 3,800 people are currently 

employed in production, research (biosciences) 

and marketing organizations 

in Vienna and the surrounding area. 

Their activities include the development 

and production of blood plasma 

compounds, recombinant coagulation 

factors, fibrin sealants and vaccines 

such as the FSME vaccine, which protects 

against tick-borne encephalitis. 

In 2008, Baxter also founded Baxter 

Innovation GmbH, in which all Austrian 

and international R&D is clustered. 

The Boehringer Ingelheim Regional 

Center Vienna (RCV) is responsible for 

the pharmaceutical business in more 

than 30 Central and Eastern European 

countries and manages the entire clinical 

research of this region. The company 

is also the dedicated oncology 

research center of the international 

group as well as an important site for 

biopharmaceutical development and 

production. With more than 1,100 employees 

and research expenses of 143 

million euros in 2010, the Boehringer 

Ingelheim RCV ranks among the top 

companies and employers of the Austrian 

life science sector. 

Table 1 

Quality of Life – top 10 

introDUCtion 

The Austrian subsidy of Eli Lilly was 

founded in June 1976. Altogether almost 

190 employees work in the different 

branches in Vienna. Since 1997, 

Vienna has been the company’s headquarters 

for CEE (Central and Eastern 

Europe), for parts of the management 

of the EMS region (European Mid Size) 

and AMERASIA (Africa, Middle East, 

Russia and Asia), as well as the Regional 

Medical Center responsible for 

research activities. The site in Vienna is 

a central hub and a platform for international 

research activities. The Area 

Medical Center Vienna is responsible 

for the planning, coordination and implementation 

of clinical studies. 

Sanochemia Phamazeutika AG was 

founded in 1990 and has been listed 

on the Frankfurt Stock Exchange since 

1995. Sanochemia is a research-based 

1 Vienna Austria 108.6 

2 Zurich Switzerland 108 

3 Geneva Switzerland 107.9 

4 Vancouver Canada 107.4 

4 Auckland New Zealand 107.4 

6 Dusseldorf Germany 107.2 

7 Frankfurt Germany 107 

7 Munich Germany 107 

9 Bern Switzerland 106.5 

10 Sydney Australia 106.3 

Quality of life according to the Mercer Quality of Living Survey 2010; 100 = New York; Source: Mercer 2010

Von From der Science Forschung To Products zum Produkt 

Die In its ZIT role unterstützt as the technology Wiener Unternehmen 

agency of 

als the Technologieagentur City of Vienna, ZIT der provides Stadt Wien support im 

gesamten to Vienna-based Innovationsprozess: firms throughout mit mone- the 

angeboten grants, related und technologiespezifischer 

consulting offers and a 

Infrastruktur. technology-specific Informieren infrastructure. Sie sich, 

welches Inform yourself Förderprogramm which funding für Ihr programmes 

Projekt am 

besten are best passt suited und for nutzen your project. Sie die Möglichkeit 

Take 

der advantage unbürokratischen of unbureaucratic Technologieberatung, 

technology- 

tären entire Förderungen, innovation process: begleitenden with Beratungs- 

monetary um oriented mit ExpertInnen consulting aus and dem establish ZIT-Netzwerk contact 

zur with Lösung experts technologischer from the ZIT network Fragen to in solve 

Verbindung technological zu problems. 

treten. 

Informationen Information on zu 

Förderprogrammen, 

funding programmes, 

aktuellen current calls Calls and und 

Beratungsangeboten: 

consulting offers: 

www.zit.co.at 

T +43 4000 86 165

12 

pharmaceuticals organization specializing 

in drug development for the treatment 

of diseases affecting the central 

nervous system. Sanochemia‘s bestknown 

product is synthetically produced 

galantamine which is used in 

the treatment of Alzheimer’s disease. 

Otto Bock Healthcare Products GmbH 

develops and manufactures high-tech 

prosthetics and innovative products for 

people with limited mobility around the 

world. The Austrian subsidiary of the 

German Otto Bock Group is a competence 

center for mechatronics. The leg 

prosthesis system C-Leg ® controlled by 

a microprocessor and the myoelectric 

arm prosthesis DynamicArm ® , which 

helps the patient regain elbow function, 

were both fully developed in Vienna. 

These global players are supplemented 

by a fast growing number of biotech 

and medical technology start-ups 

and a superior research infrastructure. 

The City of Vienna strongly promotes 

life sciences with financial incentives 

and the fostering of networks. These 

networks as well as state-of-the-art 

technology hubs facilitate interaction 

between global players, start-ups, research 

institutions and educational facilities 

with the aim of ensuring the fast 

and effective transfer of technologies 

between the scientific and the business 

communities. Up to 2018, the City 

of Vienna together with the Republic of 

Austria will be investing 52 million euros 

into the Campus Vienna Biocenter 

(CVBC) a cutting-edge shared core facility. 

Over a 10-year period the city will 

invest another 10 million euros in the Vienna 

Institute of BioTechnology Equipment 

GmbH located at LifeScience 

Vienna Muthgasse in the 19 th district. 

In addition to the state-of-the-art infrastructure, 

customized funding for startups 

and established companies is offered 

by different agencies. 

Tailored Funding and Services 

Austria and in particular Vienna offer 

a broad range of financial sup- 

introDUCtion 

port programs from national and city 

agencies. On behalf of the Austrian 

Federal Ministry of Economy, Family 

and Youth, austria wirtschaftservice 

(aws), the Austrian funding bank aims 

to stimulate the economy through financial 

support and know-how transfer. 

aws provides financial support 

to high-technology start-ups with its 

programs “LISA PreSeed” and “LISA 

Seedfinancing”. The PreSeed program 

provides funding for proof of 

principle experiments or the development 

of prototypes before a high-tech 

business is founded. The maximum 

amount of this nonrefundable grant is 

200,000 euros. Starting up an innovative 

and internationally competitive 

high-tech company requires considerable 

know-how, a lot of courage and 

sufficient capital. With “LISA Seedfinancing” 

aws funds the start-up phase 

of young high-tech companies with up 

to EUR 1 million, combined with customized 

advice and support. These 

funding programs are embedded in a 

comprehensive life science program, 

ranging from the life science business 

plan competition “Best of Biotech” to

introDUCtion 

international location marketing under 

the national brand Life Science Austria 

(LISA). The business financing by aws 

is supplemented by the Austrian Science 

Fund (FWF) which funds basic 

academic research and the Austrian 

Research Promotion Agency (FFG) 

which is in charge of applied research 

funding. 

In Vienna several agencies supplement 

federal funding: ZIT – The Technology 

Agency of the City of Vienna, 

the Vienna Science and Technology 

Fund (WWTF), the Vienna Business 

Agency and the university business 

incubator INiTS. 

ZIT provides support mainly for small 

and medium-sized enterprises loca- 

Lisavienna – Life science austria Vienna 

ted in Vienna in the form of grants, 

technology-specific infrastructure, as 

well as free services like technology 

transfer consulting. ZIT’s research 

funding program supports industrial 

and experimental R&D projects 

managed by Viennese businesses, 

where the investment is expected to 

result directly or indirectly in product, 

service or process innovations. Cash 

grants of up to 500,000 euros are 

awarded for the best R&D projects. 

In 2010, 168 life science projects 

in Vienna were able to attract funding 

amounting to 35.5 million euros 

(funding cash value) from the different 

available funding programs of 

aws, FFG, Vienna Business Agency, 

WWTF and ZIT. 

LISAvienna aims to unlock the potential of the life sciences in Vienna by supporting the commercial application of scientific 

discoveries. As a joint initiative of the Republic of Austria and the City of Vienna, LISAvienna helps to ensure that the economic 

potential of the life sciences is fully exploited and turned into marketable products, improved processes and new 

services. The main focus of LISAvienna’s activities is on custom-tailored advice and assistance for innovative enterprises. 

The initiative is supported by austria wirtschaftsservice (aws) and ZIT – The Technology Agency of the City of Vienna. 

What We Offer 

LISAvienna provides a broad range of essential services free of 

charge to entrepreneurs, investors and researchers in Austria’s 

largest life science location: 

› Consulting – Contacts and advice on financing and subsidies, infrastructure, technology competences and 

collaborations, human resources as well as internationalization 

› Marketing – Positioning Vienna as a significant research and business location at international trade fairs and 

providing information about the life sciences in Vienna in local and national media 

› Qualification – Life science related seminars on the market and regulatory environment, legal aspects as well as 

financing and organization for entrepreneurs, researchers and students 

› Networking – Setting up and strengthening networks in the life science community with the aim of fostering fruitful 

exchanges of ideas and experience 

› Knowledge – Preparation of analyses, background papers and studies on the strategic development and positioning 

of Vienna as a life science location 

Visit www.LISAvienna.at to learn more about Vienna as a top location for the life sciences and get further information 

on the support and funding available on site. 

13

14 

academic Hot spots in Vienna 

Vienna is home to seven universities, ten non-profit research institutes and five other organizations per- 

forming life science research. This makes the city a globally renowned hot spot for research and teach- 

ing activities that attracts more than 35,000 students in life sciences alone. They are trained by a grow- 

ing number of researchers and teaching staff that in 2010 amounted to more than 14,000 people – the 

majority (52%) of them are female. With almost 5,200 life science papers in peer-reviewed journals, the 

scientific output in life sciences was significant. 45 life science patents filed in 2010 prove that Vienna is 

also a fertile ground for technology transfer. 

Lifescience Vienna muthgasse 

Lifescience Vienna muthgasse is the most recent life science location 

in Vienna. it bundles university and research institutions 

such as the University of Natural Resources and Life Sciences 

(BOKU) or the Austrian Institute of Technology (AIT) with life sciences 

companies and organizations offering beneficial synergies. 

With state-of-the-art infrastructure, Lifescience Vienna muthgasse 

accommodates the requirements of different fields of research 

such as biology, chemistry and physics. the first phase of the 

spectacular project ”Biotech i” with more than 24,000 m² is already 

in use. the next building, Biotech ii will provide 29,000 m² of 

office and lab space. the WHite sPaCe will add another 25,500 

m² of rental space. www.lifescience-vienna.com 

University of technology 

the tU Vienna is among the most successful technical universities 

in europe and is austria's largest technical research and 

educational institution. the tU Vienna provides expertise in bioanalytics 

and sensor development, biomechanics, biomedical 

engineering, chemical technologies, electrodynamics, material 

sciences and software development. an experienced technology 

transfer unit forms the professional interface towards industry 

partners to catalyze partnerships that bring new developments 

to the market. www.tuwien.ac.at 

aCaDemia

aCaDemia 

medical University of Vienna 

University of Veterinary medicine 

the Vetmeduni Vienna is austria's only university for veterinary 

education and research. the facility centers around an animal 

hospital for clinically demanding cases. equipment and facilities 

for teaching and research are state-of-the-art and numerous 

associated organizations as well as life science companies are 

located on the campus. the objectives of Vienna's Vetmeduni 

focus on new goals in preventive and curative veterinary medicine 

for livestock, companion animals, and wildlife, and on safe 

food from healthy animals. VetWiDi GmbH, an enterprise of the 

Vetmeduni Vienna, forms the interface between research and 

economics at the university and supports the scientists in all 

aspects of university technology transfer. www.vetmeduni.ac.at 

the Campus of the medUni Vienna is austria’s largest research 

and teaching institution. its activities are based on three key pillars 

– research, teaching and patient care. the heart of the campus is 

Vienna’s General Hospital (aKH), europe’s biggest hospital. each 

year 100,000 patients are treated as inpatients in 31 university 

clinics, 48,000 surgeries are conducted and 605,000 outpatients 

receive treatment in the day-clinics of the aKH. numerous medical 

institutions, such as st. anna Children’s Hospital, and a variety 

of research institutes and business enterprises have established 

themselves in the vicinity. their presence offers innovative synergies 

and incentives, all of which ultimately benefit the patients. 

www.meduniwien.ac.at 

Campus Vienna Biocenter 

the CVBC at neu marx, is one of the leading international biomedical 

research centers worldwide. With a broad spectrum of 

research institutions it is home to a variety of research laboratories, 

several internationally successful biotech companies, recent 

start-ups as well as privately and publicly funded services. in addition, 

teaching is a major activity on the campus. access to stateof-the-art 

infrastructure has become an important and decisive 

element for cutting-edge research. therefore, the CVBC set up 

the Campus science support Facilities (CsF GmbH) featuring a 

comprehensive range of new technologies with substantial funding 

from the austrian ministry of science and research and the 

City of Vienna. www.viennabiocenter.org 

15

16 

aCaDemia 

the Life sciences in Vienna: spotlight on research and teaching 

A brochure on the life sciences in Vienna 

would be incomplete without 

considering research activities which 

go beyond the business side. In fact, 

commercial activities in the life sciences 

are often based on outstanding 

academic research. LISAvienna asked 

22 institutions active in the life sciences 

to participate in a survey* to gather 

up-to-date statistics on life science 

research activities in Vienna. Because 

commercial activities in biotech and 

medtech are linked to many different 

disciplines such as agriculture, biology, 

chemistry, engineering, material 

sciences, medicine, pharmaceutics 

and veterinary medicine, a very broad 

and extended life science definition 

has been applied for the set-up of the 

sample. The bandwidth of the institutes’ 

landscape is particularly large. 

It includes classical academic education 

at the University of Vienna as well 

as training in specialist disciplines 

in basic and applied research facilities. 

This extensive scientific range 

traditionally attracts a large number 

of national and international private 

companies that support research with 

large amounts of external funding or 

even completely self-financed institutions. 

Numerous innovations owe their 

existence to this proximity between 

research and industry. Short profiles 

of the 22 organizations that contrib- 

Table 2 

uted their data are included in this report 

(see p. 18). 

Key Figures at a Glance 

Vienna is home to seven universities, 

ten non-profit research institutes and 

five other organizations performing 

noteworthy research and teaching 

activities in the life sciences. By the 

end of 2010, these institutions employed 

roughly 14,100 people in the 

life sciences (n = 21), 52 % of them 

were women (n = 20). With more than 

35,000 students in the life sciences 

alone, Vienna educates more young 

scientists than any other city in Austria. 

5,182 life science papers were 

published in peer-reviewed journals 

by researchers based in the organizations 

included in the sample (n = 20). 

Furthermore, 45 (n = 18) life science 

patents were filed last year. In 2010, 

the total life science budget of the 

organizations amounted to 699 million 

euros (n = 16), of this amount 194 

million euros (n = 19) came from thirdparty 

funding. 

Long Traditions and 

Cutting-edge Research 

Vienna owes its success as one of the 

most important life science centers 

in Europe today to its long tradition 

academic institutions – Facts & Figures i 

in scientific and medical research. 

Names such as Semmelweis, Billroth 

and Landsteiner have all taken their 

place in the annals of the city’s history. 

The University of Vienna, founded 

in 1365, is Austria‘s largest university. 

The Medical University of Vienna 

was originally founded in 1365 

as a Medical Faculty of the University 

of Vienna. Since 2004 the Med- 

Uni Vienna is an autonomous university. 

The University of Veterinary 

Medicine was founded in 1765 by 

Empress Maria Theresa as the first 

veterinary medicine educational establishment 

in the German-speaking 

world. In 1815, the Vienna University 

of Technology was established and in 

1872 the University of Natural Resources 

and Life Sciences was founded. 

Since the 1990s the institutional 

landscape has diversified immensely. 

Nowadays cutting-edge research 

is not only performed in well-established 

universities but also in research 

institutions such as the Max F. Perutz 

Laboratories, the Institute of Molecular 

Pathology (IMP) or institutes 

operated by the Austrian Academy 

of Sciences (ÖAW) like the Center 

of Molecular Medicine (CeMM), the 

Gregor Mendel Institute of Molecular 

* Detailed information on the methodology 

can be found at www.LISAvienna.at 

Number of research institutions active in life science covered by the report .............................................................................. 22 

Universities .......................................................................................................................................................................... 5 

Applied universities ............................................................................................................................................................. 2 

Non-profit research institutes.............................................................................................................................................10 

Other .................................................................................................................................................................................... 5 

Patent applications in the life sciences in 2010 (n = 18) ................................................................................................................ 45 

Total life science budget in 2010 (n = 16) ...................................................................................................................EUR 698.44 M 

Third-party funds spent on life science research in 2010 (n = 19) .............................................................................EUR 194.10 M

aCaDemia 

Plant Biology (GMI) and the Institute 

of Molecular Biotechnology (IMBA). 

New Types of Collaborations 

New forms of institutions have 

emerged to address research questions 

that concern tangible societal 

and industrial problems and to allow 

for new types of collaboration with 

commercial and societal partners. 

These include institutes and labs supported 

by the Christian Doppler Research 

Association (CDG), the Ludwig 

Boltzmann Gesellschaft (LBG) 

and the Karl Landsteiner Association. 

Furthermore, technology-focused 

competence centers like the Austrian 

Centre of Industrial Biotechnology 

(ACIB) and the Center for Virtual Reality 

and Visualization Research (VRVis) 

have been set up and complement 

existing institutions like the Austrian 

Institute of Technology (AIT) and the 

Austrian Research Institute for Chemistry 

and Technology (OFI). 

Talent is the Key to Success 

Perfect organizational structures and a 

top infrastructure are without a doubt 

crucial for the delivery of excellent research 

results. However, the people 

working in these structures are the key 

to success. Their talent and motiva- 

Table 3 

tion make the difference. At the end 

of 2010, 1,186 highly educated and 

motivated people worked in Vienna 

for the non-profit research institutions 

which were included in LISAvienna's 

survey. Women accounted for half this 

number. These employees are active 

in a wide variety of professions from 

medical doctors, clinical researchers, 

lab researchers, computer specialists 

and engineers to project managers, 

financial experts, administrative and 

public relations experts. Today, the life 

sciences also attract a large number 

of students: At Vienna‘s universities 

35,288 students are registered in these 

courses, of these 33,184 at universities 

and 2,104 at applied universities. 

Input and Output 

Despite the controversial discussions 

on peer-review processes, they are 

still the standard of quality assurance 

in the academic world. Only 

publications that have been reviewed 

by experienced colleagues are published 

in high impact journals with an 

international readership. Researchers 

at the institutions that participated in 

LISAvienna's survey published 5,182 

life sciences papers in peer-reviewed 

journals in 2010 – including Cell, Nature 

or New England Journal of Medicine 

and Science. Scientific output, 

academic institutions – Facts & Figures ii 

Number of employees in the life 

sciences (head count, end of 2010) 

Number of students in the life 

sciences (winter semester 2010) 

Life science publications in 

peer-reviewed journals in 2010 

Third-party funding spent in 2010 

on life science (million euros) 

Universities Applied universities 

Non-profit 

research institutes 

of course, also has other dimensions 

like education of the next generation 

of researchers but also, for example, 

the generation of patents for promising 

new inventions. In 2010, the academic 

and non-profit institutions in 

the sample filed a total of 45 patent 

applications. Clearly, this output requires 

significant and ongoing public 

funding – especially as research in the 

life sciences can be very time-consuming 

and costly. The 16 institutions 

that provided LISAvienna with their 

financial data spent roughly EUR 699 

million on the life sciences in 2010. 

Furthermore, 19 institutions received 

EUR 194 million for research projects 

in the life sciences last year. 

Top Research Hot Spots in Vienna 

In recent years, five science and technology 

centers have emerged at various 

locations across Vienna where 

research institutions, hospitals and 

businesses co-locate. Dynamic startups 

and outstanding academic institutes 

are concentrated at the Campus 

Vienna Biocenter, around the Vienna 

General Hospital which is one of 

Europe's largest hospitals, at Life- 

Science Vienna Muthgasse, on the 

15-hectare campus of the University 

of Veterinary Medicine as well as at 

the Vienna University of Technology. 

Other Total 

10,817 510 1,186 1,589 14,109 

33,184 2,104 – – 35,288 

4,430 24 387 341 5,182 

150.0 0.6 35.1 8.4 194.1 

17

18 

academic Directory 

23% (5) 

23% (5) 

types of 

institutions 

Non-profit research institutes 

Universities 

Applied universities 

Other 

9% (2) 

academic institutes – alphabetical List 

AGES – Austrian Agency for Health and Food Safety 

Founded in 2002 

45% (10) 

Fig. 4: Distribution of different types of research 

institutes (see above) 

The dynamic development of the Viennese 

life science companies would not 

have been possible without the support 

of a first class academic infrastructure. 

With more than 35,000 students in 22 

academic institutions in the life sciences 

alone, Vienna educates more 

young scientists than any other city 

in Austria. The bandwidth of the institutes’ 

landscape is particularly large. It 

includes classical academic education 

at the University of Vienna as well as 

training in specialist disciplines in ba- 

The Austrian Agency for Health and Food Safety (AGES) is a government agency 

and a non-profit research organisation. AGES executes federal state tasks in the 

areas of agriculture, food and feed safety control, control of infectious diseases, 

veterinary medicine, radiation protection medical devices and pharmaceuticals. 

Focus of research is soil protection, agricultural production potentials (varieties, 

plant genetic resources, seeds, crop protection and plant health), GMOs, animal 

health, epidemiology of food-borne and infectious diseases, nutrition and risk 

assessment. 

Employees: 1,428; 56% female Articles published: 72 Total budget: EUR 124.07 M 

Third-party funding: EUR 1.56 M 

aCaDemiC DireCtory 

sic and applied research facilities. This 

extensive scientific range traditionally 

attracts a large number of national and 

international private companies that 

support research with large amounts 

of external funding or even completely 

self-financed institutions. Nu merous 

inno va tions owe their exis tence to this 

proximity between research and industry. 

The list below contains short portraits 

and additional information on the 

life science institutes located in Vienna 

in alphabetical order. 

Vienna's Largest Life science institutions 

University of Vienna 

University of Natural Resources and 

Life Sciences, Vienna 

Medical University of Vienna 

University of Veterinary Medicine 

Vienna 

University of Applied Sciences FH 

Campus Wien 

Vienna University of Technology 

University of Applied Sciences 

Technikum Wien 

Institutions Students 

875 

656 

1,448 

2,348 

7,192 

9,961 

Austrian Agency for Health and 

Food Safety (AGES) 

spargelfeldstrasse 191 

1220 Vienna 

tel: +43-5-0555-0 

Fax: +43-5-0555-22019 

cooperation@ages.at 

www.ages.at 

12,808 

Fig. 5: Size of the largest Viennese life science 

institutions in terms of students


ABCSG – Austrian Breast & Colorectal Cancer Study Group 


In the beginning was an idea: founded in 1984, the Austrian Breast & Colorectal 

Cancer Study Group (ABCSG) initially formulated its objective to effectuate substantial 

improvements in the treatment of breast and colorectal cancer with highlevel 

scientific activities. This objective has since been implemented – today, the 

ABCSG is one of the largest and most successful clinical trial groups in Europe. 

Employees: 26; 92% female 

ACIB – Austrian Centre of Industrial Biotechnology 


As an independent and interdisciplinary non-profit research company, ACIB conducts 

top level research in Vienna, Graz and Innsbruck. Under the slogan “Innovations 

from Nature,” ACIB makes use of the tools and concepts of nature for 

industrial production. Established at the location Life Science Vienna Muthgasse 

are the research areas Cell Design & Engineering and Bioprocess Engineering; 

further research areas of ACIB include Biocatalytic Synthesis, Enzymes for Polymers 

and Protein Design & Engineering. 

Employees: 48; 57% female Articles published: 6 Total budget: EUR 3.56 M 

Patents filed: 1 Third-party funding: EUR 0.14 M 

AIT – Austrian Institute of Technology 


The Austrian Institute of Technology (AIT) is Austria‘s largest non-university research 

institute and addresses unmet societal and industrial needs. Two of its five departments 

place a strategic focus on life sciences: the AIT Health & Environment Department 

is focused on translational research in the fields of preclinical and clinical diagnostics, 

prevention as well as the sustainable exploitation of biological resources. 

The AIT Safety & Security Department is making a significant contribution to the ICT 

dimension of life sciences. Software for medical telemonitoring, therapy management, 

movement analysis and brain signal investigation are being developed. 

Employees: 257 Articles published: 93 Total budget: EUR 26.38 M 


Austrian Breast & Colorectal 

Cancer Study Group (ABCSG) 

nussdorfer Platz 8 


tel: +43-1-4089230 

Fax: +43-1-4090990 

info@abscg.at 

www.abscg.at 

Austrian Centre of Industrial 

Biotechnology (ACIB) 

muthgasse 11 


tel: +43-1-47654-8034 

tel: +43-1-47654-8039 

office@acib.at 

www.acib.at 

Austrian Institute 

of Technology (AIT) 

Donau-City-strasse 1 


tel: +43-5-0555-0 

Fax: +43-5-0555-4000 

office@ait.ac.at 

www.ait.ac.at 

19

20 

BOKU – University of Natural Resources and Life Sciences, Vienna 

Founded in 1872 as k.k. Hochschule für Bodenkultur 

The University of Natural Resources and Life Sciences, Vienna, the Alma Mater 

Viridis, links the natural sciences, engineering and economics. In this way, BOKU 

contributes to the protection of living space and quality of life, the management 

of natural resources and to securing nutrition and health. Biotechnology is one of 

BOKU‘s seven main research areas and is concentrated in the Vienna Institute 

of BioTechnology: At Muthgasse, research activities include biopharmaceutical 

technology and bioprocess engineering. Agro and environmental biotechnology 

are located in Tulln. 

Employees: 2,207; 44% female Articles published: 496 

Students: 9,961 Patents filed: 2 Third-party funding: EUR 30.39 M 

CeMM – Research Center for Molecular Medicine 


CeMM, the Research Center for Molecular Medicine of the Austrian Academy of 

Sciences, is an international, independent and interdisciplinary research institute. 

“From clinic to clinic”: driven by medical needs, CeMM integrates basic research 

and clinical expertise to pursue innovative diagnostic and therapeutic approaches. 

The main research interests focus on decoding molecular mechanisms related 

to cancer, inflammation and immune disorders, with the aim of creating a basis for 

the predictive, preventive and personalized medicine of the 21st century. 



CCRI – Children's Cancer Research Institute 


The Children's Cancer Research Institute (CCRI) operated by the St. Anna Kinderkrebsforschung 

Association is a non-profit research institution that is solely funded 

by volunteers' donations and competitive research grants. It was founded 

in 1988 with the overall aim of improving the treatment of malignant childhood 

diseases. The scientific focus is on basic laboratory, translational and clinical research 

– in close collaboration with the St. Anna Children’s hospital–, with special 

attention to leukemia and bone marrow transplantation as well as tumor biology 

and immu nology. 

Employees: 93; 71% female Articles published: 64 


University of Natural Resources 

and Life Sciences, Vienna (BOKU) 

Gregor-mendel-strasse 33 


tel: +43-1-47654-0 

Fax: +43-1-47654-1005 

office@boku.ac.at 

www.boku.ac.at 

Research Center for Molecular 

Medicine (CeMM) 

Lazarettgasse 14, aKH Bt 25.3 


tel: +43-1-40160-70011 

Fax: +43-1-40160-970 000 

office@cemm.oeaw.ac.at 

www.cemm.oeaw.ac.at 

Children's Cancer Research 

Institute (CCRI) 

Zimmermannplatz 


tel: +43-1-40470-0 

tel: +43-1-40470-0 

office@ccri.at 

www.ccri.at

floorfour agentur für Kommunikation 

ReSeaRch 

needS 

LifeScience Vienna Muthgasse: 

Join the perfect location with 

state-of-the-art infrastructure. 

diaLoGue 

Education & REsEaRch at thE samE placE 

Vienna Institute of Biotechnology/University 

of Natural Resources & Life Sciences, Novartis, 

AIT/Austrian Institute of Technology, Themis, 

et al. 

www.lifescience-vienna.com 

Print: CMYK 80-15-100-10 Muthgasse

22 

CDG – Christian Doppler Forschungsgesellschaft 


The Christian Doppler Research Association (CDG) supports application-oriented 

basic research in what are known as Christian Doppler Laboratories. These research 

laboratories are established for a maximum of seven years by highly qualified scientists 

in universities and non-university research institutions in collaboration with 

companies. In Vienna, 18 CD Labs can be assigned to the life sciences. Research 

topics range from food analysis, flavoring agents and cellulose chemistry to the 

medical field where allergies, cancer, heart diseases and immunological disorders 

and also laser technologies for medical purposes for example take center stage. 

GMI – Gregor Mendel Institute of Molecular Plant Biology 


The GMI was founded by the Austrian Academy of Sciences in 2000 to promote 

research excellence in the area of plant molecular biology. Research at the GMI is 

curiosity driven and covers many aspects of molecular genetics, including basic 

mechanisms of epigenetics, population genetics, chromosome biology, developmental 

biology and stress signal transduction. Arabidopsis thaliana is the primary 

model organism used – although other organisms are also studied. 



IMBA – Institute of Molecular Biotechnology 


IMBA uses model organisms and cutting-edge functional genomics to investigate 

fundamental molecular processes and their contribution to disease. In interdisciplinary 

research groups, IMBA pursues an integrative approach that combines 

functional screening, cellular RNAi, stem cell and imaging technologies with the 

knowledge for rapidly generating mouse disease models to examine the role of 

genes in physiology and pathogenesis. Numerous cooperations with leading academic 

and industrial partners are an integral part of IMBA’s strategy and commitment 

to delivering outstanding results from its basic research. 


Patents filed: 6 


Christian Doppler Forschungsgesellschaft 

(CDG) 

sensengasse 1 


tel: +43-1-504 2205 

Fax: +43-1-504 2205-20 

office@cdg.ac.at 

www.cdg.ac.at 

Gregor Mendel Institute 

of Molecular Plant Biology (GMI) 

Dr.-Bohr-Gasse 3 


tel: +43-1-79044-9000 

Fax: +43-1-79044-9001 

office@gmi.oeaw.ac.at 

www.gmi.oeaw.ac.at 

Institute of Molecular 

Biotechnology (IMBA) 



tel: +43-1-79044 

Fax: +43-1-79044-110 

office@imba.oeaw.ac.at 

www.imba.oeaw.ac.at


IMP – Research Institute of Molecular Pathology 


At the IMP, more than 200 scientists from over 30 countries carry out curiositydriven, 

basic research in the molecular life sciences. Their projects are broadly organized 

into four topic areas: life at the molecular and cellular levels, information 

processing and storage in neural circuits, mechanisms of organismal development 

and disease, and interdisciplinary approaches that bring ideas and methods 

from other fields to bear on biological questions. The common goal in all of these 

areas is to elucidate the mechanisms and principles that underlie complex biological 

processes. All research results are published in refereed journals. 


Patents filed: 2 

KLG – Karl Landsteiner Gesellschaft 


The Karl Landsteiner Association is a non-profit research organization. It was 

founded in 2004, with the aim of accelerating patient-oriented scientific research 

in Vienna and Lower Austria. It is the largest medical research society in Austria; 

research is mainly performed at the premises of medical suppliers and is thus 

close to patients. The society covers a broad range of medical disciplines and 

results can often be implemented in daily routine with immediate benefits for patients. 

The Institutes are chaired by highly eminent individuals. Quality assurance 

is performed by recurrent evaluation of the institutes. 



LBG – Ludwig Boltzmann Gesellschaft 


The LBG is a non-university research institution in the fields of human medicine 

and life sciences focusing on translational and clinical research as well as 

humanities. After a comprehensive restructuring in 2002, there are 20 Ludwig 

Boltzmann Institutes, and 5 Clusters today. Goal of this restructuring was to 

implement a high level of quality. New Ludwig Boltzmann Institutes are exclusively 

founded by means of a public call for proposals. Institutes are then set 

up for a period of seven years with the option of prolonging their runtime for 

another seven years. 



Research Institute of Molecular 

Pathology (IMP) 



tel: +43-1-79730 

Fax: +43-1-7987153 

office@imp.ac.at 

www.imp.ac.at 

FORSCHUNG FORTSCHRITT 

F Ö R D E R U N G 

Karl Landsteiner Gesellschaft 

(KLG) 

Franziskanergasse 4a 

3100 st. Pölten 

tel: +43-676-5747531 

Fax: +43-2748-7303 

sekretariat@karl-landsteiner.at 

www.karl-landsteiner.at 

Ludwig Boltzmann Gesellschaft 

(LBG) 

nussdorfer strasse 64, 6. stock 


tel: +43-1-5132750 

Fax: +43-1-5132310 

office@lbg.ac.at 

www.lbg.ac.at 

23

24 

MFPL – Max F. Perutz Laboratories 


The Max F. Perutz Laboratories are the research center for molecular biology of 

the University of Vienna and the Medical University of Vienna. With more than 60 

research groups, the MFPL is the largest basic research institute on the Campus 

Vienna Biocenter. Besides doing research, the institute’s second main focus 

is educating and training the next generation of scientists. The MFPL offer undergraduate 

studies, an international PhD program, post doc training and junior 

group leaders positions. 



MedUni Vienna – Medical University of Vienna 

Founded in 1365 as the Medical Faculty of the University of Vienna 

Medical University Vienna is the largest and most traditional medical institution in 

Austria. With 31 university departments and clinics, 12 centers of medical theory 

and a large number of highly specialised laboratories, it also ranks among the 

main European top research institutions in the field of biomedicine. 7,200 students 

and 2,300 teaching personnel on campus and in 13 training hospitals make 

it the largest medical training facility in the German-speaking area and one of the 

top training establishments in Central Europe. 

Employees: 5,112; 55% female Articles published: 1,871 Total budget: EUR 270.00 M 

Students: 7,192 Patents filed: 16 Third-party funding: EUR 74.58 M 

ofi – Austrian Research Institute for Chemistry and Technology 

Founded in 1946 as the association “Chemisches Forschungsinstitut der Wirtschaft Österreichs” (CFI) 

ofi provides services for pharmaceutical products all over Europe, including preclinical 

development, preparation and release of active ingredients and drugs, as 

well as the development and testing of primary packaging. One focus of research 

is the interaction of polymers with the goods packaged, e.g. within extractables 

& leachables studies. Chromatographic Multimethods using mass spectrometry 

are developed for safety screening, along with in-vitro bioassays, to detect 

biological effects within compatibility studies. 

Employees: 18; 33% female Total budget: EUR 2.32 M 



Max F. Perutz Laboratories 

(MFPL) 



tel: +43-1-4277-24001 

Fax: +43-1-4277-9240 

office@mfpl.ac.at 

www.mfpl.ac.at 

Medical University of Vienna 

(MedUni Vienna) 

spitalgasse 23 


tel: +43-1-40160-0 

Fax: +43-1-40160-910 000 

office@meduniwien.ac.at 

www.meduniwien.ac.at 

Austrian Research Institute for 

Chemistry and Technology (ofi) 

Brehmstrasse 14a 


tel: +43-1-7981 601-0 

Fax: +43-1-7981 601-520 

office@ofi.at 

www.ofi.at


University of Applied Sciences FH Campus Wien 

Founded in 2011, University of Applied Sciences status since 2004 

The University of Applied Sciences, FH Campus Wien, cultivates an intensive 

exchange with research organizations, teaching, healthcare institutions and private 

industry and is thereby constantly improving the high scientific quality and 

practical relevance of the courses. FH Campus Wien cooperates in the fields of 

“applied life sciences” and “health” with the University of Vienna, the University 

of Natural Resources and Life Sciences, Vienna, the University of Veterinary Medicine 

Vienna and the Medical University of Vienna. Various research projects in 

these fields play an important part in FH Campus Wien R&D activities. 

Employees: 480; 53 % female Articles published: 14 

Students: 1,448 

University of Applied Sciences Technikum Wien 


The University of Applied Sciences Technikum Wien is Austria's largest purely 

technical university of applied sciences. Research at the UAS is currently focused 

on embedded systems, renewable energy and life science technologies. The 

research activities in the field of life sciences cover a wide range, from projects 

in eHealth, tissue engineering, ambient assisted living and ambient assistive 

technologies to topics such as mechanical ventilation technology, rehabilitation 

technology, biomechanics and motion analysis. 

Employees: 30; 23 % female Articles published: 10 

Students: 656 Third-party funding: EUR 0.63 M 


Founded in 1365 as Alma Mater Rudolphina 

The University of Vienna was founded in 1365 and is the oldest university in the 

German-speaking world and one of the largest in Central Europe. Research and 

teaching in the life sciences are predominately at the core of three of its 18 faculties 

and centers – that is the Faculty of Life Sciences and the Center for Molecular 

Biology and the Faculty of Chemistry. A wide spectrum of scientific subjects ranging 

from immunology, molecular and organismic biology as well as pharmaceutical 

and nutritional sciences, biodiversity and biochemistry is covered. 

Employees: 1,874; 46 % female Articles published: 1,455 

Students: 12,808 Third-party funding: EUR 22.56 M 


FH Campus Wien 

Favoritenstrasse 226 


tel: +43-1-6066877-6600 

tel: +43-1-6066877-6609 

office@fh-campuswien.ac.at 

www.fh-campuswien.ac.at 


Technikum Wien 

Hochstaedtplatz 5 


tel: +43-1-3334077-0 

Fax: +43-1-3334077-269 

info@technikum-wien.at 

www.technikum-wien.at 


Dr.-Karl-Lueger-ring 1 


tel: +43-1-4277-0 

www.univie.ac.at 

25

26 

Vetmeduni Vienna – University of Veterinary Medicine, Vienna 


The University of Veterinary Medicine, Vienna (Vetmeduni Vienna) is the only university 

in Austria focusing on veterinary medicine. Cutting-edge infrastructure on 

campus and at a number of branches in and around Vienna support excellence in 

research, teaching and veterinary medicine. A special asset of Vetmeduni Vienna 

is its animal hospital that provides essential hands-on training for students. In 

addition, a number of spin-off companies have established their premises on the 

university campus. 

Employees: 1,086; 59% female Articles published: 395 

Students: 2,348 Third-party funding: EUR 7.42 M 


Founded in 1815 as Imperial and Royal Polytechnical Institute 

The Vienna University of Technology (TU Vienna) is among the most successful 

technical universities in Europe and is Austria‘s largest scientific-technical research 

and educational institution. Research areas cover all classic engineering 

disciplines, many of them are highly relevant for biotech and medtech industries. 

TU Vienna for example hosts expertise in bioanalytics and sensor development, 

biomechanics, biomedical engineering, chemical technologies, electrodynamics, 

material sciences and software development. 


Students: 875 Patents filed: 8 Third-party funding: EUR 15.05 M 

VRVis Center for Virtual Reality and Visualization Research 


VRVis is Austria's leading research company in the field of visual computing with 

a research group in medical visualization. Together with the Institute for Computer 

Graphics at the Vienna University of Technology and the visualization group at the 

Austrian Academy of Sciences, VRVis forms one of the largest computer graphics 

research groups in Europe. VRVis is an active partner for research initiatives of 

the federal government and the City of Vienna. Its higher aim is to strengthen the 

innovation and competitiveness of Austria. 




University of Veterinary Medicine, 

Vienna (Vedmeduni Vienna) 

Veterinaerplatz 1 


tel: +43-1-25077-0 

tel: +43-1-25077-1090 

office@vetmeduni.ac.at 

www.vetmeduni.ac.at 


Karlsplatz 13 


tel: +43-1-58801-0 

Fax: +43-1-28801-41099 

office@tuwien.ac.at 

www.tuwien.ac.at 

VRVis Center for Virtual Reality 

and Visualization Research 

Donau-City-strasse 1 


tel: +43-1-20501-30100 

Fax: +43-1-20501-30900 

office@vrvis.at 

www.vrvis.at

28 

Life science Companies in Vienna 

Vienna is not only the economic and political center of Austria, but also the most 

dynamic life science location in the country. Within the city borders the highest 

concentration of life science companies in Austria can be found. Especially in bio- 

technology Vienna is the leading cluster in Austria and is furthermore developing 

into one of the leading clusters in medical technology. 

Legend 

Dedicated biotech and biotech-active companies 

Dedicated medtech and medtech-active companies 

Life science related companies 

For definitions of the categories refer to glossary on page 151. 

ComPanies

ComPanies 

top 10 of Vienna's Life science Companies 

1 Otto Bock Healthcare Products GmbH 

2 Intercell AG 

3 Affiris AG 

4 Agfa HealthCare Ges.m.b.H. 

5 VIVISOL Heimbehandlungsgeräte GmbH 

6 Technoclone GmbH 

7 NABRIVA Therapeutics AG 

8 Avir Green Hills Biotechnology AG 

9 TissueGnostics GmbH 

10 Carl Reiner GmbH 

Dedicated biotech and medtech companies sorted according to employee number 

29

ComPany statistiCs 

Biotechnology in Vienna – Facts & Figures 

Biotechnology in Austria is among 

the industry sectors with the greatest 

future potential. In the last ten 

years, a lively scene has developed 

nationwide with Vienna hosting 61 

companies. As shown in Tab. 4, the 

capital is home to 43 companies that 

are completely dedicated to biotechnology 

(called dedicated companies, 

see OECD definition p. 151). They 

have been attracting attention since 

day one – particularly in the most 

demanding discipline of biotechnology: 

the development of new drugs. 

Around 70% of all Vienna-based biotech 

companies are active in this field 

(see Fig. 6). Other operations comprise 

largely various services in the 

life sciences field or industrial and 

agricultural biotechnology R&D. 

Alongside the dedicated companies, 

there are 18 in some cases considerably 

larger companies in which biotechnology 

represents one of several 

activities. They are referred to here 

as biotechnology-active companies. 

The subsidiaries of international phar- 

maceutical companies such as Baxter, 

Boehringer Ingelheim or Eli Lilly, which 

fall into this category, can be consid- 

Table 4 

ered as the nucleus out of which Austria's 

modern biotech industry arose. 

Dynamic Start-up Scene 

In recent years, the news coming out of 

Vienna has been predominantly positive. 

Enterprises such as the vaccine 

specialist AFFiRiS, the cancer experts 

at Apeiron or the next generation antibody 

company F-star have made international 

names for themselves due to 

excellent clinical results and licensing 

agreements with leading pharmaceutical 

companies. The fertile climate also 

attracts newcomers such as PDC Biotech 

which moved to Vienna from Canada 

in 2008 to develop drugs against 

preterm labor. Most recently (and after 

this survey was concluded), the vaccine 

developer Hookipa Biotech managed 

to pocket some of the rare early-stage 

venture capital. Renowned international 

investors like Sofinnova Partners or 

Forbion brought in more than 7 million 

euros in the first financing round. 

Most biotech companies engage in the 

field of health/medicine but numerous 

companies are also active in areas 

apart from drug development (see Fig. 

Biotechnology in Vienna – Key Figures 2010 

23 % (10) 

5 % (2) 

areas of 

activity 

2 % (1) 

Health/medicine (incl. animal health) 

Non-specific services 

Industrial biotechnology 

Agricultural biotechnology 

70 % (30) 

Fig. 6: Distribution of activity fields of Viennese 

dedicated biotech companies 

Total number of primary biotechnology companies......................................................................................................................61 

Number of dedicated biotechnology companies .............................................................................................................. 43 

Number of other biotechnology-active companies (e.g. pharma, chemicals or seeds manufacturers) ...........................18 

Total number of employees (headcount) in primary biotechnology companies ......................................................................7,498 

Number of employees in dedicated biotechnology companies .................................................................................... 848 

Number of employees in biotech-active companies ................................................................................................... 6,650 

Total revenues of primary biotechnology companies ....................................................................................................EUR 883 M 

Revenues of dedicated biotechnology companies .............................................................................................. EUR 97 M 

Revenues of other biotechnology-active companies ......................................................................................... EUR 786 M 

R&D expenditure of dedicated biotechnology companies ........................................................................................... EUR 146 M 

Total amount of financing raised by dedicated biotechnology companies ..................................................................... EUR 58 M 

31

32 ComPany statistiCs 

21% (9) 

23% (10) 

age 

structure 

2008 – 2010 

< 2002 

average age: 

7.1 years 

Clinical Pipeline 

Biologics 

Small Molecules 

2005 – 2007 

2002 – 2004 

Fig. 8: Number of therapeutics under 

development of Vienna-based, 

dedicated biotech companies 

30% (13) 

26% (11) 

Fig. 7: Distribution of Vienna-based dedicated 

biotech companies according to their 

founding year 

6). Good examples are Mycosafe or Virusure. 

Both companies are spin-offs 

of the University of Veterinary Medicine 

in Vienna and operate today as 

successful specialists for in-vitro testing 

of bacteria or viruses and prions. 

Furthermore, EUCODIS Bioscience is 

an enzyme engineering company with 

customers in the phar ma ceutical, biotech 

no logy, diagnostics and other industries. 

The firm manu factures and 

markets more than 50 well-characterized 

enzymes worldwide. 

Turnover: 1 Billion Euro Mark in Sight 

The average age of a Viennese biotechnology 

company is only 7.1 years 

(see Fig. 7). Due to their youth and 

highly research-oriented nature, the 

dedicated companies generated sales 

of 97 million euros which is relatively 

insignificant when compared to other 

future industries such as IT or medical 

technology. However, the special 

business model of the biotechnology 

companies with its long development 

times has been understood in Vienna: 

Long-term development of the biotechnology 

sector is being encouraged. 

Where this route may lead can 

25 

20 

15 

10 

5 

0 

25 

6 

preclinical 

11 

2 

Phase I 

9 

be seen in the mostly established biotech-active 

companies which earned 

approx. 786 million euros in 2010 (see 

Tab. 4). Together with the sales earned 

by dedicated companies, Vienna has 

the one billion mark in revenues in 

sight. Positive developments like these 

are honored by investors. Last year, 

58 million euros of capital flowed into 

Vienna-based biotech companies. 14 

million euros of this came from venture 

capital firms, another 28 million euros 

came from other private sources like 

business angels. By now, the industry 

sector has reached a critical mass, 

which means that it can also cope with 

development setbacks in individual 

companies and survive without crippling 

damage. 

Strong Investment in Research 

and Development 

In 2010, the dedicated biotech companies 

spent 146 million euros on research 

and development. Thus, the investment 

is 1.5 times higher than the yearly sales 

achieved by dedicated biotech firms. 

This shows that the industry is still 

young, but furthermore it demonstrates 

that a considerable amount of capital 

0 0 0 

Phase II 

Phase III 

2 

0 

Approved


has been raised from venture capital as 

well as from cooperation agreements 

with pharma ceutical companies to 

build a strong pipeline of R&D projects 

which is the basis for future commercial 

success. 

Biotech “Made in Vienna” – 

22 Products in Clinical Development 

Two biopharmaceutical products developed 

in Vienna are currently on the 

market: an anti-viral nasal spray against 

the common cold, developed by Marinomed, 

and a vaccine against Japanese 

Encephalitis, developed by Intercell. 

Nine further biological agents are 

expected to demonstrate their efficacy 

for patient therapy in clinical phase II. 

Among them is a compound against 

serious skin infections and bacterial 

pneumonia caused by drug-resistant 

bacteria, developed by Nabriva. Finally, 

there are 13 components (see Fig. 

8) in phase I. Companies like Apeptico 

are at this stage. More than 30 compounds 

could be added to the clinical 

pipeline in coming years if the preclinical 

projects clear further development 

hurdles. In total, the “Vienna pipeline” 

of the dedicated companies amounts 

Table 5 

Drug Candidates in Phase ii 

to 55 active ingredient projects. This 

is a number that corresponds well to 

the amount of projects carried out by 

a big pharmaceutical company. After 

conclusion of the survey, Apeiron acquired 

a phase III in the indication of 

neuroblastoma in children. 

Nearly 7,500 Jobs in Biotechnology 

Overall nearly 7,500 people are employed 

in the biotech industry in Vienna, 

of which 848 people work in dedicated 

and 6,650 people in biotech-active 

companies (see Tab. 4). The proportion 

of women among employees in dedicated 

biotech companies is 56%, much 

higher than in almost any other hightech 

sector (see Fig. 10). As elsewhere 

in Europe, the biotech companies in 

Vienna are relatively small. As shown 

in Fig. 9, almost half employ less than 

ten people – expensive, know-how intensive 

services such as the set up and 

execution of clinical trials or management 

of the patent portfolio are typically 

outsourced. This in turn provides fertile 

ground for specialized service providers 

that have also settled in the capital. 

Every fifth biotech-active company belongs 

to this group. 

Company Drug candidate Indication 

Activartis Trivax Renal cell carcinoma 

AFFiRiS AG AD02 Alzheimer‘s disease 

Apeiron AG 

APN201 

APN01 

Inflammatory skin conditions 

Acute Respiratory Distress Syndrome (ARDS) 

Avir Green Hills Biotechnology AG deltaFLU Influenza 

Intercell AG 

IC43 

IC41 

V710 (terminated) 

Pseudomonas aeruginosa infections 

Hepatitis C 

Nosocomial infections (Staphylococcus aureus) 

Marinomed Biotechnologie GmbH MAM-06.301 Type 1 allergy and autoimmune diseases 

Nabriva BC-3781 

44% (19) 

employee structure 

< 10 50 – 99 

10 – 49 100 – 249 

Fig. 9: Size structure of Vienna-based dedicated 

biotech companies according to their staff 

44% (371) 

Male 

2% (1) 

5% (2) 49% (21) 

56% (477) 

Female 

Fig. 10: Proportion of male and female employees 

in Vienna‘s dedicated biotech firms 

Antibiotics for serious infections caused 

by resistant pathogens 

33

34 

Walter schmidt 

together with his partner Frank 

Mattner, set up AFFiRiS AG which 

has been managed by both since 

2003 and it was no accident that 

they chose Vienna. Following his 

doctorate, Schmidt worked on 

research in Max Birnstiel’s team at 

the Institute of Molecular Pathology 

in Vienna. He was already a 

founder member of Intercell AG in 

1998. 

aFFiris aG 

Vienna-based AFFiRiS AG is one of the 

world’s leading pioneers in the development 

of vaccines against widespread 

diseases. It’s innovative platform – the 

AFFITOM © technology – enables it to 

develop custom-designed vaccines 

against the body’s own proteins which 

are at the center of chronic conditions 

such as Alzheimer‘s disease, Parkinson’s 

disease, arteriosclerosis or hypertension. 

Blockbuster Vaccines 

AFFiRiS first attracted attention in 

2008 with a large-scale licensing deal. 

The British pharmaceutical company 

GlaxoSmithKline signed a contract 

worth a total of 430 million euros giving 

it the rights to the two most advanced 

Alzheimer’s vaccines developed by 

AFFiRiS. Both partners have since 

made such good progress that the licensing 

agreement has been extended 

to include another vaccine developed 

by AFFiRiS. Having achieved the primary 

study objective of running two phase 

I trials at once, AFFiRiS AG was able to 

demonstrate the safety and the excellent 

tolerance of the two Alzheimer’s 

BioteCH sUCCess stories 

Category .......................................................... Health/medicine 

Foundation ......................................................................... 2003 

staff ....................................................................................... 80 

vaccines AD01 and AD02. What was 

particularly remarkable was that initial 

indications of efficacy were already 

showing up. A phase II study with AD02 

is currently running in several European 

countries. The intention is to treat 

420 patients in all. However, developing 

active ingredients for Alzheimer’s is 

not the only project AFFiRiS is involved 

in. The pipeline is full to bursting. There 

are more than ten other vaccines in development. 

The preclinical studies for 

Parkinson’s and arteriosclerosis are almost 

complete and the clinical phase I 

trials are scheduled to start. Development 

of the Parkinson’s vaccine PD01 

was even awarded a financial grant by 

the prestigious Michael J. Fox Foundation 

in October 2011. Development 

successes have repeatedly made it 

easy for the company to attract capital. 

So far, however, the company has 

stayed faithful to one investor. MIG 

Fonds, the leading specialist for venture 

capital in the German-speaking 

countries, has invested 11.5 million 

euros in the company since it was set 

up. Substantial public funding was also 

provided by austria wirtschaftsservice, 

FFG and ZIT.


aPeiron Biologics aG 


Foundation ......................................................................... 2006 

staff ....................................................................................... 21 

Vienna’s APEIRON Biologics AG has already 

worked wonders in only five years. 

Out-licensing, in-licensing, a pipeline 

spanning preclinical to phase III projects 

– the company has already achieved all 

of this even though it only started operations 

in early 2006. At the same time, the 

management, led by chief executive officer 

Hans Loibner, pays strict attention 

to capital efficiency. So far, the company 

has been financed by private investors 

and employees as well as from public 

funding from aws, FFG and ZIT. In addition, 

they closed a licensing contract 

with GlaxoSmithKline (GSK) in February 

2010, which could earn Apeiron up to 

236 million euros. In the course of this 

deal, GSK also became a shareholder 

of Apeiron. GSK has already transferred 

12.5 million euros of this in advance and 

received the rights to APN01, an enzyme 

that could be used in the treatment of 

acute respiratory distress syndrome 

and a variety of other diseases. The 

concept was initially researched in the 

laboratories of Josef Penninger, scientific 

director of the Institute of Molecular 

Biotechnology at the Austrian Academy 

of Sciences (IMBA) in Vienna. The geneticist 

is a co-founder and major share- 

holder of Apeiron. It was his idea to fight 

acute respiratory distress syndrome 

with recombinant ACE2. Nowadays, the 

angiotensin-converting enzymes are 

linked mainly to the regulation of blood 

pressure. The intention of current clinical 

studies is to demonstrate that their 

potential is far from exhausted. 

Apeiron has subsequently in-licensed 

new clinical projects to complement its 

pipeline. In the process, the company 

took over the recombinant human enzyme 

SOD, status phase II, from Polymun 

Scientific GmbH. SOD is about to 

enter a clinical trial for the topical treatment 

of skin damage following radiation 

therapy as a part of cancer treatment. 

Apeiron also made use of its connections 

to Big Pharma. As a result, it acquired 

an antibody-IL2 fusion protein for 

the treatment of neuroblastoma in children 

from the German Merck KGaA. The 

last cooperation that Apeiron entered 

into was with St. Anna Children’s Cancer 

Hospital in Vienna for an antibody in the 

same indication but with a different subset 

of patients. The phase III project involves 

study centers in 20 countries. 160 

children have already been recruited. 

Hans Loibner 

has been CEO of APEIRON Biologics 

AG in Vienna since October 

2005. He has 35 years experience 

working both in Big Pharma and 

Biotech, with a focus on cancer 

immunotherapy. After spending 

20 years in the R&D management 

of Sandoz and Novartis, he set up 

the cancer immunotherapy specialist 

Igeneon in 1999 and acted 

as CEO until mid 2004. 

35

36 

thomas muster 

is the Chief Executive Officer, 

founder and scientific manager of 

AVIR Green Hills Biotechnology 

AG. After starting his scientific 

career at the University of Natural 

Resources and Life Sciences 

in Vienna, Thomas Muster was 

drawn to the Mount Sinai School 

of Medicine in New York where 

he worked on retroviruses such 

as HIV and influenza viruses. 

Fighting flu where it enters the human 

body. This is the aim of AVIR Green 

Hills Biotechnology AG which is developing 

next generation influenza 

vaccines. The motto: “A nasal vaccine 

spray instead of injection”. In April, the 

company started a trivalent phase I/II 

trial during which the seasonal influenza 

vaccine was tested for the first 

time in its final composition. 

Fighting the Flu! 

80 volunteers between the ages of 

16 and 60 were included in the study. 

The trial was conducted at the Department 

of Clinical Pharmacology at 

the Medical University of Vienna and 

included a trivalent formulation – this 

means a vaccine comprising three influenza 

strains H1N1, H3N2 and B. In 

the clinical trial, AVIR Green Hills uses 

its particularly efficient live-attenuated 

deltaFLU vaccine from which the 

pathogenicity factor NS1 has been 

removed. This approach combines 

maximum efficacy with excellent 

safety and tolerance. This has already 

been demonstrated in previous clinical 

trials. The vaccine was produced 


aVir Green Hills Biotechnology aG 


Foundation ......................................................................... 2002 

staff ....................................................................................... 40 

in cell cultures, a modern method that 

replaces the traditional production 

method using hens’ eggs. 

Leading European Specialist 

AVIR Green Hills is also well-connected 

at an international level. In the European 

Commission’s 6 th Framework 

Program, the company led the FLU- 

VACC consortium which received 9.2 

million euros of funding for the development 

of an intranasal nasal influenza 

vaccine. Alongside the public funding, 

which included a recent grant of 1.6 

million euros from the Austrian Research 

Promotion Agency (FFG) and 

substantial financing from aws and ZIT, 

the research work of AVIR Green Hills 

is mainly financed by business angels. 

A new round of financing was only 

completed last year. Additionally, 

there are advanced activities to conclude 

licensing contracts for the intranasal 

vaccine deltaFLU in several 

territories. With reports of success 

like this in the bag, AVIR Green Hills is 

an attractive candidate for investment 

and for commercial success.


PDC Biotech GmbH 


Foundation ..........................................................................2008 

staff ......................................................................................... 4 

Company founders from North America 

don't often find their way to Europe. Diane 

Kalina and Patricia Griffin made an exception 

in this case: PDC Biotech GmbH 

which they set up in Vienna has brought 

them success in the federal capital. The 

two managing directors were working as 

consultants in the biotechnology sector 

in Canada and among their clients was 

Theratechnologies Inc. 

Preventing Premature Labor 

The company wanted to concentrate on 

its Phase III project and so was on the 

lookout for a buyer for a very promising 

earlier stage technology; a peptide that 

can prevent preterm labor and painful 

uterine contractions during menstruation. 

Premature births are among the greatest 

peri natal challenges in industrialized 

countries. They are usually preceded by 

preterm labor. The prostaglandin F2αreceptor 

antagonist is intended to prevent 

this. So far there are no alternative 

treatments that are effective and safe for 

the fetus and mother. Along with emotional 

stress and the risk to the child’s life, 

preterm births cause significant costs. 

Experts assume these to be in excess 

of 25,000 euros which is what it costs to 

treat a premature baby. Kalina and Griffin 

identified the need, in-licensed the drug 

candidate PDC31 and set up PDC Biotech 

in Vienna. Seed financing was successfully 

obtained by aws. With a set-up 

grant of 1 million euros, the founding 

team was able to inspire prestigious investors. 

Edmond de Rothschild Investment 

Partners and MIG invested approximately 

4 million euros shortly after 

the set-up. Furthermore, PDC received 

funding by ZIT in the framework of the 

call “Patients in Focus 2009”. 

Using the funds from the Series A round, 

the company is now completing a Phase I 

trial to assess safety as well as effects on 

uterine contractility in healthy women 

with primary dysmenorrhea. The results 

should ultimately impress and attract further 

investors for a Series B round. The 

company's immediate aim post-Series B, 

is to advance PDC31 to the next stage 

of development – Phase II – and study 

the effects of PDC31 in pregnant women 

with preterm labour. The goal is to determine 

whether PDC31 can inhibit uterine 

contractions halt the progression of preterm 

labor to protect young life. 

Diane Kalina and 

Patricia Griffin 

are the founders and managing 

directors of PDC. During their 

careers both have gained experience 

in management positions 

with leading pharma companies 

on both sides of the Atlantic. 

Prior to starting up PDC, both cofounders 

worked as consultants 

for pharmaceutical and biotech 

companies. 

37


medtech in Vienna – Facts & Figures 

The healthcare system in Austria enjoys 

an excellent international reputation. 

This is due not least to the renowned 

hospitals located in the country's capital 

Vienna which have both superbly 

qualified medical staff and first-class 

technical facilities incorporating stateof-the-art 

technology. As a result, Austria 

and especially Vienna create not 

only an attractive market for medical 

technology products but also form an 

important location for the development 

and production of several medical devices. 

This activity is based on a long, 

in some cases centuries old tradition 

of engineering and precision mechanics 

in the city's companies. 

Medical devices, as defined by the 

Global Medical Devices Nomenclature 

Agency (GMDN), are the main 

products of the 33 dedicated medical 

technology companies resident 

within the city limits of Vienna (see 

Tab. 7). Examples are Braincon Technologies 

Group (electromechanical 

and e-health solutions) or Orthorobot 

GmbH (dental technology). They are 

involved exclusively in research, development 

and manufacture of these 

devices. In another five Vienna-based 

Table 7 

companies, medical technology is one 

of several areas of work. Among these 

are Sempermed GmbH (gloves) or 

Telecare Systems GmbH (emergency 

call systems). These firms are called 

medtech-active companies according 

to the OECD classification for biotech 

firms that is also applied here to medical 

technology. 

Broad Range of Activity 

The areas of activity pursued by the 

medical technology companies are 

very varied (see Tab. 6). Three areas 

dominate: firstly the development of 

specialized software and other products 

for the trend areas of eHealth and 

telemedicine, secondly the production 

of precision electromechanical devices 

for patient monitoring, surgery, care 

or rehabilitation, and thirdly, a large 

number of Viennese medtech companies 

are active in research, development 

and sale of consumables for dayto-day 

hospital use. 

Innovations by New Companies 

Vienna as a location is also a breeding 

ground for up-and-coming medtech 

medtech in Vienna – Key Figures 2010 

areas of activity* 

Software for medicine, telemedicine 

and e-health 

Total number of primary medtech companies ............................................................................................................................. 38 

Number of dedicated medtech companies ...................................................................................................................... 33 

Number of other medtech-active companies ..................................................................................................................... 5 

Total number of employees (headcount) in primary medtech companies ..............................................................................1,661 

Number of employees in dedicated medtech companies ..............................................................................................831 

Number of employees in the medtech-active companies .............................................................................................. 830 

Total revenues of primary medtech companies ............................................................................................................. EUR 835 M 

Revenues of dedicated medtech companies .....................................................................................................EUR 116 M 

Revenues of other medtech-active companies ................................................................................................. EUR 719 M 

R&D expenditure of dedicated medtech companies ...................................................................................................... EUR 30 M 

Total amount of financing raised by dedicated medtech companies ................................................................................ EUR 5 M 

Table 6 

41 % 

Electromechanical medical devices 36 % 

Consumables 27 % 

Dental technology 9 % 

Diagnostic and therapeutic radiation 

technology 

9 % 

Reusable and surgical instruments 9 % 

Technical aids for invalids 9 % 

Active implantation technology 5 % 

Anesthesiology and ventilation 5 % 

Hospital equipment 5 % 

In-vitro diagnostics 5 % 

Non-active implantable technology 5 % 

Ophthalmic and optical technologies 5 % 

Means based on biological materials 0 % 

Others 0 % 

* multiple answers possible by dedicated 

medtech companies 

39

40 ComPany statistiCs 

9% (3) 

9% (3) 

18% (6) 

3% (1) 

age structure 

2000 – 2010 < 1960 

1990 – 1999 

1960 – 1969 

3% (1) 

average age: 

17.9 years 

8 of top 10 World market Leaders Present in Vienna 

Company Global Sales Sales Rank 

Johnson & Johnson 16,5 #1 

Siemens Healthcare 12,1 #2 

GE Healthcare 11,2 #3 

Medtronic 10,2 #4 

Baxter International (Medtech and Biotech) 8,8 #5 

Philips Healthcare 7,8 #6 

Abbott Laboratories 5,9 #7 

Boston Scientific 5,7 #8 

Not present in Vienna 

1970 – 1979 

1980 – 1989 

58% (19) 

Fig. 11: Distribution of Vienna-based dedicated 

medtech companies according to their 

founding year 

Table 8 

companies. As shown in Tab. 9, further 

companies were established last 

year such as MySugr Apps, which is 

working on a new format for monitoring 

diabetes via mobile phones. Jeder 

GmbH has dedicated itself to a new 

dental device. Another 2010 start-up 

is Vasema GmbH, a developer of new 

sensors for determining skin health. It 

will be exciting to see when these new 

products made in Vienna will be used 

in hospitals for the patient's good. 

These young medtech firms complement 

the group of global players like 

Otto Bock or Agfa Healthcare that are 

active in Vienna. With their almost century-old, 

longstanding tradition, Carl 

Reiner or Franz Kacer & Sohn GmbH 

are an exception to the Vienna scene. 

More than half the firms – more precisely 

58% – were set up less than ten 

years ago (see Fig. 11). One of them is 

EMCOOLS Medical Cooling Systems 

AG, founded in 2005. The enterprise 

has developed a single use cooling device, 

which is adherent to the patient’s 

skin. The so-called EMCOOLSpad is 

highly adjustable during the cooling 

procedure. The company’s aim is to be- 

come the leader in homecare applications 

for skin cooling. Founded in 2008, 

Miracor GmbH is also a representative 

of the younger group among dedicated 

medtech companies. The firm develops 

a new standard of care for cardiac 

diseases. These younger start-ups 

complement a significant proportion of 

enterprises (18%) ranging between 10 

and 20 years of age. The average age 

of a Vienna-based medical technology 

company is 17.9 years. 

Global Market Leaders in Vienna 

For most of the global medtech players 

Vienna is too important to be missed. 

Only two of the world’s top 10 are not 

present in the federal capital. All the others 

– among them the market leaders 

Johnson & Johnson, Siemens Healthcare 

and GE Healthcare – have a local 

subsidiary which enriches the medtech 

scene in Vienna and reinforces its international 

standing (see Tab. 8). 

800 Million Euros in Revenues 

Overall, the sale of medical devices 

in the federal capital generates more 

Covidien 5,4 #9 

Becton Dickinson 5,0 #10


than 800 million euros (see Tab. 7). 

Around 116 million euros of this sum is 

attributable to the group of dedicated 

medical technology companies (see 

definition on p. 151). The sometimes 

considerably larger medtech-active 

companies like Carl Zeiss produce 

total revenues of 719 million euros in 

Vienna. 

Short Development Times 

In contrast to biotechnology, medical 

technology is characterized by significantly 

shorter development times 

and – generally speaking – a lower 

development risk combined with a 

lower attrition rate. This can be seen 

above all in the ratio of investment in 

research and development to turnover. 

With the 116 million euros in sales 

already referred to, they are generating 

revenue that is approximately four 

times higher than their R&D expenditure 

of 30 million euros. Viennese 

medtech companies spend more on 

R&D than their counterparts in the 

rest of the country. The venture capi- 

Table 9 

tal investment amounted to around 5 

million euros in 2010. 

1,600 People in Dedicated Firms 

Like their counterparts in the biotechnology 

industry, the medical technology 

companies are also relatively 

small in terms of staff. Well in excess 

of half (58%) of the firms employ less 

than ten people (see Fig. 12), which 

is typical for many high-tech industries. 

However, with a share of around 

one third (36%), a large number of 

the companies have already left the 

most difficult decade of their early 

existence behind them. All together, 

the medtech firms in Vienna employ 

about 1,660 people. Half of them 

work at the dedicated medtech 

companies and the other half in the 

group of medtech-active companies. 

Male employees dominate the medical 

technology area (see Fig. 13), 

although not as heavily as in comparable 

sectors such as information 

technology or mechanical engineering. 

The proportion of female employees 

is 41 %. 

medtech Companies Founded 2010 in Vienna 

MySugr Apps OG: The team develops software to help diabetes patients collect their personal data electronically and store 

them on mobile phones by means of a “serious social game”. 

Jeder GmbH: The company is engaged in the development of a device, which makes the implanting of artificial teeth easier and 

safer – for both the doctor and the patient. 

VASEMA GmbH: Vasema develops a high-tech sensor to diagnose skin diseases early. This will increase the chances of re- 

covery and reduce healthcare costs. 

3% (1) 

3% (1) 

36% (12) 

employee structure 

< 10 

10 – 49 

50 – 99 

59 % (490) 

Male 

0% 

> 249 

100 – 249 

Fig. 12: Size structure of dedicated medtech 

companies according to their staff 

41 % (341) 

Female 

58% (19) 

Fig. 13: Proportion of male and female employees 

in Vienna‘s dedicated medtech firms 

41

42 

Peter rossegger 

has been the managing director 

of Carl Reiner since March 2011. 

He joined the company in 1988 

for the first time and then left it 

in 1990 for a period of five years 

to pursue other opportunities in 

the medtech area. After his return 

in 1995, Peter Rossegger established 

the international marketing 

and distribution of the company's 

innovative jet ventilator system 

TwinStream. 

Carl reiner GmbH 

The Reiner family was working in the 

Austrian capital city of Vienna as surgical 

instrument manufacturers as long 

as 150 years ago. Today, the roots of 

Carl Reiner GmbH reach almost as far 

back into the past with its predecessor 

having been established in the heart of 

Vienna's hospital and university quarter 

in 1912. Carl Reiner's building in the 

Mariannengasse is still the company's 

headquarters but other buildings in 

Vienna and the site in Graz have been 

added in the meantime and reflect the 

company’s growth. 

From Tonsil Compressors … 

Since it was set up, the Carl Reiner 

company has dedicated itself to the 

construction and development of 

state-of-the-art surgical instruments 

and equipment. What started back 

then with the manu facture of tonsil 

compressors based on Dr. Haslinger's 

model, reached its provisional peak in 

2005 with the innovative Twinstream 

respirator. 

The old-established Viennese company 

took the plunge into the global 

market with the first microprocessor- 

meDteCH sUCCess stories 

Category ....................................... medical Device Development 

Foundation .......................................................................... 1912 

staff ....................................................................................... 30 

controlled unit for jet ventilation. The 

special ventilation technique was researched 

by Carl Reiner in cooperation 

with the ENT clinic of Vienna’s General 

Hospital (AKH) – Europe's largest hospital 

– and other partners. The special 

feature of this innovative procedure is 

that it enables patients to be ventilated 

without a separate air tube. 

The space gained as a result is particularly 

important during operations on 

the lung or trachea when surgeon and 

anesthetist have to share access to 

the patient. Now, thanks to integrated 

pipes and nozzles, the apparatus can 

take the respiratory air directly to the 

patient. 

… to High-tech Respirators. 

With its broad product range, Carl 

Reiner GmbH is also widely recognized 

to be a skilful contact in widespread 

indications such as cardiology and 

urology. The Viennese medical technology 

specialist now carries out the 

planning of complete medical facilities 

and offers integrated system solutions 

to achieve the aim becoming a singlesource 

supplier for its customers.


CryPtas it-security GmbH 

Category ........................................................................ eHealth 

Foundation ......................................................................... 2003 

staff ....................................................................................... 15 

Since it was set up in 2003, CRYPTAS 

it-security GmbH has specialized in the 

development of security solutions in the 

field of electronic healthcare systems. 

The company focuses, among other 

things, on solutions in the eHealth sector 

which allow feasible management of 

asymmetric encryption systems. 

eHealth is more than just the use of IT 

in healthcare. By networking information 

and processes, additional benefits 

are provided for the patient and the 

health service provider. The only obstacle 

is: data security. Health data is one 

of the most sensitive information and, 

therefore, has to be protected in the 

best possible manner with IT security 

technologies. The innovative software 

CAVE (Card Authetication Virtualization 

Environment), developed by CRYPTAS 

has recently been supporting the electronic 

administration of the Statutory 

Health Insurance for Dentists in Westphalia-Lippe: 

the intelligent Smart Card 

System makes online billing easier and 

saves time, money and effort for service. 

Digital certificates on smart cards 

can be used for strong user authentication, 

digital document signature and of 

course also for the encryption of sensi- 

tive information – all are crucial for today's 

eHealth applications. Security and 

protection of data privacy must not be 

seen as cumbersome features – they 

are critical for establishing trust which is 

the basis for user acceptance. Although 

smart card technology was always considered 

to be secure, it was also labeled 

user-unfriendly, the second major success 

factor for user acceptance. CRYP- 

TAS has solved this problem by developing 

a clientless smart card concept. 

CAVE enables smart cards to be used 

without the need for previously installed 

software. Instead, the processes are 

outsourced to a central environment 

that can be made very secure. As a result, 

users no longer need to deal with 

complicated technical processes and 

can use the system immediately and 

without prior knowledge. It is enough to 

simply connect via the web browser to 

the online service by employing a userfriendly 

plug & play technology and insert 

the chip card. CRYPTAS received 

support from ZIT during the development 

of CAVE. The IT company developed 

this system on its own and fully 

researched the technology behind it as 

part of the ZIT-Call “Patients in Focus 

2009” funding project. 

stefan Bumerl 

is managing director of CRYPTAS 

it-security GmbH which he set 

up in 2003. He has worked in 

the field of data security, strong 

authentication and smart cards 

for over 15 years and is acknowledged 

nationally and internationally 

as an expert in this sector. 

He and his company have 

implemented many projects for 

protecting digital identities. 

43

44 

Jon H. Hoem 

has been CEO of Miracor since 

the company was founded in 

May 2008. He has 23 years of 

experience of advanced medical 

devices in cardiology and cardiac 

surgery. Prior to joining Miracor, 

he was Senior R&D Engineer 

at GE Vingmed Sound, Vice 

President of Sales&Marketing in 

Medi-Stim and VP Europe for the 

US medical technology company 

AtriCure. 

Miracor Medical Systems is one of the 

younger companies in Vienna’s medical 

technology scene. It was founded in May 

2008 with capital backing from Earlybird 

and Delta Partners. The company wants 

to establish a new standard of care to 

treat cardiac diseases such as heart attack 

and heart failure using the PICSO 

technology. This concept was conceived 

by Miracor’s founder and Chief 

Scientific Advisor, Prof. Werner Mohl, 

who is a practising cardiac surgeon at 

the Medical University of Vienna. 

Patients recovering from an interventional 

procedure can benefit from the Pressure-controlled 

Intermittent Coronary Sinus 

Occlusion (PICSO) technology. The 

system consists of an innovative cardiac 

catheter and a control unit. This unit is 

used for controlled inflation and deflation 

of the balloon at the catheter tip. After 

treating a heart attack using a stent, the 

CE-marked unit is used to intermittently 

block the coronary sinus venous blood 

in a controlled manner thus improving 

the microcirculation in the compromised 

cardiac tissue. In around 350,000 heart 

attack patients in the USA and Europe, 

the microcirculation in the heart muscle 

is less than optimal even after the actu- 


miracor medical systems GmbH 

Category ....................................... medical Device Development 

Foundation ......................................................................... 2008 

staff ....................................................................................... 11 

al blockage in the arterial blood vessel 

has been removed. Initial clinical trials 

in March 2011 showed that PICSO has 

the potential to reduce ischemia in these 

patients. The plan now is to corroborate 

the results in the broader-based, multicenter 

RAMSES study. The concept has 

impressed the German venture capitalist 

fund SHS which was the lead investor 

in Miracor’s second financing round in 

September 2011. Since its foundation in 

May 2008, Miracor has secured a total of 

14.9 million euros in venture capital and 

grants to develop the company. Full European 

market launch of PICSO will start 

in the second half of 2013. For Miracor 

this would be the impulse to make the 

leap across the Atlantic. 

The outcome of the multi-center 

RAMSES trial will lay the foundations 

for establishing European sales and reimbursement. 

Europe will be the test 

market for the new technology providing 

both clinical and commercial proof of 

concept. Several leading medical device 

corporations are seeking medical devices 

which address the big unmet clinical 

need which Miracor is targeting. This exit 

route has lately proven to be very profitable 

for medtech investors.


tissueGnostics GmbH 

Category .......................... software and Hardware Development 

Foundation ......................................................................... 2003 

staff ....................................................................................... 35 

The pathologist’s experience still 

comes up trumps when evaluating 

blood and tissue samples. The quantitative 

analysis of different cell types in 

blood or tissue is determined by a laboratory 

employee who counts the cells. 

A shortage of qualified staff and an increasing 

number of analysis samples 

challenge laboratory systems of today. 

Automating Blood Sample Analysis 

Vienna-based TissueGnostics GmbH 

has set itself the target of automating 

these processes with a new software 

program thereby revolutionizing the 

analysis of blood and tissue samples. 

Having machines carry out the analysis 

of tissue samples and pre-classification 

of leucocytes on blood slides sounds 

much easier than it really is. Georg 

Steiner and Dr. Rupert Ecker, the present 

managing directors of TissueGnostics, 

researched the basic principles 

of the technology 10 years ago. They 

set up TissueGnostics in 2003 and a 

year later presented the technology to 

doctors for the diagnosis of prostate 

cancer in tissue samples. The requirements 

are a high-power microscope 

and a software program which uses a 

specially developed algorithm to identify 

and display pathogenic patterns in 

cells. With TissueFAXS, HistoFAXS and 

HemoFAXS, TissueGnostics markets 

three different systems for analysing tissue, 

stained tissue sections and blood 

samples. The products are already being 

marketed globally with the help of 

distributors. The company has its own 

branches in the USA and Romania. The 

international expansion was financed 

by the Wiener Wachstumsfonds which 

has an almost 50 % stake in the company. 

The best argument in favor of the 

TissueGnostics systems is the saving 

in time: Once the slides are on the microscope, 

the rest is plain sailing. 

Large Number of Applications 

What used to be laborious detail work 

now takes place automatically with a 

minimum of time and effort. The system 

is also completely objective. Analyses 

can be saved and assessed retrospectively. 

The systems developed by TissueGnostics 

have already proven their 

suitability in a large number of practical 

applications in facilities around the 

world, like the Harvard Medical School 

and University of Heidelberg. 

Georg steiner 

together with Rupert Ecker, 

manages the medical technology 

company TissueGnostics GmbH. 

The two biologists Steiner and 

Ecker already worked together at 

Vienna’s University Clinic in the 

mid-nineties and since then have 

dedicated themselves to improving 

medical microscopy which 

also includes the setting up of 

TissueGnostics in 2003. 

45

LiFe sCienCe DireCtory 

Company Directory 

ABA – Invest in Austria 

Opernring 3 


Tel.: +43-1-5885-80 

Fax: +43-1-5868-659 

Abbott GmbH 

Perfektastrasse 84A 


Tel.: +43-1-891-120 

Fax: +43-1-891-1244 

Sector of activities: sales 

ABF Pharmaceutical Services GmbH 

Altmannsdorfer Strasse 104 


Tel.: +43-1-8901-200-0 

Fax: +43-1-8901-200-11 

Founded: 2005 

Staff: 20 

Working fields: human health 

Sector of activities: services, sales 

ACR – Austrian Cooperative Research 

Haus der Forschung 

Sensengasse 1 


Tel.: +43-1-2198-573 

Fax: +43-1-2198-573-13 

M R 

B Biotech dedicated b Biotech active M Medtech dedicated m Medtech active R Life science related 

B 

B 

B 

B 

M R 

M R 

M R 

office@aba.gv.at 

www.investinaustria.at 

www.abbott.at 

www.abf-pharma.com 

office@acr.at 

www.acr.at 

A 

47

48 

AActivartis Biotech GmbH 

B M R 


Zimmermannplatz 10 


Tel.: +43-1-40170-4080 

Fax: +43-1-40170-64080 

Contact: Prof. Dr. Thomas Felzmann (CEO) 

Founded: 2003 

Staff: 6 


Sector of activities: R&D, production www.activartis.com 

ad rem team GmbH – therapie4you 

Auenbruggergasse 2/11 


Tel.: +43-1-7103165 

Fax: +43-1-7104065 

Founded: 1999 

Staff: 6 


Aedos Management & Beratungs Ges.m.b.H 

Sandleitengasse 17/20/Top 3 


Tel.: +43-1-87600-5152 

Fax: +43-1-87600-53 

Contact: Ing. Mag. Michael Pieler (Managing Director) 

AFFiRiS AG 

Karl-Farkas-Gasse 22 


Tel.: +43-1-7981575-300 

Fax: +43-1-7981575-311 

Contact: Dr. Walter Schmidt (CEO) 

Founded: 2003 

Staff: 80 


Sector of activities: R&D, production 

M R 

therapie4you@ad-rem-team.com 

www.ad-rem-team.com 


B 

B 

M R 

B M R 

www.aedos.at 

office@affiris.com 

www.affiris.com


Agfa HealthCare Ges.m.b.H. 

Diefenbachgasse 35 


Tel.: +43-1-89966-600 

Fax: +43-1-89966-110 

Contact: Albrecht Müller 

Founded: 1989/2005/2007 

Working fields: software for medicine, telemedicine and eHealth 

Agneter PharmaConsulting GmbH 

Mariahilfer Strasse 71 / 15 


Tel.: +43-1-52642-44 

Contact: Dr. Ernst Agneter (Managing Director) 

Akron Molecules GmbH 

Campus Vienna Biocenter 5 


Tel.: +43-1-7987882-200 

Fax: +43-1-7987882-222 

Founded: 2010 


Sector of activities: R&D 

Alcon Ophthalmika GmbH 

Mariahilferstrasse 120 


Tel.: +43-1-5966-9070 

Fax: +43-1-5966-970-11 


B M R 

M R 


B 

B M R 

B 

M R 

www.agfahealthcare.com 

www.pharmaconsulting.at 

A 

office@akron-molecules.com 

www.akron-molecules.com 

www.alcon.com 

49

50 

AAlgOss Biotechnologies GmbH 

Schumanngasse 15 


Tel.: +43-1-40758-20 

Fax: +43-1-40758-2010 

Contact: Dr. Rolf Ewers 

Founded: 2002 

Staff: 3 



Allergopharma Vertriebsges. mbH 

Siebenhirtenstrasse 30 


Tel.: +43-1-61571-540 

Fax: +43-1-61571-53 

Founded: 1969 


Alvetra u. Werfft GmbH 

Boltzmanngasse 11 


Tel.: +43-1-3191456-331 

Fax: +43-1-3191456-344 

Contact: Herbert Frantsits 

Founded: 1948 

Working fields: animal health 

AME International GmbH 

Hoyosgasse 5 


Tel.: +43-1-50359-79 

Fax: +43-1-50359-7920 

Contact: Mag. Heinz Messinger (Manging Director) 

Founded: 1995 

Staff: 18 

Working fields: hospital hardware, medical software, telemedicine and eHealth 


B M R 

M R 


office@algoss.at 

www.algoss.at 

office@allergopharma.at 

www.allergopharma.at 


B 

b M R 

B M 

R 

office@alvetrawerfft.at 

www.alvetrawerfft.at 

office@ame-international.com 

www.ame-international.com


Amgen GmbH 

Prinz-Eugen-Strasse 8-10 


Tel.: +43-1-502-17 

Fax: +43-1-50217-20 

Founded: 1995 

Staff: 100 


Sector of activities: sales info-at@amgen.com 

www.amgen.at 

An der Grub Bio Research GmbH 

Ortliebgasse 25/1 


Tel.: +43-1-489-42-14-0 

Fax: +43-1-489-42-14-50 

Founded: 1987 

Working fields: non-specific services 

Sector of activities: production, sales 

AOP Orphan Pharmaceuticals AG 

Wilhelminenstrasse 91 


Tel.: +43-503-72440 

Fax: +43-503-72445 

Contact: Dr. Rudolf Widmann (CEO) 

Founded: 1996 

Staff: 50 



Apeiron Biologics AG 

Campus-Vienna-Biocenter 5 


Tel.: +43-1-8656577-0 

Fax: +43-1-8656577-800 

Contact: Dr. Hans Loibner (CEO) 

Founded: 2003 

Staff: 21 



M R 


B 

B M R 

b M R 

B M R 

office@andergrub.com 

www.andergrub.com 

office@aoporphan.com 

www.aoporphan.at 

A 

apeiron@apeiron-biologics.com 

www.apeiron-biologics.com 

51

52 

AAPEPTICO Forschung und Entwicklung GmbH 

c/o mingo bueros 

Mariahilferstrasse 136, Top 1.15 


Tel.: +43-664-143-2919 

Fax: +43-664-147-7280 

Contact: Dr. Bernhard Fischer (CEO) 

Founded: 2008 | Staff: 5 



Aptiv Solutions GmbH 

Pyrkergasse 10/6 


Tel.: +43-1-360700-8813 

Fax: +43-1-360700-8810 

Contact: Mag. Marion Neusser 

Founded: 2007 

Staff: 6 


Sector of activities: services 

ARAX Capital Partners GmbH 

B M R 

M R 


office@apeptico.com 

www.apeptico.com 

marion.neusser@ 

aptivsolutions.com 

www.aptivsolutions.com 

Grinzingerstrasse 87 


Tel.: +43-1-370-74740 

Fax: +43-1-370-747422 

Contact: Christian Tiringer 

Founded: 2007 

Staff: 8 

Sector of activities: services office@arax.at 

www.arax.at 

Arsanis Biosciences GmbH 

Helmut-Qualtinger-Gasse 2 


Contact: Eszter Nagy (MD, PhD) 

Founded: 2010 

Staff: 20 




B 

B 

M R 

B M R 

office@arsanis.com 

www.arsanis.com


Arthur D. Little Austria GmbH 

Schottengasse 1 


Tel.: +43-1-515-41-0 

Contact: Mag. Stefan Höffinger (Managing Director) 


Askin & Co. GmbH 

Albert-Schweitzer-Gasse 6 | 1140 Vienna 

Tel.: +43-1-97988-44 | Fax: +43-1-97988-46 

Contact: K. R. Ing. Herbert Lugbauer 


Working fields: electromechanical medical technology, hospital hardware, 

non-active implantable technology, ophthalmic and optical technology, reusable 

instruments, single use technology, diagnostic and therapeutic radiation technology, 

software for medicine, telemedicine and eHealth 


Asprion Augenprothetik GmbH 

Spitalgasse 15/2/10 


Tel.: +43-1-40623-71 

Founded: 1925 

Working fields: non-active implantable technology 


Assign Clinical Research GmbH 

Donau City Strasse 6 


Tel.: +43-1-4033805-26 

Fax: +43-1-4033805-66 

Contact: Mag. Katharina Trinks (Head of Clinical Project Management) 

M R 


B 

B 

M R 

B M R 

B 

M R 

A 

adlittle.vienna@adlittle.com 

www.adlittle.at 

askin@askin.co.at 

www.askin.co.at 

info@asprion.at 

www.asprion.at 

officeCR@assigngroup.com 

www.assigngroup.com 

53

54 

AAssista Laborelectronics GmbH 

Döblinger Hauptstrasse 95 


Tel.: +43-1-36984-40 

Founded: 1980 


Astellas Pharma Ges.m.b.H. 

Linzer Strasse 221 E 2 


Tel.: +43-1-877-2668-0 

Fax: +43-1-877-1636 

Contact: Berthold Cvach (Managing Director) 

Founded: 1973 

Staff: 55 



Astra Tech GmbH 

Schlosshoferstrasse 4/4/19 


Tel.: +43-1-21461-50 

Founded: 1995 


AstraZeneca Österreich GmbH 

Schwarzenbergplatz 7 


Tel.: +43-1-71131-0 

Fax: +43-1-71131-221 

Contact: Dr. Christian Dreger 

Founded: 1963 


M R 


assista@lbe.co.at 

www.assista.at 


B 

B 

B 

B 

M R 

M R 

M R 

office@at.astellas.com 

www.astellas.at 

info.at@astratech.com 

www.astratech.at 

info.at@astrazeneca.com 

www.astrazeneca.at


Astrid Bioscience GmbH 

Währingerstraße 61/2/7 


Tel.: +43-1-229-7382 

Fax: +43-1-229-7329 

Contact: Zoltan Kovacs 

Working fields: bioinformatics 

Astro-Pharma GmbH 

Allerheiligenplatz 4 


Tel.: +43-1-9619313 

Fax: +43-1-9619314 

Contact: Mag. Helmut Kaisergruber (Owner) 

Founded: 2003 

Staff: 17 



Atomed HandelsgmbH 

Draschestrasse 88 


Tel.: +43-1-6060580 

Fax: +43-1-6060580-22 

Founded: 2000 


Austria Wirtschaftsservice GmbH (aws) 

Ungargasse 37 


Tel.: +43-1-50175-594 

Fax: +43-1-50175-908 

Contact: Johannes Sarx 

B M R 

M R 


B 

B 

B 

M R 

M R 

info@astridbio.com 

www.astridbio.com 

office@astro-pharma.at 

www.astro-pharma.at 

office@atomed.at 

www.atomed.at 

j.sarx@awsg.at 

www.awsg.at 

A 

55

56 

AAustrian Biotech Industry 

Wiedner Hauptstrasse 63 


Tel.: +43-5-90900-3367 

Fax: +43-5-90900-280 

Contact: Dr. Franz Latzko (Managing Director) 

Founded: 2001 

Austrian Standards Institute 

Heinestrasse 38 


Tel.: +43-1-21300 

Fax: +43-1-21300-355 

Contact: Regina Slameczka 


Austromed 

Bossigasse 24/7 


Tel.: +43-1-87770-12 

Fax: +43-1-87770-20 

Avir Green Hills Biotechnology 

Research and Development Trade AG 

Forsthausgasse 11 | 1200 Vienna 

Tel.: +43-1-3199-670 

Fax: +43-1-3196-099 

Contact: Thomas Muster (CEO, CSO) 

Founded: 2002 

Staff: 40 



M R 


office.abi@fcio.wko.at 

http://biotechindustry.at 


B 

B 

B 

M R 

M R 

B M R 

office@austrian-standards.at 

www.austrian-standards.at 

office@austromed.org 

www.austromed.org 

office@greenhillsbiotech.com 

www.greenhillsbiotech.com


Axon Neuroscience 

Forschungs- und Entwicklungs GmbH 

Campus Vienna Biocenter 5 / Rennweg 95b 


Tel.: +43-1-7966-8980 

Fax: +43-1-7966-89820 

Contact: Dr. Michael Novak (CSO) 




B.R.A.H.M.S. Austria GmbH 

Wehlistrasse 27B 


Tel.: +43-1-585-6667-0 

Fax: +43-1-585-6667-9 

Contact: Hermann Schmidt 


B.R.A.H.M.S. Diagnostica GmbH 

Schönbrunner Strasse 45 



B&K Bettschart&Kofler 

Medien- und Kommunikationsberatung GmbH 

Porzellangasse 35 / Top 3 


Tel.: +43-1-3194378-12 

Fax: +43-1-3194378-20 

Contact: Mag. Gaby Reiner 

B M R 

M R 


B 

B 

B 

M R 

M R 

B 

office@axon-neuroscience.at 

www.axon-neuroscience.at 

office@brahms.at 

www.brahms.at 

office@brahms.at 

www.brahms.at 

reiner@bkkommunikation.com 

www.bkkommunikation.com 

57

58 

BBalmung Medical Handel GmbH 

Vienna Twin Tower 

Wienerbergstrasse 11 


Tel.: +43-1-99460-6412 


Bard Medica S.A. 

Thaliastrasse 125a/1/5 


Tel.: +43-1-4949-130 

Fax: +43-1-4949-13030 

Contact: E. Scherbaum (CS-Manager) 


Working fields: non-active implantable technology, single use technology, 

components based on biological materials, others 


BASF Österreich GmbH 

Handelskai 94-96 


Tel.: +43-1-87890-227 

Fax: +43-1-87890-120 

Contact: Joachim Meyer (Managing Director) 

Founded: 1951 


BASKO HEALTHCARE 

Office Park I; Top B02 


Tel.: +43-1-283533-0 

Fax: +43-1-283626-2 

Contact: Herbert Strauß 

Founded: 1986 


M R 


office@balmung.cc 

www.balmung.cc 


B 

B 

B 

B 

M R 

M R 

M R 

info.bardmedica@crbard.com 

www.bard.de 

basf.at@basf.com 

www.basf.at 

www.basko.com


Bauerfeind GmbH 

Dirmhirngasse 68-74 


Tel.: +43-800-4430-130 

Fax: +43-800-4430-131 

Founded: 1984 


Baumgartner Ewald Feinoptik GesmbH 

Baxter Healthcare GmbH 

Stella-Klein-Löw-Weg 15 


Tel.: +43-1-71120-0 

Fax: +43-1-71120-2451020 

Founded: 1996 



M R 


B 

B 

B 

b 

M R 

M R 

M R 

info@bauerfeind.at 

www.bauerfeind.at 

Nuschinggasse 14 


Tel.: +43-1-86592-01 

Fax: +43-1-86592-0118 

Contact: Sabine Baumgartner 

Founded: 1974 

Staff: 35 

Sector of activities: production office@feinoptik.at 

www.feinoptik.at 

Bausch & Lomb GesmbH 

Office Park I, Top B02 



office-wien@bausch.com 

www.bausch-lomb.at 

www.baxter.at 

B 

59

60 

BBaxter Innovations GmbH 

Industriestrasse 67 


Tel.: +43-1-20100-0 

Fax: +43-1-20100-510 

Founded: 1960 

Staff: 3.800 



Bayer Austria Ges.m.b.H 

Herbststrasse 6-10 


Tel.: +43-1-71146-0 

Founded: 1970 

Staff: 143 


Beiersdorf GmbH 

Laxenburger Strasse 151 


Tel.: +43-1-61400-370 

Fax: +43-1-61400-320 


Bertmann feinmechanische Erzeugnisse 

und Werkzeugbau Gesellschaft m.b.H. 

Sulzengasse 3 


Tel.: +43-1-6884611-0 

Fax: +43-1-6884613-20 

Founded: 1974 

Working fields: active implantable technology, electromechanical medical 

technology 


b M R 

M R 


www.baxter.at 

www.bayer.at 

www.beiersdorf.at 

office@bertmann.at 

www.bertmann.at 


B 

B 

B 

M R 

M R


rt 2-D Support. 

lobal technical support team provides you trusted advice you can depend on. 

BIMED Dr. Karner Spitalbedarfs GmbH 

B M R 

pert Siebenhirtenstrasse 13 

le preparation 1230 Vienna to spot excision, our experienced 

Tel.: +43-1-86984-55 

are ready to help you with all your 2-D questions 

Contact: Susanne Binder 

s. Get direct Sector access of activities: to sales our 2-D experts through 

ient Web-based form. 

perts are: 

ined technical support professionals in the 

cs field 

ced with many Bio-Products years of hands-on & Bio-Engineering research and AG 

ooting expertise Schottenring 10 


d to supporting you with the utmost personalized care 

Tel.: +43-1-53239-90 

le from anywhere Fax: +43-1-53239-909 in the world, anytime 

Contact: Dr. Johann Eibl (Chairman) 

Founded: 1996 



ad your trusted advisor for 2-D by visiting us on 

www.expressionproteomics.com/ask/ 

he Web at 

Bio-Rad 

discover.bio-rad.com 

Laboratories GmbH 

at 1-800-4BIORAD Hummelgasse (1-800-424-6723); 

88/3-6 

US, contact 1130 your Vienna local sales office. 

JOB # 

CLIENT 

PUB/PRINTER 

PUB DATE 

Tel.: +43-1-877-8901 

Fax: +43-1-876-5629 

Contact: Eva Welleditsch 

Founded: 1977 

Staff: 13 

Working fields: lab equipment, consumables/reagents 

Sector of activities: production, services, sales 

Bioaktiva Pharmaceuticals GmbH 

Döblinger Hauptstrasse 16 


Tel.: +43-1-374-5307 

Fax: +43-1-946-1816 

Founded: 2000 


DESCRIPTION/ 

HEADLINE 

FILE NAME 

Expert 2D Diagnosis 

05-0859_Trusted2 

B M R 

office@bimed.at 

www.bimed.at 

bio@bio.co.at 

austria@bio-rad.com 

www.bio-rad.com 

11.3.05 

df 


202-7331 

Bio Rad 

European Biotech News 

FILE TYPE 

LIVE 

TRIM 

pdfx1a 

210mm x 275mm 

MAC 

P/U #(S) 

Client # 

qc 

info@bioaktiva.com 

05-0859 www.bioaktiva.com 

11.24.05 

BLEED 215mm x 280mm 

ORDER. # R61020177 


B 

B 

M R 

M R 

DATE 

OPERATOR 

B 

61

62 

BBiogen Idec Austria GmbH 

Stella-Klein-Löw-Weg 15/3 


Tel.: +43-1-484-4613 

Fax: +43-1-484-461311 

Founded: 1997 



Biolab GmbH 

Pelzgasse 7 


Tel.: +43-1-9827-575 

Fax: +43-1-9827-589 

Founded: 1983 

Staff: 3 

Working fields:in-vitro diagnostic technology, lab equipment, 

consumables/reagents 


biolution GmbH 



Tel.: +43-1-786-9595 

Fax: +43-1-786-959520 

Contact: Dr. Iris Grünert (Managing Director) 

Founded: 2002 

Sector of activities: production, services 

Biomarker Design Forschungs GmbH 

Divischgasse 4 


Tel.: +43-1-29107-41 

Fax: +43-1-29107-6385 

Contact: Renate Berger-Mostler (Managing Director) 

Founded: 2009 

Staff: 8 

Working fields: human health, animal health 


M R 

B M R 


austriainfo@biogenidec.com 

www.biogenidec.at 

office@biolab.co.at 

www.biolab.co.at 

office@biolution.net 

www.biolution.net 

info@bmdf.at 

www.biomarker-design.at 


B 

B 

B 

M R 

M R


Biomay AG 

Vienna Competence Center, Lazarettgasse 19 


Tel.: +43-1-79662-96100 

Fax: +43-1-79662-96111 

Contact: Dr. Reiner Henning (CEO) 

Founded: 1984 

Staff: 14 


Sector of activities: R&D, production, services 

Biomechanische 

Forschungs-Gesellschaft m.b.H. 


info@biomay.com 

www.biomay.com 

Rechte Wienzeile 5/2 


Tel.: +43-1-58664-46 

Fax: +43-1-58664-4630 

Contact: Kurt Peter Judmann 


Sector of activities: services info@bmf.at 

www.bmf.at 

Biomedica Medizinprodukte GmbH & Co. KG 

Divischgasse 4 | 1210 Vienna 

Tel.: +43-1-291-0711 

Fax: +43-1-290-1429 

Contact: Dr. Michaela Weblacher (Product Manager & Sales IVD), 

Dr. Petra Eibensteiner (Product Manager & Sales Life Science), Mario Wunsch, 

Prof. Wolfgang Woloszczuk (CEO) 


Working fields: human health, lab equipment, consumables/reagents 

Sector of activities: R&D, services, sales 

Biomedizinische Forschungsgesellschaft m.b.H. 

B M R 

B m R 

B M R 

B M R 

biomedica@bmgrp.at 

www.biomedica.co.at 

www.bmgrp.com 

B 

Lazarettgasse 19 


Tel.: +43-1-40810-91 

Fax: +43-1-40810-9113 

Contact: Martha Eibl (CEO) 

Founded: 1998 

Staff: 19 


Sector of activities: R&D office@biomed-research.at 

63

64 

BbioMérieux Austria GmbH 

Eduard-Kittenberger-Gasse 95b 


Tel.: +43-1-8650-650 

Fax: +43-1-8650-661 

Founded: 1993 



Biomodels Austria 

Universitäres Zentrum für Biomodelle GmbH 

Veterinärplatz 1 


Tel.: +43-1-25077-2801 

Fax: +43-1-25077-2809 

Contact: Prof. Dr. Thomas Rülicke 

Founded: 2002 

Bioplant R&D 

Anton-Frank-Gasse 13 


Tel.: +43-1-47654-6560 

Fax: +43-1-3697615 

Contact: Dr. Karin Gruber (CEO), Univ. Prof. Dr. Margit Laimer (CSO) 

Founded: 2009 

Staff: 5 

Working fields: agricultural biotechnology 

Sector of activities: R&D, services 

Biosanol Naturprodukte GmbH 

B M R 


office.at@eu.biomerieux.com 

www.biomerieux.com 

biomodels@vu-wien.ac.at 

www.biomodels.at 

office@bioplant.at 

www.bioplant.at 

Millergasse 40 


Tel.: +43-1-595-1598 

Fax: +43-1-595-1293 

Contact: Dr. Christina Schmidbauer 

Founded: 2008 


Sector of activities: R&D, production info@biosanol.com 

www.biosanol.com 

M R 

B M R 


B 

B 

M R


BioScript International 

Bennogasse 16/9a 


Tel.: +43-1-990-82-33 

Contact: Dr. Ruth Willmott 

Biotechnology Consulting 

Life Science Unternehmensberatung 

P. O. Box 4 


Tel.: +43-664-1432-919 

Fax: +43-664-25330333-779 

Founded: 2003 

Staff: 3 



Biotest Austria GmbH 

Einsiedlergasse 58 


Tel.: +43-1-5451561-0 

Fax: +43-1-5451561-45 

Contact: Dr. Gerald Schrot 

Founded: 1968 

Staff: 15 



Biotronik Vertriebs-GmbH 


office@bioscript.de 

www.bioscript.de 

B 

biotechconsulting@aon.at 

www.biotechnologyconsulting.eu 

info@biotest.at 

www.biotest.at 

Am Euro Platz 2, Stiege 2 


Tel.: +43-1-61544-50 

Fax: +43-1-61544-5010 

Founded: 1979 

Staff: 30 

Working fields: active implantable technology 

Sector of activities: sales office@biotronik.at 

www.biotronik.at 

B 

B 

B 

B 

M R 

M R 

M R 

M R 

65

66 

BBiozym Biotech Trading GmbH 

Wehlistrasse 27 b 


Tel.: +43-1-334-0156-0 

Fax: +43-1-334-0156-88 

Contact: Ingo Stefan Nagler 



BIUTEC R&D GmbH 

Seeböckgasse 32b 


Tel.: +43-1-4083-5800 

Fax: +43-1-4083-58034 

Contact: DI Dr. Helmut Effenberger 

Boehringer Ingelheim RCV GmbH & Co.KG 

Biopharmaceuticals & Operations 

Together To The Top B 

Dr. Boehringer-Gasse 5-11 | 1120 Vienna 

Tel.: +49-6132-77-0 

Fax: +49-6132-77-98287 

Contact: Dr. Julia Knebel (Marketing Manager), Pauline Bronzel 

Founded: 1948 

Staff: 1.100 



Boston Scientific GmbH 


In a fast moving market we develop and manufacture your 

biopharmaceuticals in a time-to-clinic and time-to-market 

approach. 

As a one-stop shop we offer a full spectrum of services for 

therapeutics derived from microbial support@biozym.com 

fermentation and cell 

culture – from small to large scale and www.biozym.com from DNA to final 

dosage form. 

We have globally licensed facilities and an unrivalled product 

track record for worldwide supply. 

Use our know-how, resources and capacity to reach the top 

with us as your partner. 

Contact us! 

www.biopharma-cmo.com 

Bio-CMO@boehringer-ingelheim.com 

wien@biutec.at 

www.biutec.at 

bio-cmo@ 

boehringer-ingelheim.com 

www.biopharma-cmo.com 

Wienerbergstrasse 11, Turm A/ 19 OG 


Tel.: +43-1-60810 

Contact: Christian Jajet 

Staff: 44 


technology, non-active implantable technology, reusable instruments, single 

use technology 

Sector of activities: sales www.bostonscientific.com 

M R 

M R 


B 

b M R 

B 

M R


Bracco Österreich GmbH 

Floridsdorfer Hauptstrasse 1 


Tel.: +43-1-4893495 

Fax: +43-1-489495-204 

Contact: Rudolf Richter 


Braincon Technologies Group 

Grinzinger Allee 5 | 1190 Vienna 

Tel.: +43-1-61067-0 | Fax: +43-1-61067-93 

Contact: Christian Schön, Davul Ljuhar (Managing Director) 

Founded: 1992 

Staff: 12 


diagnostic and therapeutic radiation technology, software for medicine, 

telemedicine and eHealth 

Sector of activities: R&D, production, services, sales 

Bruker Austria GmbH 

Lemböckgasse 47b / Top 10 


Tel.: +43-1-80478-81 

Fax: +43-1-80478-81-99 

Contact: Dieter Bertelmann 


BS-Immun GmbH 

Bestandsspezifische Impfstoffe und Autovakzinen 

Gastgebgasse 5-13 


Tel.: +43-1-997-1739 

Fax: +43-1-236969-89 

Contact: Dr. Astrid Weiss (Managing Director) 




B M R 

B M R 

B M R 


B 

M R 

office@bracco.at 

www.bracco.com 

d.ljuhar@bct.co.at 

www.ams-braincon.com 

office@bruker.at 

www.bruker.at 

office@bsimmun.at 

www.bsimmun.at 

B 

67

68 

BBSN medical Medizinprodukte GmbH 



Tel.: +43-1-61400-666 

Fax: +43-1-61400-480 

Founded: 2001 


BSTÄNDIG VERBANDSTOFFABRIK GmbH 

Brünner Strasse 19 


Tel.: +43-1-271-2172 

Founded: 1912 


CareTec GmbH 

Stubenbastei 1 


Tel.: +43-1-5138081-0 

Fax: +43-1-5138081-9 

Contact: Dr. Dietmar H. Litschel 

Sector of activities: R&D, production, sales 

Carl Reiner GmbH 

Mariannengasse 17 | 1090 Vienna 

Tel.: +43-1-4026251-0 

Fax: +43-1-4026251-19 

Contact: Peter Rossegger (Managing Director) 

Founded: 1912 

Staff: 30 

Working fields: anesthetic and respiratory technology, electromechanical 

medical technology, reusable instruments 


M R 

B M R 


medical.sales@bsnmedical.com 

www.bsnmedical.com 

office@bstaendig.at 

www.bstaendig.at 

office@caretec.at 

www.caretec.at 

Medizintechnik für Diagnose und Therapie 

Manufaktur chirurgischer Instrumente 

office@carlreiner.at 

www.carlreiner.at 


B 

B 

B 

M R 

M R


Carl Zeiss GmbH 

Laxenburger Strasse 2 | 1100 Vienna 

Tel.: +43-1-79518-911 | Fax: +43-1-79518-900 

Founded: 1902 

Staff: 83 

Working fields: dental technology, electromechanical medical technology, 

non-active implantable technology, ophthalmic and optical technology, 

reusable instruments, single use technology, diagnostic and therapeutic 

radiation technology, software for medicine, telemedicine and eHealth 


CAS ® Clean-Air-Service AG 

EURO PLAZA / Am Euro Platz 2 


Tel.: +43-1-71728-285 

Fax: +43-1-71728-283 

Contact: DI Holger Messner 


CBC Capricorn Biotech Consulting e.U. 

Untere Weissgerberstrasse 49/19 


Tel.: +43-1-91306-31 

Contact: Martin Götting (General Manager, Consultant) 

Founded: 2009 


CECOG – Central European Cooperative 

Oncology Group 

Schlagergasse 6/6 


Tel.: +43-1-409-77-25-11 

Fax: +43-1-409-77-26 

Contact: Dagmar Just 

Founded: 1999 

Staff: 8 


B m R 


B 

B 

B 

M R 

M R 

M R 

austria@zeiss.org 

www.zeiss.at 

austria@cas.ch 

www.cas-austria.at 

office@cbcmg.com 

www.cbcmg.com 

dagmar.just@cecog.at 

www.cecog.org 

C 

69

70 

CCenter for Anti-Infective Agents 

Eckpergasse 13 


Tel.: +43-1-479 70 24 

Fax: +43-1-470 08 98 

Contact: Dr. Ursula Theuretzbacher (Managing Director) 



Centogene GmbH 



Tel.: +43-1-7985006-300 

Fax: +43-1-7985006-804 



CESAR Central European Society 

for Anticancer Drug Research 

Hanglüssgasse 4/1-3 


Tel.: +43-1-5223093-10 

Fax: +43-1-5223093-14 

Contact: Mag. Lucia Blahova 




Chemgineering Planung GmbH 

Perfektastrasse 45 


Tel.: +43-1-2557413-0 

Contact: Dr. Michael Bodenteich 

M R 


utheuretzbacher@cefaia.com 

www.cefaia.com 

office@centogene.com 

www.centogene.at 

office@cesar.or.at 

www.cesar.or.at 

www.chemgineering.com 


B 

B 

B 

B 

M R 

M R 

M R


Chemomedica Medizintechnik und 

Arzneimittel Vetriebsges.m.b.H. 

Wipplinger Strasse 19 | 1013 Vienna 

Tel.: +43-1-53326-6618 | Fax: +43-1-5324-705 

Contact: Mag. Alexander Hayn (Managing Director) 


Working fields: anesthetic and respiratory technology, dental technology, 

electromechanical medical technology, hospital hardware, 

single use technology, others 


CLIMED 


a.hayn@chemomedica.at 

www.chemomedica.at 

Medizinische Produkte 

Schlachthausgasse 50/14 


Tel.: +43-1-71225-41 

Contact: Werner Supperer 

Founded: 1996 

Working fields: reusable instruments 

Sector of activities: sales info@climed.at 

www.climed.at 

Clinical Investigation Support 

Pharmaforschung GmbH 

Kaiserstrasse 43 / Top 4 


Tel.: +43-1-52340-15 

Fax: +43-1-52340-15-99 

Contact: Dr. Gerhard Nahler 

Founded: 1990 

Staff: 3 


CMS Reich-Rohrwig Hainz 

Rechtsanwälte GmbH 

CIS-Wien@aon.at 

www.cis-qa.com 

Ebendorferstrasse 3 


Tel.: +43-1-40443-2450 

Fax: +43-1-40443-92450 

CMS_LawTax_CMYK_from101.eps 

Contact: Dr. Johannes Juranek 

Founded: 1970 

Staff: 176 

Sector of activities: services www.cms-rrh.com 

B 

B 

B 

B 

M R 

M R 

M R 

M R 

C 

71

72 

C b 

CoaChrom Diagnostica GmbH 

Stolzenthalergasse 6 


Tel.: +43-1-699-9797 

Fax: +43-1-699-1897 

Contact: Bernhard Kolmer (Managing Director) 

Founded: 1994 

Staff: 8 

Working fields: human health, non-specific services 


CogVis software und consulting gmbh 

Pulverturmgasse 3/1a | 1090 Vienna 

Tel.: +43-1-9971594-20 

Fax: +43-1-9971594-91 

Contact: PD Dr. Martin Kampel (Director) 

Founded: 2007 

Staff: 6 

Working fields: electromechanical medical technology, technical aids for 

disabled, software for medicine, telemedicine and eHealth 


Coloplast Ges.m.b.H 

Thomas-Klestil-Platz 10 


Tel.: +43-1-7075751-0 

Fax: +43-1-707575140 

Founded: 1993 


Confidence DNA Analysen GmbH 

M R 


info@coachrom.com 

www.coachrom.com 

info@cogvis.at 

www.cogvis.at 

at@coloplast.com 

www.coloplast.at 

Hutweidengasse 22/1 


Tel.: +43-1-368-4554 

Fax: +43-1-367-9664 

Contact: Susanne Haas 

Founded: 2003 

Staff: 3 

Sector of activities: services office@confidence.at 

www.confidence.at 

M R 


B 

B 

B 

M R 

M R


ConvaTec (Austria) GmbH 

Schubertring 6 


Tel.: +43-1-51284-84 

Fax: +43-1-51284-94 

Staff: 7 

Working fields: single use technology 


Cook Österreich GmbH 

Neustiftgasse 5/1/9 


Tel.: +43-1-97567-121 

Fax: +43-1-97567-126 

Founded: 2007 


Crosstec Handels-GmbH 

Rotenlöwengasse 19 


Tel.: +43-1-31031-000 

Fax: +43-1-31031-020 

Contact: Rudolf Sindelar (Managing Director) 


Working fields: non-active implantable technology, reusable instruments, 

single use technology, components based on biological materials 


CRYPTAS it-security GmbH 

Franzosengraben 8/4.OG 


Tel.: +43-798-96960 

Fax: +43-798-969698 

Founded: 2003 




B 

B 

B 

M R 

M R 

M R 

B m R 

C 

convatec.austria@convatec.com 

www.convatec.com 

oe.orders@cookmedical.com 

www.cookgroup.com 

office@crosstec.eu 

http://crosstec.eu 

office@cryptas.com 

www.cryptas.com 

73

74 

CCSL Behring GmbH 

Altmannsdorferstrasse 104 


Tel.: +43-1-80101-2480 

Fax: +43-1-80101-2810 

Contact: Norbert Piana (Managing Director) 

Founded: 1977 

Staff: 16 



D.A.T.A. GmbH 


office.vienna@cslbehring.com 

www.cslbehring.at 

Invalidenstrasse 5-7 


Tel.: +43-660-1214-458 

Fax: +43-1-710-3631 

Contact: Tina Albert 

Founded: 1997 


Sector of activities: production, services office@data.at 

www.data.at 

Dahlhausen GmbH 

Großmarktstrasse 18 


Tel.: +43-1-6675-454 

Fax: +43-1-6675-457 

Contact: Ulrich Dahlhausen (Managing Director) 

Founded: 1984 

Staff: 7 

Working fields: anesthetic and respiratory technology, single use technology 

Sector of activities: sales www.dahlhausen.at 

DAIICHI SANKYO AUSTRIA GmbH 

Effingergasse 21 



M R 

info@daiichi-sankyo.at 

www.daiichi-sankyo.at 


B 

B M R 

B 

B 

M R 

M R


Dako Österreich GmbH 

Pathology Products 

Hietzinger Hauptstrasse 50/7 


Tel.: +43-1-408-4334 | Fax: +43-1-408-4336 

Contact: Rosemarie Havranek (Managing Director) 

Founded: 2002 

Staff: 5 | Working fields: electromechanical medical technology, in-vitro 

diagnostic technology, software for medicine, telemedicine and eHealth 


Delegate Healthcare Solutions GmbH 

Hintzerstrasse 5/2 


Tel.: +43-1-7106822 

Fax: +43-1-7106822-15 

Contact: Dr. Hans-Dieter Räbel 

Founded: 2007 

Deloitte Consulting GmbH 

Renngasse 1/ Freyung 

Postfach 18 


Tel.: +43-1-53700-4860 

Fax: +43-1-53700-1000 

Derma Medical Systems 

Handels- und EntwicklungsgmbH 

Wiedner Hauptstrasse 140 


Tel.: +43-1-31869-90 | Fax: +43-1-31869-909 

Contact: Thomas Wenkart (MD, CEO) 


Working fields: electromechanical medical technology, software for medicine, 



B M R 


B 

B 

M R 

M R 

B M R 

info.at@dako.com 

www.dako.at 

D 

info@delegate-group.com 

www.delegate-group.com 

www.deloitte.com 

derma@ 

dermamedicalsystems.com 

www.dermamedicalsystems.com 

75

76 

DDermapharm 

GmbH 

Türkenstrasse 25/12 


Tel.: +43-1-3193001-0 

Fax: +43-1-3193001-40 

Contact: Martin Schröckenfuchs (Managing Director) 

Founded: 2001 


dialog gentechnik 



Tel.: +43-1-90-72677 

Fax: +43-1-90-72606 

Contact: Brigitte Gschmeidler 

Staff: 12 

Dionex - 

A Part of Thermo Fisher Scientific 



Tel.: +43-1-616-5125 

Fax: +43-1-616-5125-55 

Contact: Klaudia Tlachac 

Working fields: lab equipment 


Dokusys 

Elektronische Dokumentations- & Datenverarbeitungssysteme GmbH 

Rußbergstrasse 54 


Tel.: +43-57-555-0 

Fax: +43-57-555-9000 

Contact: Bernhard Riedinger 

Founded: 2007 


M R 

B M R 


office@dermapharm.at 

www.dermapharm.at 

office@dialog-gentechnik.at 

www.dialog-gentechnik.at 

austria@dionex.com 

www.thermoscientific.com/ 

dionex 

office@dokusys.net 

www.dokusys.net 


B 

B 

B 

M R 

M R


Donauchem GmbH 

Lisztstrasse 4 


Tel.: +43-1-71148-0 

Fax: +43-1-71148-5 

Contact: Dr. Alain de Krassny 

Founded: 1973 

Working fields: consumables/reagents 


Dräger Medical Austria GmbH 

Perfektastrasse 67 


Tel.: +43-1-6093-602 

Fax: +43-1-6996-242 


A. Duschek GmbH 



Tel.: +43-1-888-3112 

Fax: +43-1-888-3112-40 



medical technology, non-active implantable technology, single use technology, 

components based on biological materials 


Dutalys GmbH 

Muthgasse 11/2 


Tel.: +43-1-99718-32 

Fax: +43-1-99718-3201 

Contact: Dr. Roland Beckmann (CSO) 

Founded: 2008 

Staff: 4 




B 

B 

B 

M R 

M R 

M R 

B M R 

www.donauchem.at 

info-austria@draeger.com 

www.draeger.at 

office@aduschek.at 

www.aduschek.at 

office@dutalys.com 

www.dutalys.com 

D 

77

78 

Ddwh simulation services 

Neustiftgasse 57-59 


Tel.: +43-1-5860-180 

Fax: +43-1-5860-1801 

Contact: Niki Popper 


e|n|w|c Natlacen Walderdorff 

Cancola Rechtsanwälte GmbH 



Tel.: +43-1-71655-0 

Fax: +43-1-71655-99 

Contact: Nicole Reiter 

eBioscience 



Tel.: +43-1-79640-40-0 

Fax: +43-1-79640-40-400 

Contact: Dr. Irene Rech-Weichselbraun 

Founded: 1998 

Staff: 55 

Working fields: non-specific services, consumables/reagents 


Ecolab GmbH 

Erdbergstrasse 29 


Tel.: +43-1-7152-550 

Fax: +43-1-7152-550-2850 

M R 


www.drahtwarenhandlung.at 

wien@enwc.com 

www.enwc.com 

irene.rech-weichselbraun@ 

eBioscience.com 

www.eBioscience.com 

www.at.ecolab.eu 


B 

B 

M R 

b M R 

B 

M R


Edwards Lifesciences Austria GmbH 

Anton-Baumgartner-Strasse 125|6|1 


Tel.: +43-1-20220-0 

Fax: +43-1-24220-150 

Contact: Anna van Maldegem 

Founded: 2000 

Staff: 16 

Working fields: non-active implantable technology, single use technology 


Ekomed Handels-Ges.m.b.H 

Eli Lilly GmbH 

Kölblgasse 8-10 


Tel.: +43-1-71178-0 

Fax: +43-1-71178-206 

Contact: Peter Salzmann 

Founded: 1976 

Staff: 180 

b M R 


E 

edwards_austria@edwards.com 

www.edwards.com 

Franz-Heider-Gasse 7 


Tel.: +43-1-8692771 

Fax: +43-1-8692771-17 

Contact: Bernhard Holzheu (Managing Director) 

Founded: 1993 

Staff: 4 

Working fields: in-vitro diagnostic technology, single use technology 

Sector of activities: production, services, sales office@ekomed.at 

EMCOOLS 

Medical Cooling Systems AG 

Brucknerstrasse 6/7a 


Tel.: +43-2252-890-152-0 

Fax: +43-2252-890-152-119 

Contact: Michael Kühling (CEO) 



Sector of activities: production 

B 

B 

M R 

M R 

B M R 

Lilly_aut@lilly.com 

www.lilly.at 

emcools-office@emcools.com 

www.emcools.com 

79

80 

Eemergentec biodevelopment GmbH 

Gersthofer Strasse 29-31 


Tel.: +43-1-4034-966-0 

Fax: +43-1-4034-966-19 

Contact: Arno Lukas (CEO), Dr. Bernd Mayer (CSO) 

Founded: 2002 

Staff: 12 

Working fields: bioinformatics 


en.co.tec Schmid KG 

Breitenfurter Strasse 401-413/25/R1 


Tel.: +43-1-8863-491 

Fax: +43-1-8863-491-18 

Founded: 1999 

Staff: 4 

Endo Unique Handelsgesellschaft m.b.H 

Neumayrgasse 21 


Tel.: +43-1-49527-99 

Contact: Gerald Fritsch 


Engler Steritech GmbH 

Rotenmühlgasse 61/1 


Tel.: +43-1-607-4169 

Fax: +43-1-607-4669 

Contact: Georg Engler (Managing Director) 

B M R 

M R 


office@emergentec.com 

www.emergentec.com 

office@encotec.com 

www.encotec.com 

www.endounique.at 

engler@englersteritech.at 

www.englersteritech.at 


B 

B 

B 

M R 

M R


Eppendorf Austria GmbH 

Ignaz-Köck-Strasse 10 


Tel.: +43-1-8901364-41 

Fax: +43-1-8901364-20 

Contact: Dipl.-Ing. Mathias Wenisch (Managing Director) 



EQ-SERVE EDV & Labortechnik GmbH 

Bürgergasse 11 


Tel.: +43-1-796-8526 

Fax: +43-1-796-8526-22 

Erbe Elektromedizin Ges.mbH 

Modecenterstrasse 14 TOP B1 


Tel.: +43-1-8932-446 

Fax: +43-1-8932-4463 

Contact: Christian Böhm 

Founded: 1968 

Ernst Stöhr GmbH 

Mauerbachstrasse 4 


Tel.: +43-1-9791211 

Fax: +43-1-9792153 

Contact: Ernst Stöhr 



B 

B 

M R 

M R 

B M R 

B 

M R 

office@eppendorf.at 

www.eppendorf.at 

office@eq-serve.com 

http://eq-serve.com 

erbe-aut@erbe-med.com 

www.erbe-med.at 

ernststoehrgmbh@aon.at 

E 

81

82 

EEubio 

Schwendergasse 17 


Tel.: +43-1-8950-145 

Fax: +43-1-8950-14514 

EUCODIS Bioscience GmbH 

Campus Vienna Biocenter II 

Viehmarktgasse 2 a/ 2. OG | 1030 Vienna 

Tel.: +43-1-8900-804 

Fax: +43-1-8900-804 ext. 11 

Contact: Thomas Fischer (CEO) 

Founded: 2007 

Staff: 21 

Working fields: industrial processing 


Euromed 

Medizinisch Technische ProdukthandelsgmbH 

Nobilegasse 23-25 


Tel.: +43-1-9793850 

Fax: +43-1-9793850-20 


Evercyte GmbH 


eubio@eubio.at 

www.eubio.at 

office@eucodisbioscience.com 

www.eucodisbioscience.com 

office@euromed.org 

www.euromed.org 

Muthgasse 18 


Tel.: +43-664-4227-861 

Contact: Otto Kanzler (CEO) 

Founded: 2011 

Staff: 4 


Sector of activities: R&D, services otto.kanzler@evercyte.com 

www.evercyte.com 

M R 


B 

B M R 

B 

M R 

B M R


ExperGen Drug Development GmbH 

Hernalser Hauptstrasse 24 


Tel.: +43-1-40597-86 

Contact: Dr. Paul Meng 

Founded: 2006 


F-star 

Biotechnologische Forschungs- und Entwicklungs-GmbH 



Tel.: +43-72055-4215 

Fax: +43-1-8655-550 

Contact: Dr. Kevin FitzGerald (CEO) 




Felcon Reinraum- und Prozesstechnische 

Anlagen Produktionsgesellschaft m.b.H. 

Kerngasse 38 


Tel.: +43-1-8885545-0 

Fax: +43-1-8885545-23 

Contact: Ing. Hans Lintner (Managing Director) 

FEMTOLASERS Produktions GmbH 

Fernkorngasse 10 


Tel.: +43-1-503-7002-0 

Fax: +43-1-503-7002-99 

Contact: Andreas Stingl (CEO) 


Working fields: electromechanical medical technology, ophthalmic and optical 

technology 


B M R 

B M R 


B 

B 

M R 

M R 

office@expergen.at 

www.expergen.at 

office@f-star.com 

www.f-star.com 

felcon.austria@aon.at 

www.felcon.at 

info@femtolasers.com 

www.femtolasers.com 

F 

83

84 

FFerdinand Menzl Medizintechnik GmbH 

Donaufelderstrasse 199 


Tel.: +43-1-25589-600 

Fax: +43-1-25589-6060 

Contact: Manfred Menzl (Managing Director) 

Founded: 1976 

Staff: 8 

Working fields: single use technology, others 


Fisher & Paykel Healthcare GmbH & Co KG 

Wagramer Strasse 19 


Tel.: +43-800-293-123 

Fax: +43-800-293-122 


Fonds zur Förderung der 

wissenschaftlichen Forschung (FWF) 


info@menzl.com 

www.menzl.com 

info@fphcare.de 

www.fphcare.de 

Sensengasse 1 


Tel.: +43-1505-6740-0 

Fax: +43-1505-6739 

Founded: 1968 

Staff: 90 

Sector of activities: services office@fwf.ac.at 

www.fwf.ac.at 

FOSS GmbH 

Eitnergasse 7 


Tel.: +43-1-2781-631 

Fax: +43-1-2781-631-15 


M R 

info.at@foss.de 

www.foss.dk 


B 

B 

B 

B 

M R 

M R 

M R


Franz Kacer & Sohn GmbH 

Frankgasse 3 


Tel.: +43-1-4052-567 

Contact: Thomas Krach 

Founded: 1972 

Working fields: technical aids for disabled 


Fresenius Medical Care Austria GmbH 

Lundenburgergasse 5 


Tel.: +43-1-29235-01 

Founded: 1976 

Staff: 27 



Dr. Friedrich Bertoni Gesellschaft mbH 

Jochen-Rindt-Strasse 21 


Tel.: +43-1-61688-70 

Fax: +43-1-61688-7060 

Founded: 1974 



Fuji Film Österreich 

Gesellschaft m.b.H. Nfg. KG 

Traviatagasse Ecke Pfarrgasse | 1230 Vienna 

Tel.: +43-1-6162-6060 | Fax: +43-1-61626-06/58 

Contact: Thomas Scheibenbauer (Marketing/Sales) 


Working fields: electromechanical medical technology, in-vitro diagnostic 

technology, reusable instruments, single use technology, software for 

medicine, telemedicine and eHealth 


B M R 


B 

B 

B 

M R 

M R 

M R 

kacer@kacer.at 

www.kacer.at 

fmc.austria@fmc-ag.com 

www.fmc-ag.com 

office@drbertonigmbh.at 

www.drbertonigmbh.at 

office@fujifilm.at 

www.fujifilm.at 

F 

85

86 

G 

gcp gamma capital partners AG 

Schönbrunner Strasse 218-220 Stiege A / Top 4.04 


Tel.: +43-1-51310-72 

Fax: +43-1-51310-72200 

Contact: Burkhard Feurstein (Managing Partner), Dr. Oliver Grabherr, 

Hannes Ambacher (Cofounder) 

Founded: 2002 


GE Healthcare Austria GmbH & Co OG 

Technologiestrasse 10 


Tel.: +43-1-97272-2607 

Fax: +43-1-97272-2222 


GENOSENSE Diagnostics GmbH 

Donau-City-Strasse 1 


Tel.: +43-1-2530-253-190 

Fax: +43-1-2530-253-191 

Contact: Prof. Dr. Manfred Müller 

Founded: 2001 

Staff: 10 



Genzyme Austria GmbH 

Franz-Klein-Gasse 5 


Tel.: +43-1-77465-38 

Fax: +43-1-77465-389 


M R 


office@gamma-capital.com 

www.gamma-capital.com 

info@genosense.com 

www.genosense.com 


B 

B 

M R 

B M R 

B 

M R 

www.ge-healthcare.com 

www.genzyme.com


Gepa-Med Medizintechnik GmbH 

Sprengersteig 4 


Tel.: +43-1-489-6353 

Fax: +43-1-489-635343 

Contact: Gerhard Pavecic 


Gesellschaft Österreichischer Chemiker 

Nibelungengasse 11/6 


Tel.: +43-1-587-4249 

Fax: +43-1-587-8966 

Contact: Dr. Erich Leitner, Gabriela Ebner 

Founded: 1897 

Staff: 1900 

GHX Austria GmbH 

Simmeringer Hauptstrasse 24 


Tel.: +43-1-74040-5711 

GJM Handel und Service GmbH 

Lange Gasse 58 


Tel.: +43-1-40808-41 

Fax: +43-1-40808-43 

Contact: Gerd R. Melmuka (Executive Vice President) 



reusable instruments, single use technology 



B 

B 

B 

B 

M R 

M R 

M R 

M R 

office@gepa.at 

www.gepa.at 

office@goech.at 

www.goech.at 

info-AT@ghxeurope.com 

www.ghx.at 

G 

office@omegamedtech.at 

www.omegamedtech.at 

87

88 

GGlaxoSmithKline Pharma GmbH 

Albert-Schweitzer-Gasse 6 


Tel.: +43-1-97075-0 

Fax: +43-1-97075-170 

Contact: DI Alexander Barta (Director Business Development) 


Globopharm GmbH 


at.info@gsk.com 

www.glaxosmithkline.at 

Breitenfurter Strasse 251 


Tel.: +43-1-8031727 

Fax: +43-1-8031727-372 

Contact: Dr. Kurt Burghart 

Founded: 1994 


Sector of activities: services office@globopharm.at 

www.globopharm.at 

GN ReSound Hörtechnologie GmbH 

Wimbergergasse 14-16 


Tel.: +43-1-5245400-400 

Fax: +43-1-5245400-444 

Contact: Norbert Gabriel 


Grabner Instruments 

Messtechnik Gesellschaft m.b.H 

Dr.-Otto-Neurath-Gasse 1 


Tel.: +43-1-2821-6270 

Fax: +43-1-2807-334 

Founded: 1987 

M R 

www.gnresound.at 

info.grabner-instruments@ 

ametek.at 

www.grabner-instruments.com 


B 

B 

B 

M R 

b M R 

M R


Dr. Grossegger & Drbal GmbH 

Ruthgasse 19/1 


Tel.: +43-1-368-17-97 

Fax: +43-1-367-70-23 

Founded: 1980 

Staff: 5 

Working fields: others 

Sector of activities: production office@alpha-trace.at 

www.alpha-trace.at 

Habel Medizintechnik 

Ignaz-Köck-Strasse 20 


Tel.: +43-1-29266-420 

Fax: +43-1-29012-45 

Founded: 1952 



Haemonetics Handelsgesellschaft mbH 

Mariahilferstrasse 123/3.Stock 


Tel.: +43-1-294-2900 


Haplogen GmbH 

Kaiserstrasse 32 


Tel.: +43-1-40160-70026 

Contact: Dr. Georg Casari (CEO) 

Founded: 2010 

B M R 

B M R 


B 

B 

M R 

M R 

H 

office@habel-medizintechnik.at 

www.habel-medizintechnik.at 

info.at@haemometics.com 

www.haemonetics.com 

office@haplogen.com 

www.haplogen.com 

89

90 

HHarrison Clinical Research 

Eastern Europe Forschungsges.mbH 

Kärntner Ring 10/Top 12a 


Tel.: +43-1-5046591-0 

Fax: +43-1-5046591-44 

Founded: 2004 

Staff: 6 



Hauser M. Medizintechnik 

Maurer-Lange-Gasse 136 


Tel.: +43-1-8654-477 

Fax: +43-1-8654-4779 

Founded: 1997 


HEILAND Medical Vertriebs-GmbH 

Computerstrasse 6 


Tel.: +43-1-718-1961 


Heilbehelfe Frühwald 

Dipl. Ing. Frühwald & Söhne 

Börseplatz 7 


Tel.: +43-1-5332100 

Contact: Ing. Karl Frühwald 

Founded: 1969 


M R 


gudrun.sonvilla@harrison-cro.com 

www.harrisonclinical.com 

office@medstore.at 

www.hauser-medizintechnik.at 

office@heiland-medical.at 

www.heiland-medical.at 

office@fruehwald.net 

www.fruehwald.net 


B 

B 

B 

B 

M R 

M R 

M R


Heinen + Löwenstein GmbH 

Clemens-Holzmeister-Strasse 4 


Tel.: +43-1-615-1134 

Fax: +43-1-25330-339793 

R.Heintel GmbH 

Josefstädterstrasse 82 | 1081 Vienna 

Tel.: +43-1-40389-56 | Fax: +43-1-40389-5650 

Contact: Markus Pöltenstein (Managing Director) 


Working fields: anesthetic and respiratory technology, dental technology, 

electromechanical medical technology, hospital hardware, non-active implantable 

technology, ophthalmic and optical technology, reusable instruments, single use 

technology, technical aids for disabled 


Heraeus Kulzer Austria GmbH 

Nordbahnstrasse 36/2/4/Top 4.5 


Tel.: +43-1-4080-9410 

Fax: +43-1-4080-94171 

Contact: Alexandra Lacek-Cipone (Managing Director) 

Founded: 1971 

Staff: 22 

Working fields: dental technology, single use technology 


Hermes Pharma Ges.m.b.H. 

Landstrasser Hauptstrasse 2a 


Tel.: +43-1-22711-0 

Fax: +43-1-22711-3150 

Contact: Holger Dietel 

Founded: 2003 

B M R 


B 

M R 

B m R 

B M R 

info@hulaustria.at 

www.hulaustria.at 

medizintechnik@heintel.at 

www.heintel.at 

H 

alexandra.lacek@heraeus.com 

www.heraeus-dental.de 

www.hermes-pharma.at 

91

92 

HHitachi Medical Systems GmbH 


Jakschgasse 5 


Tel.: +43-1-8959-525 

Fax: +43-1-8959-52525 

Working fields: electromechanical medical technology, 

diagnostic and therapeutic radiation technology 

Sector of activities: sales austria@ 

hitachi-medical-systems.com 

www.hitachi-medical-systems.at 

HO-MED HandelsgmbH 

Florian-Berndl-Gasse 43 


Tel.: +43-1-715-9119 

Fax: +43-1-71591-1919 


HOLLISTER GmbH 

Heinrich-Collin-Strasse 1 


Tel.: +43-1-877-0800 

Fax: +43-1-87708-0022 

Contact: Mag. Stephan E. Bonnelycke 

Founded: 1999 

Staff: 10 

Working fields: technical aids for disabled 


Hospitec WarenhandelsgmbH 

Schlachthausgasse 29 


Tel.: +43-1-7982-2410 

Fax: +43-1-7982-24111 

Staff: 6 

Working fields: non-active implantable technology, ophthalmic and optical 

technology, reusable instruments, single use technology, components based 

on biological materials, others 


B M R 

B M R 

B M R 

B M R 

office@ho-med.at 

www.ho-med.at/ 

hollister.oesterreich@ 

hollister.com 

www.hollister.com 

office@hospitec.at 

www.hospitec.at 

B Biotech dedicated b Biotech active M Medtech dedicated m Medtech active R Life science related


HVD Life Science Vertriebs GmbH 

Wurzbachgasse 18 


Tel.: +43-1-982-9526 

Fax: +43-1-78636-44 

Contact: Werner Bürgler (Sales Director) 

Founded: 1998 

Staff: 7 

Working fields: in-vitro diagnostic technology, consumables/reagents 


Hygienic Technology, GMP Services & Testing 

Breitenfurter Strasse 111 


Tel.: +43-1-804-80280 

Fax: +43-1-804-802880 

ICC – Internationale Gesellschaft für 

Getreidewissenschaft und -technologie 

Marxergasse 2 


Tel.: +43-1-70772-020 

Fax: +43-1-70772-040 

Contact: Dr. Roland Poms 

Founded: 1955 

Staff: 6 


IMCL – Institut für medizinische und 

chemische Labordiagnostik Gesellschaft mbH 

Rosensteingasse 49 – 51 


Tel.: +43-1-485-6161 

Fax: +43-1-485-6161200 

B M R 

B M R 

B M R 

B M R 


office1@hvdgmbh.com 

www.hvdlifesciences.com 

kk@htt.co.at 

www.htt.co.at 

office@icc.or.at 

www.icc.or.at 

www.imcl.at 

I 

93

94 

Iimpactit GmbH 

Vienna Twin Tower 

Wienerbergstrasse 11/12a 


Tel.: +43-1-9946-06207 

Fax: +43-1-9946-05307 

In Vitro – Labor für veterinärmedizinische 

Diagnostik und Hygiene 

Rennweg 95 


Tel.: +49-1-79962-290 

Contact: Dr. Ernst Leidinger 

ingenetix GmbH 



Tel.: +43-1-74040-391 

Fax: +43-1-74040-392 

Contact: DI Dr. Irina Korschineck 

Founded: 2003 

Staff: 7 

Working fields: non-specific services, consumables/reagents 


INiTS 

Universitäres Gründerservice Wien GmbH 

Graumanngasse 7 


Tel.: +43-1-7157-267 

Fax: +43-1-7157-267-25 

Founded: 2002 


B M R 

B M R 

B M R 

B M R 


office@impactit.at 

www.impactit.at 

www.invitro.at 

office@ingenetix.com 

www.ingenetix.com 

office@inits.at 

www.inits.at 



Innovation Coaches Stadler KG 

Favoritenstrasse 16 


Tel.: +43-680-20688-53 

Fax: +43-125-33033-8417 

Contact: Mag. Manfred Stadler (MBA) 


Working fields: human health, natural resource recovery, environment, 

industrial processing, bioinformatics 


Institut für medizinische und chemische 

Labordiagnostik Gesellschaft m.b.H. 

Rosensteingasse 49-51 


Tel.: +43-1-485-6161 

Founded: 1987 

Intercell AG 



Tel.: +43-1-20620 

Fax: +43-1-20620-800 

Contact: Mag. Nina Waibel (Global Head Corporate Communications) 

Founded: 1997 

Staff: 193 



Interpharm ProduktionsgmbH 



Tel.: +43-5-997730-380 

Fax: +43-5-997730-390 

Contact: Martina Steinle 

Founded: 1969 

B M R 

B M R 

B M R 

B M R 


office@innovationcoaches.at 

www.innovationcoaches.at 

www.imcl.at 

communications@intercell.com 

www.intercell.com 

office@interpharm.at 

www.interpharm.at 

I 

95

96 

IIntervet 

Ges.mbH 

Siemensgasse 107 


Tel.: +43-1-2568-787-400 

Fax: +43-1-2568-787-419 

Contact: Dr. Jürgen Böckmann 

Founded: 1997 



INTRAMED Handels Ges.m.b.H. 

Hügelgasse 10 


Tel.: +43-1-876-0101 

Fax: +43-1-876-010166 


Inventogen GmbH 

Ingenieurbüro für Molekularbiologie 

Einsiedlergasse 36/2 


Tel.: +43-1-5480-415 

Fax: +43-664-7313-5610 

Contact: Mag. Ferdinand Kaser 


Working fields: human health, bioinformatics 


IPO Beteiligungs-Management AG 

Argentinierstrasse 42 


Tel.: +43-1-505-6320 

Fax: +43-1-505-632050 

b M R 

B M R 

B M R 

B M R 


www.intervet.at 

office@intramed.at 

www.intramed.at 

office@inventogen.com 

www.inventogen.com 

office@ipo-austria.at 

www.ipo-austria.at 



J&P MEDICAL RESEARCH Ltd. 

Auhofstrasse 15/8-9 


Tel.: +43-1-8760-432-10 

Fax: +43-1-8760-432-33 

Contact: Prof. MD Christian Joukhadar 

(Managing Director & Chief Operating Officer) 




Janssen-Cilag Pharma GmbH 

Vorgartenstrasse 206b 


Tel.: +43-1-610-300 

Fax: +43-1-616-1241 

Contact: Dr. Carine Brouillon 


JEDER GmbH 

Starkfriedgasse 62 


Tel.: +43-1-4700-165 

Fax: +43-810-955411-8233 

Contact: Mag. Andreas Bayerle (Managing Director) 

Founded: 2010 

Working fields: dental technology 


Johnson & Johnson Medical Products GmbH 

Vorgartenstrasse 206B 


Tel.: +43-1-360-25 

Fax: +43-1-360-25-502 


B M R 

B M R 

B M R 

B M R 


J 

office@jp-medical-research.com 

www.jp-medical-research.com 

www.janssen.at 

office@jedersystem.com 

www.jedersystem.com 

jnjmedicalaustria@its.jnj.com 

www.jnjmedical.at 

97

98 

JJoseph Babicky GmbH 

Goldeggasse 2 


Tel.: +43-1-50582-690 

Working fields: reusable instruments 


Jungbunzlauer Austria AG 



Tel.: +43-1-50200-0 

Fax: +43-1-50200-8 

Contact: Dr. Gass 

Staff: 300 



K.I.S Krankenhaus Informations Systeme GmbH 

Leonard-Bernstein-Strasse 10 


Tel.: +43-1-5952-1500 

Fax: +43-1-5952-15030 

Karl Storz Endoskop Austria GmbH 

Landstrasse Hauptstrasse 148/1/G1 


Tel.: +43-1-7156-0470 

Fax: +43-1-7156-0479 


B M R 

B M R 

B M R 

B M R 


office@babicky.at 

www.babicky.at 

www.jungbunzlauer.com 

office@kis.at 

www.kis.at 

storz-austria@karlstorz.at 

www.karlstorz.com 



KaVo-AUSTRIA Dentalwarenhandel GmbH 

Gutheil-Schoder-Gasse 7a 


Tel.: +43-1-665-0133 

Fax: +43-1-665-013317 

Contact: Hans Bättig 



reusable instruments, diagnostic and therapeutic radiation technology 


KCI Austria GmbH 

Lemböckgasse 49/Stiege A 


Tel.: +43-1-863-30 

Fax: +43-1-863-306 


KladoMed GmbH 

Penzinger Strasse 61 


Tel.: +43-1-577-2122 

Fax: +43-1-577-2123 


Köcher KG 

Döblinger Gürtel 21-23/8/9 


Tel.: +43-1-597-1101 


B M R 

B M R 

B M R 

B M R 

info@kavo.at 

www.kavo.at 


austria@kci-medical.com 

www.kci-medical.at 

office@kladomed.at 

www.kladomed.at 

koecher@vienna.at 

K 

99

100 

KKrainer Medtechnik Handelsgesellschaft mbH 


Ober-Laaerstrasse 222 


Tel.: +43-1-688-4332 

Fax: +43-1-688-43323 

Founded: 1979 

Working fields: non-active implantable technology, single use technology, 

others 

Sector of activities: sales info@krainer-medtechnik.at 

www.krainer-medtechnik.at 

Kwizda Agro GmbH 

Dr.-Karl-Lueger-Ring 6 


Tel.: +43-5-9977-10 

Fax: +43-5-9977-10280 

Contact: Dkfm Dr. Johann Franz Kwizda 

Founded: 1950 

Working fields: agricultural biotechnology 

Kwizda Pharma GmbH 



Tel.: +43-5-997730-0 

Fax: +43-5-997730-230 

Contact: Reinhard Mahr 

Founded: 1981 

Kybermed Handelsgesellschaft mbH 

Cottagegasse 69/13 


Tel.: +43-1-328-4800 

Fax: +43-1-328-4555 


B M R 

b M R 

B M R 

B M R 

agro@kwizda-agro.at 

www.kwizda-agro.at 

phwien@kwizda.at 

www.kwizda.at 



Lab Technologies Medizintechnik GmbH 

Schönbrunner Strasse 185 


Tel.: +43-1-419-1027 

Fax: +43-1-419-1026 


LABDIA Labordiagnostik GmbH 

Zimmermannplatz 8 


Tel.: +43-1-40077-4800 

Fax: +43-1-40077-7437 

Contact: Prof. Dr. Thomas Lion (Medical Director) 

Founded: 2006 

Staff: 15 



Labor 9000 Gerald Fiedler e. U. 

Liniengasse 9/11 


Tel.: +43-1-587-4104 

Fax: +43-1-587-41043 

Founded: 2008 



Laboratorium für Betriebshygiene 

Muthgasse 18, Z6 


Tel.: +43-1-47654-1250 

Fax: +43-1-47654-1251 

Contact: Helga Weisse 

Staff: 8 



B M R 

B M R 

B M R 

B M R 


office@labtechnologies.at 

www.labtechnologies.at 

office@labdia.at 

www.labdia.at 

office@labor9000.at 

www.labor9000.at 

labor@labh.at 

www.labh.at 

L 

101

102 

LLaborchemie Gerätevertriebs GmbH 

Kanitzgasse 21 


Tel.: +43-1-888-2601 

Fax: +43-1-889-2355 

LARS Vertrieb von Implantaten GmbH 

Mooslackengasse 17 


Tel.: +43-1-8795-225 

Fax: +43-1-8795-225-50 

Laser-Gruppe-Materialbearbeitungs GesmbH 

Missindorfstrasse 21 


Tel.: +43-1-98-55571 

Fax: +43-1-98-25846 

Staff: 5 


legis. 

Brucknerstrasse 6 


Tel.: +43-1-51365-88 

Fax: +43-1-51365-8833 

Contact: Dr. Manuela M. Pacher (Managing Director) 

B M R 

B M R 

B M R 

B M R 


office@laborchemie.com 

www.laborchemie.com 

office@larsband.at 

www.larsband.at 

prihoda@lasergruppe.at 

www.lasergruppe.at 

manuela.pacher@legis.at 

www.legis.at 



Leica Mikrosysteme GmbH 

Hernalser Hauptstrasse 219 


Tel.: +43-1-48899-0 

Fax: +43-1-48899-350 

Contact: Ing. Stefan David 

Founded: 1985 

Leonhard Lang GmbH 

Feuchterslebengasse 73 


Tel.: +43-1-8179-007 

Fax: +43-1-8179-260 


Lexogen GmbH 



Tel.: +43-1-34512-12 

Fax: +43-1-34512-1299 

Contact: Alexander Seitz (CEO) 

Founded: 2007 

Staff: 21 



LIFE RESEARCH Technologies GmbH 

Parkring 10 


Tel.: +43-699-1724-9430 

Fax: +43-516-33-3000 

Founded: 2008 



B M R 

B M R 

B M R 

B M R 


L 

www.leica-microsystems.com 

www.leonhardlang.com 

info@lexogen.com 

www.lexogen.com 

office@liferesearcht.com 

www.liferesearcht.com 

103

104 

LLife Science Austria – LISA 


Ungargasse 37 


Tel.: +43-1-50175-510 

Fax: +43-1-50175-908 

Contact: Sonja Polan 

Founded: 2002 

Staff: 5 

Sector of activities: services lisa@awsg.at 

www.lifescienceaustria.at 

LISAvienna – Life Science Austria Vienna 

Ungargasse 37 


Tel.: +43-1-50175-358 

Fax: +43-1-50175-492 

Founded: 2002 

Staff: 4 

Sector of activities: services Vienna Life Science Report 

Sector Survey: Facts and Directory 2011/2012 

life-science Karriere Services 

Breitenseer Strasse 49 


Tel.: +43-1-2367289-7208 

Fax: +43-1-983 12 29 

Contact: DI Gisela Zechner (Managing Director) 

Founded: 2002 


Lifescience-Texte 

Obermüllnerstrasse 17/42 


Tel.: +43-676-940-2667 

Contact: Dr. Eva Müller 

Founded: 2001 


B M R 

B M R 

B M R 

B M R 

office@LISAvienna.at 

www.LISAvienna.at 

office@life-science.at 

www.life-science.at 

info@lifescience-texte.de 

www.lifescience-texte.de 



LifeTech Austria Zweigniederlassung 

Applied Biosystems Division 

Mahlerstrasse 13/5-7 


Tel.: +43-1-86735-75 

Fax: +43-1-86735-72 

Contact: Mag. Andrea Janesch 

Founded: 1966 



LIMBECK, Medizinische Spezialartikel 

Ganghofergasse 22 | 1110 Vienna 

Tel.: +43-1-7675521-0 

Fax: +43-1-7675521-11 

Contact: Richard Limbeck (Owner) 

Staff: 40 


medical technology, in-vitro diagnostic technology, non-active implantable 

technology, reusable instruments, single use technology 


Linder Helmut Ing. KG 

Czerningasse 18 


Tel.: +43-1-2140105-0 

Fax: +43-1-2162970-10 


Lohmann & Rauscher GmbH 

Johann-Schorsch-Gasse 4 


Tel.: +43-1-57670-0 

Fax: +43-1-57717-99 

Contact: DI Rudolf Leitner 

Founded: 1984 


B M R 

B M R 

B M R 

B M R 


L 

Austria.order@ 

eur.appliedbiosystems.com 

www.europe. 

appliedbiosystems.com 

office@limbeck.com 

www.limbeck.com 

office@linder-labortechnik.at 

www.linder-labortechnik.at 

info@at.LRMed.com 

www.lohmann-rauscher.at 

105

106 

MM+W Dental Handels GmbH 

Albert-Schweitzer-Gasse 6 


Tel.: +43-1-9794-8420 

Fax: +43-1-9794-84220 


Marinomed Biotechnologie GmbH 



Tel.: +43-1-25077-4460 

Fax: +43-1-25077-4493 

Contact: Johanna Uhlmann (BD & L) 

Founded: 2006 

Staff: 24 



Matzka Rehatechnik GmbH 

Gentzgasse 166 


Tel.: +43-1-47915-660 

Fax: +43-1-447002-03 

Contact: Walter Matzka 

Staff: 35 


MayLab Analytical Instruments GmbH 

Postgasse 11 


Tel.: +43-1-78642-5820 

Fax: +43-1-78642-5850 

Contact: Hans Mayrhofer 



B M R 

B M R 

B M R 

B M R 


Contact@mwdental.de 

www.mwdental.at 

office@marinomed.com 

www.marinomed.com 

office@matzka.at 

www.matzka.at 

office@maylab.net 

www.maylab.net 



MCS Laborinformationssysteme GmbH 

Parkring 10 


Tel.: +43-1-51633-3111 

Fax: +43-1-51633-3010 

Contact: Heidelinde Raab 

MCW Handelsgesellschaft mbH 

Breuninggasse 6 


Tel.: +43-1-6675-6650 

Contact: Klaus Propst (Managing Director) 


medCare Medizintechnik Vertriebs GesmbH 

Hietzinger Hauptstrasse 93 


Tel.: +43-1-60362-04 

Contact: Inga Much 


Med-Lab GesmbH 

B M R 

B M R 

B M R 

B M R 

Wolfgang-Pauli-Gasse 5 | 1140 Vienna 

Tel.: +43-1-817-9050 | Fax: +43-1-817-905015 

Contact: Ing. Herbert Lugbauer (Managing Director) 


Working fields: electromechanical medical technology, hospital hardware, IVD, 

non-active implantable technology, ophthalmic and optical technology, single 

use technology, diagnostic and therapeutic radiation technology, technical aids 

for disabled, software for medicine, telemedicine and eHealth 



www.mcs-ag.com 

office@mcw.at 

www.mcw.at 

M 

info@medcare-medizintechnik.at 

www.medcare-medizintechnik.at 

med-lab@med-lab.at 

http://med-lab.at 

107

108 

MMedartis GmbH 

Wienerbergstrasse 11/12 A 


Tel.: +43-1-99460-6499 

Contact: Thomas Alge 

Founded: 1997 


Medexter Healthcare GmbH 

Borschkegasse 7/5 


Tel.: +43-1-968-0324 

Fax: +43-1-968-0922 

Mediatum GmbH 

Hietzinger Hauptstrasse 55a 


Tel.: +43-1-87755-59 

Fax: +43-1-87755-5920 

Contact: Andreas Perklitsch (Managing Director) 


Medical Sales Consultants Austria GmbH 

Peter-Jordan-Strasse 81/2/3 


Tel.: +43-1-957-9715 

Fax: +43-1-957-8261 

Contact: Walter Walla (Consultant) 


Working fields: anesthetic and respiratory technology, hospital hardware, 



B M R 

B M R 

B M R 

B M R 


www.medartis.com 

office@medexter.com 

www.medexter.com 

www.mediatum.com 

info@medicalsci.com 

www.medicalsci.com 



Medifina Medizinprodukte Vertriebs-GmbH 

Puchsbaumplatz 5/3-4 


Tel.: +43-1-2368520 

Fax: +43-1-2368520-9 

Contact: Dr. Johann Krocza 

Founded: 2006 


medikus 

medizintechnische und pharmazeutische Vertriebs GmbH 

Diefenbachgasse 35/3/Top 5 


Tel.: +43-1-9441-326 

Fax: +43-1-25330-332570 

Contact: Christian Kraule (Managing Director) 




Medmobile Medizintechnik GmbH 

Alszeile 103 


Tel.: +43-1-228 88 75 

Contact: Gerold Porenta 


Medos Medizintechnik OG 

Löwengasse 3 


Tel.: +43-1-715-1474 

Contact: Sabine Grundner 


B M R 

B M R 

B M R 

B M R 


office@medifina.com 

www.medifina.com 

office@medikus.co.at 

www.medikus.co.at 

office@medmobile.at 

www.medmobile.at 

info@medosaustria.at 

www.medosaustria.at 

M 

109

110 

MMedTech-Support 

GmbH 

Hirschstettner Strasse 19b 


Tel.: +43-664-849-6420 

Contact: Ing. Aurelius Zdrazil 


Medtronic Österreich GmbH 

Handelskai 94-96 | 1200 Vienna 

Tel.: +43-1-24044-0 

Fax: +43-1-24044-100 

Contact: Wolfgang Deutschmann 



technology, non-active implantable technology, single use technology, software 

for medicine, telemedicine and eHealth 


A. Menarini GmbH 

Pottendorfer Strasse 25-27 


Tel.: +43-1-8041-576-0 

Fax: +43-1-8041-576-150 

Founded: 1988 

Staff: 33 


MERCK GesmbH 

Zimbagasse 5 


Tel.: +43-1-57600-0 

Fax: +43-1-57733-70 

Contact: Dr. Andreas Peilowich 

Founded: 1998 

B M R 

B M R 

B M R 

b M R 


office@medtechsupport.at 

www.medtechsupport.at 

vienna@medtronic.com 

www.medtronic.at 

office@menarini-diagnostics.at 

www.menarini-diagnostics.at 

merck-wien@merck.at 

www.merck.at 



Merck Sharp & Dohme Ges.m.b.H. 

EURO PLAZA Gebäude G, 5. Stock, Am Euro Platz 2 


Tel.: +43-1-12044-0 

Fax: +43-1-12044-444 

Contact: Mag. Paul Wachter 

Founded: 1971/2004 


Merz Pharma Austria GmbH 

Guglgasse 17 


Tel.: +43-1-869160-40 

Fax: +43-1-869160-4018 



Metrohm INULA GmbH 

Shuttleworthstrasse 25 


Tel.: +43-1-40562-350 

Fax: +43-1-40562-3599 

Michor Consulting e.U. 

Schönbrunner Strasse 238/2/7 


Tel.: +43-699-1952-1662 

Contact: Dr. DI Salma Michor 


B M R 

b M R 

B M R 

B M R 

www.msd.at 


M 

pharma@merz.co.at 

www.merz-pharma-austria.at 

office@inula.at 

www.inula.at 

smichor@michor-consulting.eu 

www.michor-consulting.eu 

111

112 

MMicros 

Produktions- und Handelsges.m.b.H. 

Breitenfurterstrasse 38 


Tel.: +43-1-8027-270 

Fax: +43-1-8027-271 

Contact: Herbert Luttenberger 

Founded: 1994 

Millipore GesmbH 



Tel.: +43-1-87789260 


MIRACOR Medical Systems GmbH 

Gumpendorfer Strasse 139/5 


Tel.: +43-1-236657-612 

Fax: +43-1-236657-622 

Contact: Jon Helge Hoem (CEO) 

Founded: 2008 

Staff: 11 

Working fields: electromechanical medical technology, single use technology 


MMS Medicor Medical Supplies GmbH 

Weyeringergasse 6 Top 2 


Tel.: +43-1-50466-710 

Contact: DI Heinz Gerhards 


B M R 

B M R 

B M R 

B M R 


office@micros.at 

www.micros.at 

www.millipore.com 

jhoem@miracormedical.com 

www.miracormedical.com 

zentrale@mms-medicor.at 

www.mms-medicor.at 



Mölnlycke Health Care GmbH 

Wagenseilgasse 14 


Tel.: +43-1-2788542 

Fax: +43-1-2788542-199 

Contact: Pierre Guyot 

Founded: 1998 



MoNo chem-pharm Produkte GmbH 

B M R 


www.molnlycke.at 

Leystrasse 129 


Tel.: +43-1-33006-71-0 

Fax: +43-1-3300671-38 

Contact: Dr. Dipl.-Ing. Bernhard Wittmann 

Founded: 2000 


Sector of activities: R&D, production, services, sales mail@mono.co.at 

www.mono.co.at 

MTG Medizinisch technische Geräte 

Erzeugungs- und Vertriebsgesellschaft mbH 

Römergasse 27 


Tel.: +43-1-59791-52 

Contact: Roswitha Platner 


Müller Medizinische Labormesstechnik 

Ges.m.b.H. 

Güpferlingstrasse 11 


Tel.: +43-1-48543-77 

Fax: +43-1-48543-7725 


B M R 

B M R 

B M R 

office@mtg-wien.at 

www.mtg-wien.at 

firma@muellerwien.at 

www.muellerwien.at 

M 

113

114 

MMycosafe 

Diagnostics GmbH 



Tel.: +43-1-25077-2150 

Fax: +43-1-25077-2190 

Contact: Prof. Dr. Renate Rosengarten 

Founded: 2003 

Staff: 20 



MySugr Apps OG 

Siebenbrunnengasse 44 


Tel.: +43-699-1360-9590 

Contact: Frank Westermann 

Founded: 2010 

Staff: 5 



NABRIVA Therapeutics AG 

Leberstrasse 20 


Tel.: +43-1-74093-0 

Fax: +43-1-74093-1900 

Contact: Petra Taylor 

Founded: 2006 

Staff: 42 



NBS-C BioScience & Consulting GmbH 



Tel.: +43-1-74895-00 

Fax: +43-1-74895-01 

Contact: Mag. Dr. Frank Kricek (CEO) 

Founded: 2008 

Staff: 3 



B M R 

B M R 

B M R 

B M R 


office@mycosafe.com 

www.mycosafe.com 

frank.westermann@mysugr.com 

http://mysugr.com 

office@nabriva.com 

www.nabriva.com 

office@nbs-c.at 

www.nbs-c.at 



Neurodata GmbH 

Schulzgasse 24 


Tel.: +43-1-667-9977 

Fax: +43-1-667-4499 

Contact: Herbert Schachinger (Sales Manager) 


New England Nuclear Corp. GmbH 

Novartis Institutes for BioMedical Research 

GmbH & Co. KG 



Tel.: +43-1-866-340 

Fax: +43-1-866-34285 

Contact: Prof. Dr. Anton Stütz 

Founded: 1970 




neurodata@chello.at 

www.neurodata.at 

Biotechnologie/Radiopharmaka 

Spandlgasse 58 


Tel.: +43-1-2857-785 

Fax: +43-1-2857-780 

Contact: Karl Steinitz 

Founded: 1972 


Sector of activities: sales nen.austria@chello.at 

Nova Biomedical 

Laxenburger Strasse 33/6 


Tel.: +43-1-60309-700 

Fax: +43-1-60309-702 

Contact: Manfred Ofner (Managing Director) 

Founded: 1997 


B M R 

B M R 

B M R 

b M R 

office@novabio.at 

www.novabio.com 

www.novartis.at 

N 

115

116 

NNovo 

Nordisk Pharma GmbH 

Opernring 3 


Tel.: +43-1-405-1501 

Fax: +43-1-408-3204 

Contact: Dr. Joachim Buttgereit 

Staff: 43 


NP Neumann & Partners GmbH 



Tel.: +43-1-205588-31 

Fax: +43-1-205588-22 

Contact: Elisaweta Bubits 


NUTRICIA GmbH 



Tel.: +43-1-68826-260 

Fax: +43-1-68826-26666 

Contact: Steffen Dreher 


Nycomed Pharma GmbH 

EURO PLAZA, Gebäude F, Technologiestrasse 5 


Tel.: +43-1-8150-202 

Fax: +43-1-8150202-900 

b M R 

B M R 

B M R 

B M R 


www.novonordisk.at 

contact@neumannpartners.com 

www.neumannpartners.com 

office@nutricia.at 

www.nutricia.at 

www.nycomed.at 



Octapharma Pharmazeutika 

Produktionsgesellschaft mbH 

Oberlaaer Strasse 235 


Tel.: +43-1-61032-1313 

Fax: +43-1-6103-2300 

Contact: Herr Wicsizec 

Founded: 1983 



Odelga Handelsgesellschaft mbH 

Anschützgasse 1 


Tel.: +431-1-89147 

Fax: +43-1-89147-213 

Contact: Herbert Kacher 


Österreichische 

Forschungsförderungsgesellschaft mbH (FFG) 


www.octapharma.com 

office@odelga.at 

www.odelga.at 

Sensengasse 1 


Tel.: +43-5-7755-0 

Fax: +43-5-7755-97900 

Contact: Dr. Birgit Mayer 

Founded: 2004 

Sector of activities: services birgit.mayer@ffg.at 

www.ffg.at 

Österreichische Gesellschaft für Molekulare 

Biowissenschaften und Biotechnologie - ÖGMBT 

Muthgasse 18 


Tel.: +43-1-47654-6394 

Fax: +43-1-36006-6392 

Contact: Andrea Veitschegger (Managing Director) 

Founded: 2008 

b M R 

B M R 

B M R 

B M R 

office@oegmbt.at 

www.oegmbt.at 

O 

117

118 

OOLERUP GmbH 

Löwengasse 47/6 


Tel.: +43-1-7101500-00 

Fax: +43-1-7101500-10 

Contact: Dr. Roswitha Keller 

Founded: 1998 


Olympus Austria GmbH 

Shuttleworthstrasse 25 | 1210 Vienna 

Tel.: +43-1-29101-0 

Fax: +43-1-29101-222 

Contact: Norbert Vrany (Quality Management) 


Working fields: electromechanical medical technology, non-active implantable 

technology, ophthalmic and optical technology, reusable instruments, single 

use technology 


OmniChrom Handels-GmbH 

Frömmlgasse 40-42/15 


Tel.: +43-1-278-5701 

Working fields: human health, agricultural biotechnology, industrial processing, 

lab equipment, consumables/reagents 


onepharm 



Tel.: +43-1-25077-5900 

Fax: +43-1-25077-5999 

Contact: Bernhard Küenburg (CEO) 





B M R 

B M R 

B M R 

B M R 


support-at@olerup.com 

www.olerup.com 

sonja.klement@olympus.at 

www.olympus.at 

www.omnichrom.com 

office@onepharm.com 

www.onepharm.com 



onepharm Beteiligungs GmbH 

Billrothstrasse 39/3/10 


Founded: 2005 

OPTOTEAM Präzisionsinstrumente 

Vertriebsgesellschaft m.b.H. 

Mosetiggasse 3 


Tel.: +43-1-48449-000 

Contact: Erwin Brenner 

Founded: 1990 

Staff: 6 



OrthoMed Ganganalyse 


office@optoteam.at 

www.optoteam.at 

O 

Kahlenberger Strasse 1E/9 


Tel.: +43-688-819-3513 

Contact: Sandrina Illes (MSc) 

Founded: 2010 

Staff: 1 

Working fields: electromechanical medical technology 

Sector of activities: services illes@orthomed-ganganalyse.at 

www.orthomed-ganganalyse.at 

ORTHOMED Medizintechnik GmbH 

Annagasse 5/1/Top 4 


Tel.: +43-1-53208-31 

Fax: +43-1-53208-3431 

Contact: Eva Stricker 

B M R 

B M R 

B M R 

B M R 

orthomed@orthomed.cc 

www.ormed.at 

119

120 

OOrthorobot Medizintechnik GmbH 

Waidhausenstrasse 11 


Tel.: +43-1-91136-38 

Fax: +43-1-91136-389 

Contact: Erich Silli (CEO) 

Founded: 1999 

Staff: 4 

Working fields: dental technology 


Otto Bock Healthcare Products GmbH 

Kaiserstrasse 39 


Tel.: +43-1-523-37860 

Fax: +43-1-523-2264 

Contact: Dr. Hans Dietl (Managing Director) 


Working fields: active implantable technology, technical aids for disabled, 



PAMO Medizintechnik GmbH 

Ameisgasse 57 


Tel.: +43-416-5550 

Fax: +43-416-5551 

Founded: 2010 


Paradigm Spine Austria GmbH 

Fischhof 3/6 


Tel.: +43-1-74040-5713 

Fax: +43-1-74040-5714 


B M R 

B M R 

B M R 

B M R 


office@orthorobot.com 

www.orthorobot.com 

info.austria@ottobock.com 

www.ottobock.at 

office@pamo-med.at 

www.pamo-med.at 

info@paradigmspine.at 

www.paradigmspine.com 



PBD Diagnostics 

Hofmühlgasse 13/2/6 


Tel.: +43-664-3567-099 

Fax: +43-1-597-0338 

Contact: Paul Botan 


PDC Biotech GmbH 

Kärntner Ring 10, 5th Floor, Top 12 


Tel.: +43-1-89000-77 

Contact: Diane Kalina (Managing Director, EVP) 

Founded: 2008 

Staff: 4 



PerkinElmer VertriebsgmbH 

Brunner Strasse 59, Bau 42 


Tel.: +43-1-60731-57 

Contact: Martin Greber 


Phadia Multiplexing Diagnostics GmbH 



Tel.: +43-1-2699-505 

Contact: Alexandra Sauer 

Founded: 1999 



B M R 

B M R 

B M R 

b M R 


P 

botan@pbd-diagnostics.com 

www.pbd-diagnostics.com 

www.pdcbiotech.com 

cc.austria@perkinelmer.com 

www.perkinelmer.com 

www.phadia.com 

121

122 

PPharm-Allergan GmbH 


Twin Tower 12 A 


Contact: Dr. Thomas Keller 

Founded: 2006 



Pharmig – Verband der pharmazeutischen 

Industrie Österreichs 

Garnisongasse 4/1/6 


Tel.: +43-40-602900 

Fax: +43-40-602909 

Contact: Dr. Jan Oliver Huber (General Secretary) 

Philips Austria GmbH 

Healthcare 

Triester Strasse 64 | 1100 Vienna 

Tel.: +43-1-60101-1392 | Fax: +43-1-60101-1319 

Contact: J. Robert Pfarrwaller, Robert Körbler 

Founded: 1926 

Working fields: hospital hardware, single use technology, diagnostic and 

therapeutic radiation technology, software for medicine, telemedicine and 

eHealth, others 


Photo Dynamic Therapy LLC 

B M R 

B M R 

B M R 

B M R 


Allergan_Austria@Allergan.com 

www.Allergan.at 

office@pharmig.at 

www.pharmig.at 

Annagasse 1 


Tel.: +43-1-369-7030 

Fax: +43-1-369-7031 

Contact: Günther Hofmann 

Founded: 1994 


Sector of activities: services, sales gh@pdt.at 

www.pdt.at 

pms.austria@philips.com 

www.philips.at/healthcare 



Photonic Optische Geräte GmbH & Co. KG 

Seeböckgasse 59 


Tel.: +43-1-4865-691-0 

Fax: +43-1-4865-691-33 

Founded: 1986 

Working fields: electromechanical medical technology, ophthalmic and optical 

technology, reusable instruments 

Sector of activities: R&D, production office@photonic.at 

www.photonic.at 

PKP Handelsges.m.b.H. 

Schopenhauerstrasse 51 


Tel.: +43-1-40578-46 

Fax: +43-1-40578-4640 

Contact: Ing. Norbert Jirak 


planer dentaprise GmbH 

Kranzgasse 22 


Tel.: +43-1-4068-134 

Fax: +43-1-4082-219 

Contact: Konrad Frey 

Pohlig & Tappe GmbH & Co KG 

Altmannsdorfer Strasse 89 


Tel.: +43-1-8040-800-11 

Contact: Kurt Pohlig 

B M R 

B M R 

B M R 

B M R 


office@p-k-p.at 

www.p-k-p.at 

P 

k.frey@planer-dentaprise.at 

www.planer-dentaprise.at 

info@pohligtappe.at 

www.pohligtappe.at 

123

124 

PPONTIS Capital GmbH 

Löwelstrasse 12 


Tel.: +43-5333-2330 

Fax: +43-5333-23330 

Contact: Mag. Gerhard Fiala 

PortConsult GmbH 

Obere Donaustrasse 65-2-8 


Tel.: +43-1-890-3951 

PP Capital AG 

Kürschnergasse 4 


Tel.: +43-1-25099-130 

Fax: +43-1-25099-135 

Contact: Dr. Florian Kreuzbauer 

Founded: 2007 

PR&D – Kommunikationsdienstleistung GmbH 

B M R 

B M R 

B M R 

B M R 


office@pontiscapital.at 

www.pontiscapital.at 

admin@portconsult.at 

www.portconsult.at 

florian.kreuzbauer@ppcapital.eu 

www.ppcapital.eu 

Mariannengasse 8 


Tel.: +43-1-505-7044 

Fax: +43-1-505-5083 

Contact: Dr. Till Jelitto 

Public Relations für 

Wissenschaft & Bildung 

Founded: 2001 

Staff: 3 

Sector of activities: services contact@prd.at 

www.prd.at 



Qiagen VertriebsGmbH 

Löwengasse 47/ Top 6 


Fax: +43-80028-1019 

Founded: 1998 

quantensprung consulting GmbH 

Wipplingerstrasse 12/10 


Tel.: +43-1-9232-3850 

Fax: +43-1-9232-38585 

Quintiles GmbH 

Stella-Klein-Löw-Weg 15, Rund 4, Haus B, OG4 


Tel.: +43-1-726-3010-0 

Fax: +43-1-726-3010-1100 

Contact: Jan Filakovszky (Managing Director) 

Founded: 1996 


Redl Life Science Patent Attorneys 



Tel.: +43-1-20501-47100 

Fax: +43-1-20501 

Contact: Dr. Gerda Redl 

Founded: 2008 

B M R 

B M R 

B M R 

B M R 


office-at@qiagen.com 

www.qiagen.com 

R 

consulting@quantensprung.at 

www.quantensprung.at 

janos.filakovszky@quintiles.com 

www.quintiles.com 

office@redlpatent.com 

www.redlpatent.com 

125

126 

RF. Reiner & Co. GesmbH 

Pelikangasse 6 


Tel.: +43-1-4055287 

Fax: +43-1-4081450 

Contact: Heinz Tinkel 


RELUX Lichtmedizintechnik GmbH 



Tel.: +43-1-31907-99 

Fax: +43-1-31907-9915 

Contact: Brigitte Rumpold 

Founded: 2006 

Staff: 6 

Working fields: electromechanical medical technology 


Remesco HandelsgesmbH 

Grinzinger Allee 5/25 


Tel.: +43-1-32850-88 

Fax: +43-1-32829-49 

Contact: Franz Reisinger (Managing Director) 

Founded: 1997 

Staff: 8 



REMONDIS Austria GmbH 

Vohburggasse 4 


Tel.: +43-1-3303-900 

Contact: Thomas Breitkopf 

B M R 

B M R 

B M R 

B M R 


f.reiner@reiner.co.at 

office@relux.at 

www.relux.at 

R EMESCO 

office@remesco.com 

www.remesco.com 

info@remondis.at 

www.remondis.at 



Richard Bittner AG 

Reisnerstrasse 55-57 


Tel.: +43-1-5030-972-0 

Fax: +43-1-5030-972-40 

Contact: Marc Coucke (CEO) 

Founded: 1977 

Richard Wolf Austria GmbH 

Wilhelminenstrasse 93a 


Tel.: +43-1-4055-151 

Fax: +43-1-4055-45445 

Founded: 1994 

Staff: 11 

Working fields: hospital hardware, reusable instruments, single use 

technology, software for medicine, telemedicine and eHealth 


Roche Diagnostics GmbH 


R 

office@richard-bittner.com 

www.richard-bittner.com 

austria@richard-wolf.com 

http://at.richard-wolf.com 

Engelhorngasse 3 


Tel.: +43-1-27787-0 

Fax: +43-1-27787-12 

Contact: Mag. (FH) Christine Stadler-Häbich 

Founded: 1999 


Sector of activities: sales diagnostics.austria@roche.com 

www.roche.at 

Rösch & Handel 

Scheringgasse 2 


Tel.: +43-1-60414-900 

Fax: +43-1-60414-906 

Contact: Mag. Klaus Stromberger 

Founded: 1890 


B M R 

B M R 

B M R 

B M R 

team@roesch-handel.at 

www.roesch-handel.at 

127

128 

RRoraco Ges.m.b.H. 

Markhofgasse 19 


Tel.: +43-1-310-5868 

Fax: +43-1-310-3955 

Contact: Werner Rabsch 

Founded: 1947 

Staff: 16 

Sector of activities: production, sales office@roraco.at 

www.roraco.at 

Rüsch Austria Gesellschaft mbH 


Lazarettgasse 24 


Tel.: +43-1-402-4772 

Fax: +43-1-402-477277 

Contact: Katrin Lhotka 

Working fields: anesthetic and respiratory technology, reusable instruments, 


Sector of activities: sales rueschaustria@teleflex.com 

www.teleflex.com 

RWM Medizintechnik GmbH 



Tel.: +43-1-66200-61 

Fax: +43-1-662 00 61 

Contact: Robert Woisetschläger 


S-TARget therapeutics 

B M R 

B M R 

B M R 

B M R 

office@rwm-medtechnik.at 

www.rwm-medtechnik.at 



Tel.: +43-664-51600-32 

Contact: Christof Langer (CEO) 

Founded: 2010 

Staff: 4 


Sector of activities: R&D christof.langer@s-target.com 

www.s-target.com 



S.MED Handels GmbH 

Zachgasse 1 


Tel.: +43-1-513-9152 

Fax: +43-1-513-8695 

Contact: Ing. Max Weese (Managing Director) 

Founded: 1997 

Staff: 5 



Sanochemia Pharmazeutika AG 

Boltzmanngasse 11 


Tel.: +43-1-3191-456-335 

Fax: +43-1-3191-456-344 

Contact: Margarita Hoch 

Founded: 1980 

Staff: 200 



Sanofi-aventis 

Leonard-Bernstein-Strasse 10 


Tel.: +43-1-80185-0 

Fax: +43-1-80185-8000 


Savira Pharmaceuticals GmbH 

Veterinärplatz 1, Building IA 


Tel.: +43-1-25077-5904 

Fax: +43-1-25077-5999 

Contact: Oliver Szolar (CEO) 

Founded: 2009 

Staff: 9 


B M R 

b M 


R 

B M R 

B M R 

smed@smed.at 

www.smed.at 

M.Hoch@sanochemia.at 

www.sanochemia.at 

www.sanofi-aventis.at 

office@savira.at 

www.savira.at 

S 

129

130 

SDr. A. & L. Schmidgall GmbH & Co KG 

Wolfganggasse 45-47 


Tel.: +43-1-81158-0 

Founded: 1962 

Staff: 49 



F. Schmidl & Co GmbH 

Mariahilfer Gürtel 16 


Tel.: +43-1-5968-5200 

Fax: +43-1-5968-521 

Contact: Alfred Mayr 

Staff: 22 

Schober Laborgeräte & Umweltanalytik KEG 

Billrothstrasse 6 


Tel.: +43-1-699-882 

Founded: 1981 

Dr. Schuhfried Medizintechnik GmbH 

Van-Swieten-Gasse 10 


Tel.: +43-1-4054-206 

Fax: +43-1-4054-464 

Contact: Gernot Schuhfried 

Founded: 1949 


B M R 

B M R 

B M R 

B M R 


office@schmidgall.at 

www.dr-schmidgall.at 

office@schmidl-co.at 

www.schmidl-co.at 

office@schober-lab.at 

www.schober-lab.at 

info@schuhfriedmed.at 

www.schuhfriedmed.at 



Schülke & Mayr Ges.m.b.H 

Sempermed 

Semperit Technische Produkte GmbH 

Modecenterstrasse 22 


Tel.: +43-1-79777-520 

Fax: +43-1-79777-630 

Contact: Clemens Bichler 





S 

Seidengasse 9, Top 21 | 1070 Vienna 

Tel.: +43-1-5232-501-0 

Fax: +43-1-5232-501-60 

Contact: Mag. Alexis Dujmic 

Founded: 1988 

Staff: 27 

Working fields: consumables/reagents, others 

Sector of activities: production, services, sales office.austria@schuelke.com 

www.schuelke.com 

science 2 public e.U. 

Stiftgasse 21/16 


Tel.: +43-1-89042-8312 

Fax: +43-1-89042-8310 

Semadeni (Europe) AG 

B M R 

B M R 

B M R 

office@science2public.at 

www.science2public.at 

Kürschnergasse 6 


Tel.: +43-1-25655-00 

Fax: +43-1-25655-004 

Contact: Roland Pernsteiner 

Founded: 1952 


Sector of activities: production, sales europe@semadeni.com 

www.semadeni.com 

B m R 

sempermed@semperit.at 

www.sempermed.com 

131

132 

Ssense product GmbH 

Landstrasser Hauptstrasse 34/3/8 


Tel.: +43-1-71869-60 

Fax: +43-1-71517-24 

Contact: Thomas Kogler 

SER Solutions Österreich GmbH 

Floridsdorfer Hauptstrasse 1 


Tel.: +43-1-50395-55 

Contact: Hartmut Gailer 

Founded: 1984 

Staff: 34 



Serobac Labordiagnostika 

Handelsgesellschaft mbH 

Untere Viaduktgasse 25 


Tel.: +43-1-71372-92 

Fax: +43-1-71237-99 

Contact: Mag. Barbara Schorr 


Siemens AG Österreich 

Siemensstrasse 92 


Contact: Mag. Brigitte Ederer 

Founded: 1939 


B M R 

B M R 

B M R 

B M R 


office@senseproduct.com 

www.senseproduct.com 

www.ser.at 

serobac@serobac.at 

www.serobac.at 

Contact.at@siemens.com 

www.siemens.com 



SIGMA-ALDRICH Handels GmbH 



Tel.: +43-1-6058-190 

Fax: +43-1-6058-120 

Contact: Thomas Prulamp 

Founded: 1993 



Sigmapharm Arzneimittel GmbH 


www2.sigma-aldrich.com 

Leystrasse 129 


Tel.: +43-1-3300671-0 

Fax: +43-1-3300671-38 

Contact: Kurt Schaffer 

Founded: 1973 


Sector of activities: sales office@sigmapharm.at 

www.sigmapharm.at 

Signalomics GmbH 



Tel.: +43-1-236-2185-204 

Fax: +43-1-236-2185-299 

Contact: Mag. (FH) Robert Kuntner (MBA (Director Finance)) 

Founded: 2006 

Staff: 12 



SIGNATIS Pharma GmbH 



Tel.: +43-1-87916-760 

Contact: Wolfgang Krickl 


B M R 

B M R 

B M R 

B M R 

S 

dkemedinger@signalomics.com 

www.signalomics.com 

office@signatispharma.com 

www.signatispharma.com 

133

134 

SSigvaris 

– medizinische Kompressionsstrümpfe 

Gesellschaft mbH 

Hietzinger Hauptstrasse 22/A/2/5 


Tel.: +43-1-8776-912 

Fax: +43-1-8776-915 

Contact: Alfred Korner 


Sinapharm GmbH 

Dresdner Strasse 62-64/2/12 


Tel.: +43-1-408610-600 

Fax: +43-1-408610-620 

Founded: 2005 

Staff: 6 


Softwaremanufaktur Grünberg & Redl OG 

Gierstergasse 6 


Tel.: +43-181-10616 

Fax: +43-181-10618 

Contact: Andreas Redl 


Working fields: human health, non-specific services, 

bioinformatics 


Solvay Österreich GmbH 

Stättermayergasse 28-30 


Tel.: +43-1-716880 

Fax: +43-1-710426 

Contact: Mag. Helmut Leeb 

Founded: 1883 

Staff: 55 

B M R 

B M R 

B M R 

B M R 


sigvaris.wien@sigvaris.com 

www.sigvaris.at 

office@sinapharm.com 

www.sinapharm.com 

ar@die-softwaremanufaktur.com 

www.die-softwaremanufaktur.com 

www.solvay.at 



Sonn & Partner Patentanwälte 

Riemergasse 14 


Tel.: +43-1-5128405 

Fax: +43-1-5129805 

Founded: 1851 


sonoArena Vertriebs GmbH 

Jochen-Rindt-Strasse 21 | 1230 Vienna 

Tel.: +43-1-89041-83 

Fax: +43-1-89041-8322 

Contact: Bernhard Kowanz (Managing Director) 


Working fields: electromechanical medical technology, single use technology, 

diagnostic and therapeutic radiation technology, technical aids for disabled, 



Sorbus GmbH 

Graumanngasse 7 


Contact: Dr. Frank Sams-Dodd 

Founded: 2010 

Staff: 3 

SPANTEC GmbH 

B M R 

B M R 

B M R 

B M R 


office@sonn.at 

www.sonn.at 

office@sonoarena.com 

www.sonoarena.com 

sorbus@sorbus.at 

http://sorbus.at 

Gumpendorfer Strasse 132/2/5 


Tel.: +43-1-58513-592 

Fax: +43-1-58513-591 

Contact: DI (FH) Armin Blaha (Managing Director) 

Founded: 2008 

Staff: 10 


Sector of activities: production www.spantec.at 

S 

135

136 

SSpine-Med Ges.m.b.H. 

Twarochgasse 11 


Tel.: +43-1-4799-281 

Fax: +43-1-4700-395 

Contact: Rudolf Bernegger 


Working fields: non-active implantable technology, reusable instruments, 

single use technology 


St. Jude Medical Medizintechnik GmbH 



Tel.: +43-1-607-3060 

Contact: Jürgen Bernhard 


STADA Arzneimittel GmbH 

Muthgasse 36 


Tel.: +43-1-36785-850 

Fax: +43-1-36785-8585 

Contact: Bernd Leiter 


Stryker GmbH 

Am Euro Platz 2 | 1120 Vienna 

Tel.: +43-1-813-2000 

Fax: +43-1-813-1616 

Contact: Eric R. Perucco 



nonactice implantable technology, reusable instruments, single use technology, 

components based on biological materials 


B M R 

B M R 

B M R 

B M R 


office@spinemed.at 

www.spinemed.at 

info-austria@sjm.com 

www.sjm.com 

office@stada.at 

www.stada.at 

Contact.austria@stryker.com 

www.stryker.at 



StudyMaker – Clinical Trial Management e.U. 

Wallrisstrasse 47/5 


Tel.: +43-650-26666-64 

Contact: Dr. Daniel Doberer (Managing Director) 


Sumetzberger (Ing. Sumetzberger GmbH) 



Tel.: +43-1-74035 

Fax: +43-1-74035-200 

Founded: 1994 

Sunmed Medizintechnische Produkte GmbH 



Tel.: +43-1-69922-99 

Fax: +43-1-69922-991 

Contact: Anton Mayrhauser (Managing Director) 


Working fields: electromechanical medical technology, single use technology, 

technical aids for disabled 


SYMFONY Consulting 

Hugo-Meisl-Weg 11 


Tel.: +43-680-3200-105 

Contact: Sabine M. Fischer 


B M R 

B M R 

B M R 

B M R 


office@studymaker.at 

www.studymaker.at 

info@sumetzberger.at 

www.sumetzberger.at 

office@sunmed.at 

www.sunmed.at 

www.symfony.at 

S 

137

138 

SSZABO-SCANDIC HandelsgmbH & Co. KG 


Quellenstrasse 110 


Tel.: +43-1-4893-9610 

Fax: +43-1-4893-9617 

Founded: 1963 

Staff: 20 


Sector of activities: sales mail@szabo-scandic.com 

www.szabo-scandic.com 

Technoclone GmbH 

Brunner Strasse 67 


Tel.: +43-1-86373-0 

Fax: +43-1-86373-44 

Founded: 1987 

Staff: 42 


Sector of activities: R&D, production, services sales@technoclone.at 

www.technoclone.at 

TeleCare Systems & Communication GmbH 

Linke Wienzeile 234 


Tel.: +43-1-89988-0 

Contact: Günter Melbinger 

Telozo GmbH 

Office Park I Top 4 

1300 Vienna-Airport 

Tel.: +43-1-7007-32551 

Fax: +43-1-7007-32559 

Contact: Prof. Joachim Schlund (R&D) 





B M R 

B M R 

B m R 

B M R 

info@telecaresystems.at 

www.telecaresystems.at 

office@telozo.com 

www.telozo.com 



The Siesta Group GmbH 

Schlosshofer Strasse 11 


Tel.: +43-1-95512-13 

Fax: +43-1-95512-1350 

Contact: Dr. Georg Dorffner (CEO) 

Founded: 2001 


Themis Bioscience GmbH 



Tel.: +43-1-236-7151 

Fax: +43-1-236-7151-74 

Contact: Dr. Erich Tauber (CEO) 

Founded: 2009 

Staff: 5 



Thermo Fisher Scientific 

wissenschaftliche Geräte GmbH 


info@thesiestagroup.com 

www.thesiestagroup.com 

office@themisbio.com 

www.themisbio.com 

T 

Wehlistrasse 27b 


Tel.: +43-1-33350-34 

Fax: +43-1-33350-3426 

Contact: Horst Maglia 

Founded: 1976 

Sector of activities: sales analyze.at@thermofisher.com 

www.thermo.com 

Tiani Spirit GmbH 

Guglgasse 6 

Gasometer A 


Tel.: +43-1-23511-8511 

Contact: Martin Tiani (Managing Director) 

B M R 

B M R 

B M R 

B M R 

office@tiani-spirit.com 

www.tiani-spirit.com 

139

140 

TTissueGnostics GmbH 

Taborstrasse 10/2/8 


Tel.: +43-1-21611-90 

Fax: +43-1-21611-9090 

Contact: Katja Österreicher (Executive Vice President) 

Founded: 2003 

Staff: 35 



Torrex Chiesi Pharma GmbH 


office@tissuegnostics.com 

www.tissuegnostics.com 

Gonzagagasse 16/16 


Tel.: +43-1-4073-919-0 

Fax: +43-1-4073-919-99999 

Contact: Dr. Wolfgang Harrer 

Founded: 1995 


Sector of activities: R&D, production, services office@torrex-chiesi.com 

www.torrex-chiesi.com 

Tube Pharmaceuticals GmbH 



Tel.: +43-1-740935-100 

Contact: Dr. Wolfgang Richter 

Founded: 2011 



TÜV Austria Services 

Department Medical Devices 

B M R 

b M R 

B M R 

B M R 

www.tubepharma.at 

Deutschstrasse 10 


Tel.: +43-1-610 91-6502 

Fax: +43-1-610 91-6505 

Founded: 1872 

Working fields: others 

Sector of activities: services mt-zert@tuv.at 

www.tuv.at/medizin 



TWO PI Signal Processing Applications GmbH 

Schönbrunner Strasse 131/5 


Tel.: +43-1-523-8180 

Fax: +43-1-524-5414 

Contact: Dr. Ernestine Bennersdorfer (Business Development/Sales) 

Founded: 2003 

Staff: 8 



Uniplan Medizintechnik GmbH 

Arnikaweg 18 


Tel.: +43-1-7343602-0 

Contact: Alexander Koubele 

Unitek Maschinenbau und -handels GmbH 

Blindengasse 3a 


Tel.: +43-1-32255-100 

Fax: +43-1-33255-15 

Contact: DI Bernd Klein 


VAMED Standortentwicklung und 

Engineering GmbH & Co.KG 

Sterngasse 5 


Tel.: +43-1-60127-370 

Fax: +43-1-60127-394 

Contact: Ing. Gerhard Arthold 

Working fields: human health, lab equipment 

B M R 

B M R 

B M R 

B M R 


ebenners@two-pi.com 

www.two-pi.com 

office@uniplan-mt.com 

www.uniplan-mt.com 

office@unitek.at 

www.unitek.at 

verkauf@vamed.com 

www.vamed.com 

V 

141

142 

VVASEMA GmbH 

Brunner Strasse 67, Objekt 4, 1. Stock 


Tel.: +43-676-43079-13 

Contact: Dipl. Ing. Peter Hagl (CEO) 

Founded: 2010 

Staff: 3 

Working fields: electromechanical medical technology, single use technology 


VBC-Biotech Service GmbH 

Brehmstrasse 14 A 


Tel.: +43-1-79665-7260 

Fax: +43-1-79665-7221 

Contact: Barbara Moesl 

Founded: 2000 

Staff: 7 



Vela pharm. Entwicklung u. 

Laboranalytik GmbH 

Brunner Strasse 69/3 | 1230 Vienna 

Tel.: +43-1-89059-7911 

Fax: +43-1-89059-7910 

Contact: Andreas Nechansky (COO), Armin Franz (CFO), 

Dr. Markus Fido (CEO) 




Verein Österreichischer 

Lebensmittel- und Biotechnologen 

c/o Universität für Bodenkultur 

Muthgasse 18 


Contact: Prof. Dr. Dipl.-Ing. W. Kneifel (President) 

Founded: 1968 

B M R 

B M R 

B M R 

B M R 


peter.hagl@vasema.com 

www.vasema.com 

oligo@vbc-biotech.com 

www.vbc-biotech.com 

office@vela-labs.at 

www.vela-labs.at 

voelb@boku.ac.at 

www.boku.ac.at/voelb 



VetWIDI Forschungsholding GmbH 



Tel.: +43-1-25077-1047 

Fax: +43-1-25077-1090 

Contact: Mag. Christine Ruckenbauer 

Founded: 2004 

Staff: 2 


Sector of activities: services www.vetwidi.at 

Vidavis GmbH 

Rooseveltplatz 4-5 


Tel.: +43-664-130-1774 

Fax: +43-1-3679-165-33 

Contact: Dr. Johann Graus (Managing Director) 


Vienna Open Lab 


www.vidavis.com 

Dr. Bohr-Gasse 3 


Tel.: +43-1-79044-4591 

Fax: +43-1-79044-110 

Contact: DI Maria Halaschek-Wiener 

Founded: 2006 

Staff: 4 

Sector of activities: services office@viennaopenlab.at 

www.viennaopenlab.at 

ViennaLab Diagnostics GmbH 

Gaudenzdorfer Gürtel 43-45 


Tel.: +43-1-8120-156-0 

Fax: +43-1-8120-156-19 

Contact: Dr. Christian Oberkanins 

Founded: 1990 

Staff: 20 



B M R 

B M R 

B M R 

B M R 

info@viennalab.com 

www.viennalab.com 

V 

143

144 

VViruSure GmbH 

TechGate Vienna 

Wissenschafts- und Technologiepark 

Donau-City-Strasse 1-8 | 1220 Vienna 

Tel.: +43-1-2699-120 

Fax: +43-1-2699-12022 

Contact: Dr. Andrew Bailey (CEO) 




VISTA MEDICAL Medizintechnik GmbH 

Linzer Strasse 76 


Tel.: +43-1-786-2222 


VIVISOL Heimbehandlungsgeräte GmbH 

Richard-Strauss-Strasse 10 


Tel.: +43-1-524-6283 

Fax: +43-1-524-1642 

Contact: Mag. Andreas Budz 

Founded: 1993 

Vogelbusch Biocommodities GmbH 

Blechturmgasse 11 


Tel.: +43-1-54661-0 

Fax: +43-1-54529-79 

Contact: Katharina Harlander (Marketing) 

Founded: 2009 

Staff: 38 



B M R 

B M R 

B M R 

B M R 


andy_bailey@virusure.com 

www.virusure.com 

www.vistamedical.at 

office@vivisol.at 

www.vivisol.at 

vienna@vogelbusch.com 

www.vogelbusch- 

biocommodities.com 



VOMI – Vienna Open Medical Institute 

Palais Todesco 

Kärntner Strasse 51/ II/ Top 4 


Tel.: +43-1-53386-58 

Fax: +43-1-53386-5810 

VWR International GmbH 

Graumanngasse 7 16/18 


Tel.: +43-1-97002-0 

Fax: +43-1-97002-600 

Contact: Mag. Robert Schöls 

Founded: 2002 

Staff: 77 



Wagner & Munz GmbH Austria 

Mariahilferstrasse 123/3 


Tel.: +43-1-5999-9480 

Fax: +43-1-5999-9489 

WAT Medizintechnik HandelsgmbH 

B M R 

B M R 

B M R 

B M R 


apply@vienna-omi.at 

www.vienna-omi.at 

info@at.vwr.com 

http://at.vwr.com 

W 

office@wagnermunz.com 

www.wagnermunz.com 

Schimmelgasse 18 


Tel.: +43-1-713-6001 

Fax: +43-1-713-600120 

Founded: 1995 

Staff: 4 

Working fields: electromechanical medical technology, reusable instruments, 

single use technology, technical aids for disabled 

Sector of activities: sales wat-medtech@aon.at 

145

146 

WWaters Ges.m.b.H. 



Tel.: +43-1-877-1807 

Fax: +43-1-877-1808 



WEBA Sport- und Med. Artikel GmbH 

Lieseneckgasse 6/2 


Tel.: +43-1-2723550 

Fax: +43-1-2723550-4 


Werfen Austria GmbH 

Tillmanngasse 5 


Tel.: +43-1-25046-0 

Fax: +43-1-25046-100 


Wiener Wissenschafts-, Forschungs- 

und Technologiefonds 

Schlickgasse 3/12 


Tel.: +43-1-40231-4310 

Fax: +43-1-40231-4320 


B M R 

B M R 

B M R 

B M R 


vienna@waters.com 

www.waters.at 

office@webasport.at 

www.webasport.com 

comesa@werfen-austria.at 

www.werfen-austria.at 

www.wwtf.at 



Wilheim Müller Rechtsanwälte 

Rockhgasse 6 


Tel.: +43-1-535-8008 

Fax: +43-1-535-800850 


Wirtschaftsagentur Wien 



Tel.: +43-1-40000-8670 

Fax: +43-1-4000-86584 


Xenogenetic Biotechnologie GmbH 



Tel.: +43-1-74040-414 

Fax: +43-1-74040-415 

Contact: Mag. Tanja Walzer (Project Manager), 

Prof. Dr. Gottfried Brem (Managing Director) 

Founded: 1997 

Staff: 3 


Ze.Wa. medicalsystems GmbH 

Altmannsdorfer Strasse 104 | 1120 Vienna 

Tel.: +43-1-58678- 00 

Contact: Dr. Hubert Dreßler, Maria Simic (Office Manager), 

Peter Buchner (MBA) 



medical technology, in-vitro diagnostic technology, reusable instruments, 

single use technology, technical aids for disabled 


B M R 

B M R 

B M R 

B M R 


office@wmlaw..at 

www.wmlaw.at 

info@wirtschaftsagentur.at 

www.wirtschaftsagentur.at 

service@xenogenetik.at 

www.xenogenetik.at 

office@medicalsystems.at 

www.medicalsystems.at 

Z 

147

148 

ZZimmer Austria GmbH 

Großmarktstrasse 7a 


Tel.: +43-1-61520-600 

Fax: +43-1-61520-62 

Contact: Werner Klika (Managing Director) 

Founded: 1975 

Staff: 31 

Working fields: non-active implantable technology, reusable instruments 


ZIT – Die Technologieagentur 

der Stadt Wien GmbH 



Tel.: +43-1-4000-86165 

Fax: +43-1-4000-86587 

Contact: Peter Halwachs 


Zoll Medical Österreich GmbH 



Founded: 2004 

Staff: 3 




Zühlke Engineering (Austria) GmbH 

B M R 

B M R 

B M R 

B M R 


info.austria@zimmer.com 

www.zimmeraustria.at 

office@zit.co.at 

www.zit.co.at 

aruehringer@zollmedical.de 

www.zollmedical.at 

Landstrasser Hauptstrasse 71/2 


Tel.: +43-1-71728-420 

Fax: +43-1-71728-110 

Founded: 2009 



Sector of activities: R&D, services info@zuehlke.com 

www.zuehlke.com 



ZYMED GmbH 

Rennbahnweg 80 


Tel.: +43-1-203-2566 

Fax: +43-1-203-369520 

Contact: Mag. Richard Weidinger (Managing Director) 

Founded: 1979 


Zytoprotec GmbH 

Stadiongasse 2/13 


Tel.: +43-1-406-2002 

Fax: +43-1-406-2002-20 

Contact: Prof. Dr. Christoph Aufricht (CSO) 

Founded: 2007 

Staff: 12 



B M R 

B M R 


office@zymed.at 

www.zymed.at 

office@zytoprotec.com 

www.zytoprotec.com 

Z 

149

DeFinitions 

Glossary 

Biotechnology is … 

… defined as the application of science 

and technology to living organisms, as 

well as parts, products and models 

thereof, to alter living or non-living materials 

for the production of knowledge, 

goods and services. the concept applied 

to this survey was developed by 

the oeCD in 2004 (see P. 153). 

A dedicated biotech company is … 

… defined as a biotechnology active 

firm whose predominant activity involves 

the application of biotechnological techniques 

to produce goods or services 

and/or the performance of biotechnological 

r&D. 

A biotech-active company is … 

… defined as a firm that applies biotechnological 

techniques for the purpose of 

implementing new or significantly improved 

products or processes (per the 

oslo manual (oeCD, 1997) for the measurement 

of innovation). it excludes end 

users which innovate simply by using biotechnological 

products as intermediate 

inputs (for instance, detergent manufacturers 

which change their formulation to 

include enzymes produced by other firms 

via biotechnology techniques). 

A medical device is … 

… defined as any instrument, apparatus, 

appliance, software, material or other article, 

whether used alone or in combination, 

including the software intended by 

its manufacturer to be used specifically 

for diagnostic and/or therapeutic purposes 

such as: diagnosis, prevention, 

monitoring, treatment or alleviation of a 

disease, injury, handicap or the investigation, 

replacement or modification of 

the anatomy or of a physiological process. 

A dedicated medtech company is … 

… defined as a company whose key 

aims are the manufacture of medical devices 

or the provision of services from 

the field of medical technology. 

A medtech-active company is … 

… defined as a company with a main 

corporate aim that is not exclusively the 

manufacture of products or the provision 

of services within medical technology. 

A life science related company is … 

... defined as a company providing 

technical products and/or biotechnology/medical 

device-specific services 

for dedicated and active companies. 

examples are commercial research institutions, 

sales offices, suppliers, consultants, 

information providers and publishers, 

fairs, recruiters and other. 

151

metHoDoLoGy 

methodology of this report 

Biotechnology: In December 2004, the 

OECD standardized the broad range 

of existing definitions of the term 

biotechnology. Since then, all OECD 

countries have been called upon to 

carry out surveys on biotechnology, 

following the so-called Framework for 

Biotechnology Statistics (www.oecd. 

org). The OECD recognizes two different 

categories of companies within 

the biotech industry: dedicated biotechnology 

company and other biotechnologically 

active companies. The 

first of these definitions, according to 

the OECD, applies to biotechnologically 

active enterprises, whose core 

company goals are the application of 

biotechnological procedures in the 

manufacturing of products, the supply 

of services or in the execution of 

biotechnological research and development. 

Unlike the dedicated biotech companies, 

the central aims of other biotechnologically 

active companies do 

not exclusively lie in the application 

of biotechnological procedures. The 

OECD thereby also includes in this 

category companies where biotechnology 

makes up only one part of 

the business activity. Companies are 

defined as biotechnologically active 

companies if they use biotechnological 

procedures for recently developed or 

significantly improved products or production 

processes. The central company 

aims must not be solely in the 

use of biotechnological procedures for 

the production of products, the supply 

of services or in the execution of 

biotechnological research and development. 

Examples of such companies 

are pharma firms, chemical companies 

or seed manufacturers. 

Medtech: There are two challenges 

when attempting to isolate medical 

technology conceptually. On one hand, 

the field is extremely diverse in terms 

of content and the range of products 

covers everything from latex gloves to 

CAT scanners. On the other hand, due 

to the high innovation rate, new and 

above all innovative products are continually 

being added. 

At licensing level, the term ‘medical 

device’ applies as specified in EU directive 

93/42/EEC. The directive differentiates 

between medical devices, accessories, 

in-vitro diagnostic medical 

devices and custom-made devices. 

The medical device nomenclature 

“GMDN” (global medical device nomenclature 

for the purpose of regulatory 

data exchange) was additionally 

introduced in November 2001 to better 

illustrate the different facets of medical 

technology in international comparison. 

The GMDN consolidates the wide 

variety of medical technolo gy products 

into generic categories. It replaced the 

previously applicable universal medical 

device nomenclature system (UM- 

DNS) which was no longer up-to-date. 

GMDN is adjusted on an ongoing basis 

and currently contains 14 main categories 

with almost 9,000 terms and over 

10,000 synonyms for medical devices. 

The nomenclature was adjusted for the 

survey. One category (supplementary 

equipment) was deleted an two new 

ones were added: “software, eHealth” 

and “others”. These categories form 

the basis for the survey described in 

this brochure. 

It has been supplemented by the definition 

of dedicated companies which 

was coined by the Organisation for 

Economic Cooperation and Development 

(OECD) and was developed for 

biotechnology in 2004. With this in 

mind, when applied to medical technology, 

a company is described as a 

“dedicated company” if its key aims 

are the manufacture of products or 

the provision of services from the field 

of medical technology. A company is 

deemed to be a “company active in 

medical technology” if its main corporate 

aim is not exclusively the manufacture 

of products or the provision of 

services within medical technology. 

Survey: BIOCOM AG created a questionnaire 

based on these definitions for 

the purposes of this survey. Between 

March and June 2011 BIOCOM contacted 

a total of 402 Austrian medtech 

companies and 214 biotech firms asking 

them to fill in the questionnaire. 

The corporate database of BIOCOM 

AG was used in the selection of those 

written to and in addition the GMDN 

classification was used to identify 

other potential companies. In Vienna 

20 medtech companies and 37 biotech 

firms responded, either in writing 

or by way of additional supplementary 

telephone interviews. This equates to a 

response rate of 52% in medtech and 

61% in biotech. 

In line with OECD guidelines, care was 

taken when selecting the companies to 

ensure that all the companies recorded 

are involved in medical technology 

in Austria and are based in the country. 

For this reason, we also considered 

companies that are majority-owned 

by a non-Austrian parent company but 

which have R&D activities in Austria. 

The survey was only conducted for 

the Austrian sites of a company when 

recording jobs, business figures and 

business segments. A company with 

more than one site in Austria is only 

taken into consideration once with 

correspondingly accumulated values. 

The cut-off date for the survey was 

31.12.2010. 

153

Imprint 

This report is based on data obtained through the evaluation of a written survey among Austria's 

life science companies carried out by BIOCOM AG, Berlin in close cooperation with austria wirtschaftsservice 

and LISAvienna in spring 2011. For more information please refer to page 153. The 

editorial staff comprises Dr. Patrick Dieckhoff, Dr. Bernd Kaltwaßer (both BIOCOM) and DI (FH) 

Maria Hinnerth (LISAvienna). The data were collected by Simone Ding (BIOCOM). The layout was 

designed by Benjamin Röbig (BIOCOM) and CREVO. We thank all companies supporting this survey! 

The layout, graphics and other contents of this brochure of the Viennese life science cluster are 

protected by copyright law. 

Berlin, November 8, 2011 

Contact: 

LISAvienna, Ungargasse 37, A-1030 Vienna, www.LISAvienna.at 

BIOCOM AG, Lützowstrasse 33–36, D-10785 Berlin, www.biocom.de

V ienna Life Science Report Sector Survey: Facts and ... - LISAvienna

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?